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Abstract 
Fluorescent Labeling, Co-Tracking, and Quantification of RNA In Cellulo 
 
by 
 
Thomas Corey Custer 
 
Chair:  Nils G. Walter
 
RNA plays a fundamental, pervasive role in cellular physiology, through the maintenance 
and controlled readout of all genetic information, a functional landscape we are only 
beginning to understand.  In particular, the cellular mechanisms for the spatiotemporal 
control of the plethora of RNAs are still poorly understood.  Intracellular single-molecule 
fluorescence microscopy provides a powerful emerging tool for probing the pertinent 
biophysical and biochemical parameters that govern cellular RNA functions, including 
those of protein-encoding mRNAs.  Yet progress has been hampered by the scarcity of 
high-yield, efficient methods to fluorescently label RNA molecules without the need to 
drastically increase their molecular weight through artificial appendages that may result 
in altered behavior.  Herein, we employ a series of in vitro enzymatic techniques to 
efficiently, extensively and in high-yield, incorporate chemically modified nucleoside 
triphosphates into a transcribed messenger RNA body, between its body and tail (BBT), 
or randomly throughout the poly(A) tail (tail).  Of these, BBT and tail modified strategies 
proved the most promising methods to functionally label messenger RNA and single-
particle track their behaviors using our in-house single-molecule assay: intracellular 
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single-molecule high resolution localization and counting (iSHiRLoC).  From this research 
also was spawned a novel method to anchor an RNA to the actin cytoskeleton for the 
study of long-term interactions within a cellular context, termed: Gene-Actin Tethered 
Intracellular Co-tracking Assay (GATICA).  Here, biotinylated RNA is tethered to the actin 
surface, either through complexation with a streptavidin coupled to a biotinylated 
phalloidin molecule or actin protein.  Taken together, this body of work represents 
strategies for the labeling and visualizing, both freely diffusing and actin tethered, long-
RNAs and their interactome in real-time.   
1 
1 Select material from this chapter was taken from Pitchiaya S, Heinicke LA, Custer TC, Walter NG. 2014. Single molecule 
fluorescence approaches shed light on intracellular RNAs. Chem Rev 114: 3224-3265, on which I was co-first author and 
contributed on the Recent Applications to RNA in Cellulo section. 
 
Chapter I 
Under the Microscope: A Historical Overview of Single-Molecule Approaches and 
Analyses of Intracellular RNA1 
1.1  INTRODUCTION  
The eukaryotic cell is highly complex. Ever since Robert Hooke discovered “cells” in 1665 
when training his comparably primitive microscope on a sliver of cork, scientists have 
aimed to identify and characterize all functional components of the cell. Around the turn 
of the millennium, the Human Genome Project laid open our entire cellular catalogue, but 
shockingly discovered that less than 21,000 protein-coding genes – just ~5-times the 
number of a bacterium such as Escherichia coli – span only ~1.2% of the over 3 billion 
base pairs of the human genome (1-4). This lack of proteomic inventory initially perplexed 
the scientific community, but then spurred debates of possible underlying RNA 
contributions to cellular complexity (5, 6). The Encyclopedia Of DNA Elements 
(ENCODE) project, an international collaborative research effort, was initiated to provide 
a comprehensive picture of all functional elements within the human genome through 
unbiased, transcriptome-wide coverage by RNA deep-sequencing (RNA-seq) (7). 
Particularly striking are the discoveries that at least 75% of the genome is transcribed and 
that by far most of these transcripts do not code for proteins, but rather “non-coding” 
RNAs (ncRNAs), many of which are still uncharacterized in terms of their structure and 
function (7, 8).  Currently, more than 80,000 distinct ncRNAs have been identified in 
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human cells, which reveals an unexpected and exciting RNA landscape in our body (with 
excerpts highlighted in Figure 1.1) (9).  Many RNA elements have been found to originate 
from overlapping loci, suggesting that similar RNA sequences can be distinctly generated 
or processed to perform different biological functions (10, 11).  In an effort to understand 
the complex functional networks these RNAs are involved in, systems biology approaches 
are beginning to be implemented. Abetting such holistic approaches are single molecule 
methods that promise to provide quantitative mechanistic details for individual 
biomolecules within living cells.  
While RNA-seq has proven powerful for discovering novel cellular RNAs, the 
approach is limited by the ensemble averaging and loss of spatiotemporal information 
caused by the isolation of cellular RNA. It thus remains unclear whether, for example, 
functionally important ncRNAs are expressed in low quantities across all cells of a sample 
or selectively expressed only in a few cells, which feigns low expression by dilution within 
the averaged measurement. Single molecule approaches have emerged as an 
unparalleled means to resolve complex cellular processes that are otherwise masked by 
such ensemble averaging. The recent implementation of single molecule fluorescence 
tools to characterize of mRNA expression rates and levels, mRNA and microRNA 
localization, and ribonucleoprotein complex (RNP) association in living cells, together with 
the emergence of super-resolution imaging techniques such as PALM and STORM (12), 
endows single molecule techniques with the potential to broadly dissect the functions and 
mechanisms of ncRNAs.  
 
1.2  CELL BIOLOGY OF RNA  
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1.2.1 Life Cycle of mRNA 
1.2.1.1  Transcription and Splicing of Pre-mRNA 
The best-characterized RNAs of the cell are protein-coding messenger RNAs (mRNAs) 
and the ncRNAs involved in their processing. Over the last 50 years, biochemical, 
structural and biophysical studies have provided a wealth of information on mRNA 
biogenesis, function and localization. It is well known that mRNA does not function as a 
naked biomolecule, but rather as part of larger RNP complexes (13-15).  RNA-seq 
technologies coupled with RNA-protein crosslinking have been successful in mapping 
RNA target binding sites of RNA-binding proteins on a genomic scale (16-19).  These 
data have revealed extensive, sometimes unexpected RNP networks within the cell that 
are summarized in a recent review (20).  Not surprisingly, single molecule studies have 
been employed most extensively to study mRNA transcriptional kinetics, expression 
levels, processing and localization (see section 4), motivated by the stochasticity and cell-
to-cell variability associated with such processes (21).  Here, we survey the numerous 
mRNA-protein (mRNP) complexes formed during biogenesis and processing of 
precursor-mRNAs (pre-mRNAs) into mature transcripts (Figure 1.1) and what role each 
processing event plays in the ultimate fate of an mRNA. Within this section, we also 
provide descriptions of the housekeeping ncRNAs that are involved in each step of mRNA 
maturation.  
Pre-mRNAs are predominantly transcribed by RNA Polymerase (Pol) II and 
typically contain three distinguishable elements: protein-coding exons, flanking 
untranslated regions (5’- and 3’-UTRs), and (long) non-coding introns (22).  By the act of 
splicing, introns are excised from the pre-mRNA, ultimately resulting in a processed 
4 
 
mRNA with joined, contiguous exons (23, 24).  This process is catalyzed by the 
spliceosome, an RNP of large size, based on certain features on the pre-mRNA splice 
site: usually an intronic GU 5'-end splice site, an internal A-branch site, and AG 3'-end 
splice site. In humans and other complex metazoans, pre-mRNA is co-transcriptionally 
bound by several proteins that play a role in splicing, 5’-end capping and 3’-end 
polyadenylation. Ubiquitously expressed alternative splicing factors, such as 
heterogeneous nuclear ribonucleoproteins (hnRNPs) and serine-arginine rich-domain 
containing proteins (SR proteins), function to silence or activate splicing, respectively, and 
impact polyadenylation and mRNA export (25-30).  Sequence-dependent binding of these 
proteins, as well as other tissue- and developmental- stage specific alternative splicing 
factors, to the pre-mRNA affects its structure and, consequently, its interactions with 
additional RNA-binding proteins. The ensuing sequence of hierarchical binding events 
ultimately determines the splicing potential of any given pre-mRNA splice site (31, 32).  
Another mechanism of alternative splicing involves riboswitches, RNA structural motifs 
embedded in intergenic regions and 3’-UTRs that bind small metabolites, which in turn 
induce RNA conformational changes (33).  Unlike in bacteria, where transcription and 
translation are coupled and hence regulation of gene expression by ubiquitous 5’-UTR-
encoded riboswitches generally involves direct transcription termination or inhibition of 
translation initiation (34, 35), in eukaryotes riboswitches are typically embedded next to 
splice sites that they obscure through formation of secondary structure. Once the 
riboswitch (or, more precisely, its “aptamer” motif) binds the cognate metabolite, the 
ensuing conformational change makes the splice site accessible, leading to changes in 
splicing pattern. The end result is an alternatively spliced mRNA that may, for example, 
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contain internal stop codons that cause translation of aberrant peptides, premature 
translation termination, or destabilization of the transcript (33). 
While some splicing events are constitutive, high-throughput sequencing studies 
have revealed that nearly all multi-exon gene transcripts can be alternatively spliced, thus 
promoting transcriptomic and proteomic diversity in eukaryotic cells (36, 37).  One of the 
most profound examples of alternative splicing occurs in the DSCAM (Down Syndrome 
Cell Adhesion Molecule) gene in D. melanogaster that codes for 38,016 protein isoforms 
(38).  We note that this extreme example is most likely an exception, at least in mammals, 
as it has recently been shown that most mammalian genes code for one dominant 
transcript (39).  However, given the vast number of possible exon combinations and the 
challenge to maintain single-nucleotide splicing accuracy to avoid loss of the codon 
reading frame, it is not surprising that aberrant alternative splicing can result in the 
malfunction of proteins and ultimately disease (40, 41).  In fact, it has been suggested 
that 60% of all human disease causing genetic mutations act through altering the splicing 
code (42). 
The spliceosome itself is a dynamic macromolecular RNP machine, containing five 
small nuclear RNAs (snRNAs) termed U1, U2, U4, U5 and U6 that function in concert 
with cognate proteins to form snRNPs (43).  The snRNAs function as structural scaffolds 
and mediators of splice site selection (44).  Most snRNAs are transcribed by RNA Pol II, 
with the exception of U6, which is transcribed by RNA Pol III (45).  In total, over 200 
individual RNA and protein components are assembled and disassembled during 
spliceosomal mediated excision of an intron, ultimately linking together two exons via two 
6 
 
 
Figure 1.1. Survey of the RNA biology in a eukaryotic cell. Detailed descriptions of RNA and 
RNP complexes are provided in Section 1.2.  Reprinted with permission from ref (46).  Copyright 
2014 American Chemical Society. 
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transesterification reactions (23).  In human cell lines, approximately 80% of splicing 
occurs co-transcriptionally, while it has been proposed that post-transcriptional splicing  
occurs within interchromatin foci termed nuclear speckles (47).  Nuclear speckles consist 
of active, highly dynamic spliceosomal protein components, yet their direct role in post-
transcriptional splicing remains debated (48).  Once an intron is excised from the pre-
mRNA, a multi-protein exon-junction complex (EJC) is deposited ~20 nucleotides (nt) 
upstream of the adjoined exon-exon boundary, and in turn affects mRNA transport, 
translation and stability (49, 50).  
In contrast to RNP-mediated splicing, self-catalyzed RNA splicing occurs in Group 
I and Group II introns, largely based on structural rearrangements of the RNA (51-53).  In 
most cases, it has been shown that high salt (and Mg2+ in particular) promotes RNA 
catalysis of these introns in vitro, proving that they are RNA-based enzymes or 
“ribozymes”, yet some proteins are necessary in vivo. In addition to self-splicing introns, 
numerous other naturally occurring ribozymes have been characterized, including the 
hairpin, hammerhead, hepatitis delta virus (HDV), Varkud satellite (VS), and glmS 
ribozymes, in some cases using single molecule fluorescence tools in vitro (54-67).  
Interestingly, structural motif searches, in vitro selections, and biochemical validations of 
ribozyme catalytic activity have led to the discovery that the hammerhead and HDV 
ribozymes in particular exist as ncRNA elements within the genomes of diverse 
organisms, including humans (68-72).  The finding that RNA can catalyze enzymatic 
reactions supported the RNA World hypothesis, wherein RNA spawned life as we know 
it by both self-replicating and catalyzing the metabolic reactions necessary to sustain life 
independent of proteins (73-76). 
8 
 
 
1.2.1.2 Capping and Polyadenylation of Pre-mRNA  
In addition to intron removal, pre-mRNA is modified within the nucleus with a 5’-end 7-
methylguanosine cap (5’-cap) and a 3’-end poly(A) tail. The 5’-cap protects the mRNA 
from nucleolytic cleavage, serves as signal for the ribosome to start translation, and has 
been shown to have roles in mRNA splicing, nuclear export, stability, and translation (77).  
A 3’-end canonical hexanucleotide polyadenylation signal, AAUAAA, is found 10-30 
bases upstream of the polyadenylation site. The length and location of poly(A) tails can 
vary, both of which can affect mRNA stability, translational efficiency and transport from 
the nucleus to the cytoplasm (78).  The resulting mature mRNA typically contains a 5’-
cap, a 5’-UTR, protein coding exons, a 3’-UTR, and a poly(A) tail. UTRs, just like introns, 
are cis-acting regulatory ncRNA elements, whose primary sequence and secondary 
structure directly affect protein and RNA binding and ultimately play critical roles in the 
regulation of gene expression (22, 79).  Interestingly, the length of UTRs and the fraction 
of alternatively spliced genes scale with the developmental complexity in animals, 
indicative of the greater sophistication of mRNA regulation in higher organisms (22). 
 
1.2.1.3 Nuclear Export of mRNA 
Processed, mature mRNAs remain coated with RNA-binding proteins, including the 
EJC,TREX complex, Aly, Nxfl and SR proteins, that serve to package and compact the 
mRNA during transport across the nuclear envelope (from the nucleus into the cytoplasm) 
through the nuclear pore complex (NPC) (80-84) or through the recently discovered 
nuclear envelope budding (49).  Such transport processes, especially via the nuclear 
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pore, have been extensively investigated using microscopy techniques, to unravel 
structural and mechanistic details (49, 82, 85-89).  Classically, the NPC is considered the 
prevalent mode of RNP shuttling between the nucleus and cytoplasm. The nuclear pore 
is an almost cylindrical macromolecular complex comprised of nucleoporin protein 
building blocks (83).  Recently, it was found that RNPs can also be transported from the 
nucleus into the cytoplasm by nuclear envelope budding using mechanism similar to the 
release of herpes virus capsids (88).  Single molecule microscopy presents an exciting 
avenue to study these yet-to-be characterized RNP transport processes.  
 
1.2.1.4  Translation of mRNA 
Once in the cytoplasm, mRNAs contain numerous signals that are recognized by the 
cytoplasmic processing machinery that ultimately determines the individual fate of each 
mRNA. Some mRNAs will be destined to be translated by the ribosome, while others will 
be targeted for translational repression and decay by miRNAs or siRNAs (see section 
2.2). As transcription and mRNA maturation are not fully accurate, some transcripts will 
contain premature stop codons and are destroyed by the cell via nonsense-mediated 
mRNA decay (NMD). Each of these processes occurs in sub-compartments of the 
cytoplasm and has been the focus of numerous studies that are nicely summarized by, 
for example, Martin and Ephrussi (90). 
To be efficiently translated, mRNAs must contain a 5’-cap, appropriately positioned 
EJC, and a poly(A) tail greater than 50 nt with a poly(A) binding protein (PABP) (91, 92) 
bound. The translating ribosome in eukaryotes is comprised of each a small (40S) and a 
large (60S) subunit, together referred to as the 80S ribosome. The 40S subunit is 
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comprised of one ribosomal RNA (18S rRNA) and 33 proteins, while the 60S subunit is 
composed of three RNAs (5S rRNA, 5.8S rRNA and 28S rRNA) and 46 proteins. Most 
rRNAs are transcribed in the nucleolus by RNA Pol I, with the exception of 5S RNA, which 
is transcribed by RNA Pol III. rRNAs are chemically modified by small nucleolar 
RNA(snoRNA)-directed methylation and pseudouridylation (93).  The individual rRNA and 
ribosomal protein components assemble in a hierarchical manner and form pre-ribosomal 
components in the nucleus that are exported into the cytoplasm where assembly is 
completed (94).  
snoRNAs represent one of the best characterized classes of non-coding RNAs 
(95-97).  Localized to the nucleolus, snoRNAs are often transcribed from intronic regions 
of the genes they modify. The two major classes of snoRNAs are distinguished by the 
type of modification they mediate on rRNAs, snRNAs, and tRNAs: C/D box snoRNAs 
define the target sites for 2′-O-ribose methylation, whereas H/ACA box snoRNAs define 
the target sites for pseudouridylation. The RNA structure varies between these classes 
and likely mediates the binding between a snoRNA and its cognate modifying protein to 
produce a mature snoRNP (98).  Recent data have linked snoRNAs to cancer and as 
precursors to miRNAs, suggesting that these RNAs will need to be examined in new 
contexts (99, 100).  
Once eukaryotic initiation factors (eIFs) bind distinct segments of the 5`UTR, such 
as eIF4E the mRNA cap, translation is primed. The full 80S ribosome is then assembled 
and the ribosome begins to translocate along the mRNA to synthesize proteins via the 
sequence specific recognition of three nucleotide codons by aminoacyl-tRNAs. tRNAs 
are transcribed by RNA Pol III (similar to 5S rRNA) and are heavily site-specifically 
11 
 
modified guided by snoRNAs (101), tRNAs are evolutionarily ancient and characterized 
by a compact L-shaped tertiary structure, in aggregate carrying over 100 types of 
modifications, discovered by the first ever RNA crystallization experiment (102).  In many 
organisms, multiple copies of tRNA genes give rise to distinct levels of any given tRNA 
species, which may affect translation rates (103-105).  Maturing tRNAs are processed by 
endonucleolytic 5’-end cleavage by RNase P, an evolutionarily conserved RNP found in 
all three kingdoms of life and one of the first catalytic RNAs to be discovered (106, 107).  
Nascent polypeptides sequester another RNP highly conserved in all three 
kingdoms of life, termed signal recognition particle (SRP), which in eukaryotes contains 
one conserved RNA and at least six proteins, that direct the nascent peptide to the 
endoplasmic reticulum (ER) or plasma membrane (105, 108, 109).  The RNA component 
serves both as a scaffold and mediates global rearrangements of the SRP in response to 
binding its polypeptide cargo. The SRP directs the translocation of the growing 
polypeptide into the lumen of the ER, where the protein is then folded into its native form 
(110).  
 
1.2.1.5  Nonsense-Mediated Decay and mRNA Turnover 
Nonsense-mediated decay (NMD) is a mechanism by which the cell eliminates mRNAs 
that contain premature stop codons, many of which result from alternative or aberrant 
splicing. Numerous RNA-binding proteins, including UPF1, UPF2, and UPF3 (the latter 
two are components of the EJC) mediate NMD and are associated with the mRNA, at 
least transiently, within cytoplasmic processing bodies (P-bodies) (111),  cellular foci that 
are enriched in RNA processing and degrading enzymes (112).  One proofreading round 
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of translation is sufficient to target the mRNA for NMD. We direct the reader to some 
reviews for further mechanistic details of NMD (113-115).  
 Protein expression is highly correlated with the amount of its mRNA available. To 
be able to modulate the expression pattern of a cell over time, it is advantageous for aging 
mRNAs to be degraded (116).  Degradation occurs via two pathways, the first involving 
shortening of the poly(A) tail by a deadenylase followed by decapping of the 5’-cap by 
Dcp1p and Dcp2p, which exposes the RNA to digestion by 5’-to-3’-exonucleases. The 
second mechanism requires mRNA deadenylation, followed by digestion by the 
cytoplasmic exosome.  
 Certain disease-related proteins have been shown to affect mRNA localization and 
gene expression. For example, fragile X syndrome-associated fragile X mental 
retardation protein (FMRP) has been shown to bind mRNAs to direct their localization 
within the cell and ultimately affect protein expression of target mRNAs (117, 118).  In 
addition, it was shown that fragile-X-mental-retardation-related protein 1 (FXR1) and 
Argonaute 2 (AGO2) bind AU-rich elements (AREs) in a microRNA dependent manner 
within the 3’-UTR of mRNAs to activate translation during cellular quiescence, thereby 
providing mechanistic evidence of the importance of cis-activating regulatory elements in 
3’-UTRs (119).  In addition to FMRP, several other RNA binding proteins (RBPs), such 
as Staufen and zip-code binding proteins (ZBP), bind specific sequences within UTRs to 
localize a large fraction of transcripts to distinct sub-cellular domains (90).  In the following 
sections, we will discuss more broadly the mechanisms by which small and long ncRNAs 
control gene regulation.  
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1.2.2  SMALL NON-CODING RNA  
1.2.2.1  Types and Functions of Small ncRNAs 
RNA silencing is an evolutionarily conserved mechanism of gene silencing involving three 
main classes of small ncRNAs, including microRNAs (miRNAs), small interfering RNAs 
(siRNAs) and PIWI-interacting RNAs (piRNAs) (120).  The classical biogenesis and 
cytoplasmic mechanisms of miRNA- and siRNA-mediated gene silencing are similar, as 
both types of ncRNAs are processed from a relatively longer RNA duplex into an ~22-nt 
short single strand that engages an Argonaute-containing protein complex to bind and 
silence target mRNAs. However, miRNAs, siRNAs and piRNAs differ in origin, structure, 
and their detailed mechanism of silencing. miRNAs are endogenously expressed 
(genome-encoded), highly sequence-conserved, small ncRNAs that are only imperfectly 
complementary to typically the 3’-UTRs of mRNAs and mediate translational repression 
and mRNA decay. By contrast, siRNAs are found either endogenously or administered 
exogenously and bind to mRNAs by perfect sequence complementarity to mediate site-
specific mRNA cleavage (121).  Since target destruction is more immediate and absolute, 
siRNA mediated repression tends to be stronger than that achieved by miRNAs. Finally, 
piRNAs are ~26-30 nt in length, engage PIWI proteins, and function to silence 
transposons in the animal germline (122).  In addition to their canonical functions, the last 
several years have revealed important roles of these and similar small ncRNAs in 
epigenetic gene regulation (123) and the DNA damage response (124, 125). 
In 1993, Victor Ambros and colleagues described the first miRNA, lin-4, as a 
protein expression regulator during normal larval development of the nematode worm 
Caenorhabditis elegans, although the mechanism remained somewhat elusive (126).  In 
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1998, Andrew Fire and Craig Mello laid the foundation for RNA interference (RNAi), a tool 
that exploits the introduction of exogenous siRNAs into the cellular RNA silencing 
pathway to mediate mRNA cleavage, for which they shared the 2006 Nobel Prize in 
Physiology or Medicine (127).  Since these initial reports, small ncRNAs have been 
identified in plants, animals, and even bacteria (although these sRNAs are often 
processed from protein-coding transcripts) (128), and have been found to be a 
predominant mechanism for regulating gene expression in eukaryotes (129, 130).  On the 
one hand, it is now estimated that at least 60% of protein coding genes are regulated by 
at least one miRNA (131).  On the other hand, siRNAs are routinely exploited in functional 
genomics, and their therapeutic implications are slowly being realized, although off-target 
effects and cell-specific delivery remain challenging (132).  There are also numerous 
emerging classes of small and mid-sized ncRNAs that will not be discussed here for 
brevity, but are summarized in a recent review (133).  Given the relatively recent discovery 
of small ncRNAs and their expanding repertoire of types and functions, we will discuss, 
where appropriate, outstanding questions and the potential of single molecule microscopy 
to address them. We will specifically focus on the biogenesis, localization and function of 
siRNA and miRNAs because of their pervasive functions and the emergence of reports 
that use single molecule microscopy for functional and mechanistic probing (134-137).  
 
1.2.2.2 Biogenesis of Small ncRNAs  
miRNAs are the most ubiquitous small ncRNA in humans, with over 1,500 different 
mammalian miRNA sequences discovered to date that represent more than 1% of the 
entire genome and thus the largest gene family (138-140).  These RNAs are usually 
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transcribed by RNA Polymerase II as long primary miRNA (pri-miRNA) transcripts (141, 
142).  pri-miRNAs adopt hairpin structures with numerous bulges that are recognized and 
cleaved by the nuclear endonucleolytic microprocessor complex, mainly comprised of the 
RNase III enzyme Drosha and its cofactor DGCR8 (Pasha in invertebrates) (143).  The 
resulting pre-miRNA hairpin, ~65- to 70-nts in length and containing a 2-nt 3’-overhang, 
is then bound by Exporin-5 and RanGTP for export from the nucleus to the cytoplasm 
through the NPC.  
Once in the cytoplasm, pre-miRNAs as well as long double-stranded RNAs are 
recognized and cleaved by the RNase III enzyme Dicer and its cofactor TRBP into short, 
20-24 nt duplexes, with characteristic 2 nt 3’-overhangs bearing 3’-OH groups and 5’-
phosphates (140).  The mature miRNA duplex is loaded into the multiprotein RNA-
induced silencing complex (RISC) loading complex (RLC) that includes an Argonaute 
(AGO) protein (144).  Strand selection, thought to be dependent on the thermodynamic 
stability of the duplex and/or presence of RISC-associated protein components (145), 
occurs within the RLC, wherein one strand of the duplex (the passenger strand) is cleaved 
and/or dissociates from the complex. The mature RISC complex contains the miRNA 
guide strand bound by Argonaute and can now seek out its complementary RNA 
sequence. Of note, the cytoplasmic portion of the siRNA biogenesis pathway in mammals 
is very similar (120).  
In addition to this canonical miRNA biogenesis pathway, whose multi-step nature 
allows for tight regulation (146), miRNAs are also generated using the mirtron pathway 
(147, 148) wherein short hairpins derived from excised introns serve as Dicer substrates 
to generate miRNAs. Since mirtons are initially processed by the spliceosome, they 
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bypass regulation of the nuclear Drosha processing step and merge with the canonical 
cytoplasmic miRNA biogenesis pathway only upon nuclear export.  
 
1.2.2.3  Spatial and Functional Requirements of Small ncRNAs in the Cytoplasm 
In the cytoplasm, miRNA-loaded RISC (miRISC) binds mRNA targets to repress 
translation and then promote mRNA decay, possibly within P-bodies (136, 149-151), 
through specific sequence requirements. Nucleotides 2-7 located on the 5’-end of the 
miRNA guide strand comprise the seed sequence that is the primary determinant for 
stable binding to the 3’-UTR of miRNA targets (131).  Additional structural elements in the 
5’-UTR of targeted mRNAs have been recently shown to elicit synergistic effects with 
miRNA binding sites in the 3’-UTR to enhance RNA silencing (152).  Although several 
bioinformatic portals are available to predict putative miRNA targets (TargetScan©, 
PicTar©, and miRanda©, to name a few), few have been experimentally validated and 
their accuracy is still poor, largely owing to their reliance on relatively short seed 
sequences whose frequency of occurrence is high despite a requirement for phylogenic 
conservation (153, 154).  In light of recent reports that have underscored the importance 
of target site accessibility (155) and seed-independent miRNA binding (156), these target 
prediction algorithms warrant an overhaul. Furthermore, apart from specific seed matches 
miRNA-mediated decay requires the recruitment of additional protein components, in 
particular the Argonaute-associated proteins GW182, CCR4-NOT and RNA helicase 
eIF4A2 (152, 157).  One such protein is also thought to be responsible for the spatial 
organization of RISC assembly and miRNA mediated target repression. Li et al. described 
the altered meristem program1 (AMP1) protein dependent localization of miRNA-loaded 
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AGO1 to the ER, proposing the ER as the main sub-cellular site of repression in 
Arabidopsis (158).  Stalder et al. further reported evidence that the rough ER is the 
nucleation site for RNA silencing where both miRISC assembly and target repression 
occur (159), and hypothesized that ER localization is mediated by TRBP and PACT. 
Regardless of spatial and sequence constraints, it is still unclear whether reduced protein 
output is achieved by a miRNA efficiently repressing only a subset of molecules of a given 
type of mRNA or less efficiently repressing a large number of the same mRNA molecules. 
Moreover, the binding stoichiometries of miRNAs to mRNAs are yet to be fully 
determined. Such questions are only accessible via single molecule microscopy. 
A novel class of non-coding circular RNAs (circRNAs) was recently identified and 
characterized in mammals (160, 161).  These RNAs are processed by the spliceosome 
in an unusual head-to-tail fashion, resulting in circular transcripts that contain multiple 
miRNA binding sites and act as miRNA sponges or decoys to deplete the cell of specific 
miRNAs, essentially alleviating repression of the mRNAs they target (162).  Single 
molecule fluorescence in situ hybridization (FISH) studies have shown that circRNA-
miRNA complexes localize to P-bodies (161), although the reasons are unknown. Further 
functional characterizations of this abundant class of ncRNAs will be necessary to 
determine how universal this mechanism is for sequestering miRNAs inside cells.  
 
1.2.3  LONG NON-CODING RNA 
1.2.3.1  Discovery of Long ncRNAs  
Long non-coding RNAs (lncRNAs) or long intergenic non-coding RNAs (lincRNAs) are an 
abundant class of non-coding RNAs that have recently emerged from deep-sequencing 
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data as ubiquitous cellular transcripts of high structural and functional diversity (163-165).  
Unlike the “housekeeping” small ncRNAs that display clear evolutionary conservation in 
terms of sequence and structure, lncRNAs are more difficult to classify due to a lack of 
evolutionary conservation based on primary sequence so that they have remained 
somewhat of an enigma, despite often exhibiting functional conservation (32).  
 lncRNAs are greater than 200 nt in length with little or no protein-coding capacity. 
This diverse group of RNAs is expressed tissue-specifically and is classically defined by 
their function in epigenetics to condense chromatin and regulate DNA methylation and 
histone modification, thereby positively or negatively affecting the expression of nearby 
genes (166).  Genetic studies from the early 1990’s revealed the first lncRNA, Xist, as an 
~17,000 nt long RNA that coats and inactivates one X chromosome during dosage 
compensation in sex determination of mammals. Other lncRNAs, such as H19 and Air, 
are also involved in genetic imprinting by silencing adjacent alleles through DNA 
methylation and histone modifications (167-169).  Many novel lncRNAs have been 
identified by high-throughput sequencing of cell type-specific transcriptomes, and 
subsequent characterization has only begun to illuminate the functional nuclear and 
cytoplasmic niches of lncRNAs. The biogenesis, cognate protein partners, and functions 
of lncRNAs remain the most elusive of all ncRNAs so that we discuss only a subset of the 
best characterized lncRNAs. For further detail, we refer the reader to several recent 
reviews on specific lncRNAs, including promoter-associated RNAs (PARs) (164, 170-
172).  
 
1.2.3.2  Biogenesis of Long ncRNAs 
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lncRNAs are found throughout the genome, including intergenic regions (lincRNAs), in 
antisense, overlapping, intronic, and bidirectional regions relative to protein-coding 
genes, as well as in UTRs, promoters and enhancers (8, 173, 174).  The biogenesis of 
lncRNAs is quite similar to that of mRNAs, in that they are typically transcribed by RNA 
Polymerase II, spliced and further processed to contain a 5’-cap and polyA tail. In fact, 
some mRNAs have been shown to function as lncRNAs (175).  In addition, recent studies 
suggest that lncRNAs can be chemically modified, a feature classically associated with 
rRNAs and tRNAs (164).  It is possible that chemical modifications are present to stabilize 
lncRNA secondary and tertiary structures, or that they have evolved to preclude activation 
of the innate immune response. For example, it was recently shown that modified, but not 
unmodified, tRNAs avert activation of the innate immune response protein dsRNA-
activated protein kinase R (PKR) (176).  Yet another layer of lncRNA complexity pertains 
to the presence of adjacent snoRNAs (sno-lncRNAs) loci (177).  Thus, this novel class of 
ncRNAs harbors many surprises, leading to many functionally interesting questions that 
can be addressed using single molecule approaches. 
 
1.2.3.3 Epigenetic Gene Regulation and Other Functions of Long ncRNAs 
lncRNAs were first characterized for their nuclear functions related to epigenetic gene 
regulation by DNA methylation and chromatin remodeling. These functions require 
lncRNAs to associate with proteins such as polycomb complexes or histone modifying 
proteins (173, 178, 179).  The lncRNAs guide modifying proteins to specific DNA sites to 
repress gene expression though histone methylation of H3K9 and trimethylation of 
H3K27. Within the last five to ten years, however, numerous reports have expanded the 
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functional roles of lncRNAs to the cytoplasm where they have been shown to associate 
with importin- proteins to prevent nuclear import of a transcription factor (i.e., NRON 
lncRNA); bind an antisense mRNA to increase protein synthesis in response to stress 
(i.e., UCHL2 lncRNA); and bind the 3’UTRs of mRNAs to induce decay by dsRNA-
recognition protein Staufen1 (180-182).  Recent studies have also revealed that 
pseudogenes can act as ncRNAs to regulate gene expression of their protein-coding 
counterparts (183).  Further characterization of the elusive class of lncRNAs will be 
necessary to determine the full extent of their cellular functions. 
 
1.3 PRINCIPLES OF INTRACELLULAR SINGLE MOLECULE FLUORESCENCE 
MICROSCOPY OF RNA 
As surveyed above, our appreciation for the diversity of cellular RNAs has exponentially 
increased over the last decade. With the rapid advancement of deep-sequencing and 
bioinformatics technologies, we are likely to unearth still other classes of RNAs, a further 
increased functional diversity, as well as novel RNA-protein interactions. The current 
ensemble-averaged approaches clearly will continue to provide a wealth of information 
on RNA biology. However, biology is fundamentally stochastic in nature, leading to 
diverse, spatiotemporally inhomogeneous distributions of molecules within cells as well 
as across individual cells, even within a clonal cell line or (tumor) tissue. The resulting 
heterogeneities, short-lived and/or rare pathway and reaction intermediates, dispersed 
cellular localization and time evolution, multitude of parallel mechanisms of action and 
non-linear responses from complex, multi-hub networks together form the very foundation 
of biomolecular function. The omnipresence of such molecular dispersions warrants the 
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development of ultra-sensitive, non-invasive techniques that expose them, leading to the 
application of emergent single molecule microscopy techniques to biological samples. 
Some of the earliest implementations of single molecule microscopy have been used to 
characterize biological processes in unprecedented detail – as exemplified by the 
observation of single β-galactosidase molecules trapped in microdroplets in the presence 
of a fluorogenic substrate (184), tracking of single (oftentimes tethered) beads or particles 
in vitro or in cellulo (185-189), recording of the absorption or fluorescence of single 
pentacene molecules in p-terphenyl crystalline matrices at liquid-helium temperature 
(190, 191), and measurement of single enzyme turnovers (192).   Single molecule 
microscopy (SMM) can broadly be divided into two categories, optical observation and 
mechanical manipulation tools. Below, we will focus on optical methods that employ 
single molecule fluorescence microscopy hereon referred to as SMM) to probe the 
intracellular function of RNA. Imaging tools such as atomic force microscopy (AFM) and 
methods that apply mechanical manipulation to single molecules such as optical and 
magnetic tweezers are beyond the scope of this article, but a broad overview of such 
techniques can be found in several reviews (193, 194).  It turns out that SMM is primed 
to break the classical optical diffraction limit. According to Abbe’s law or Rayleigh’s 
resolution limit (193), diffraction limits our ability to distinguish two features located closer 
(on the lateral plane) than half the wavelength of the illuminating or emitted light, thereby 
imposing a theoretical limit on the resolution of fluorescence microscopy of 200-300 nm 
(using visible, ~500-nm illumination light). Consequently, the image of a single fluorescent 
probe, typically a few nanometers in diameter, is spread after passing the microscope 
optics over a few 100 nm on the detector. The intensity distribution of such a diffraction-  
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Table 1.1. Representative classes of RNAs found in a eukaryotic cell. Reprinted with permission from 
ref (46).  Copyright 2014 American Chemical Society. 
 
 
Category 
 
Name 
RNA 
Length (nts) 
Function References† Databases 
Single molecule 
References† 
Coding RNA 
Messenger 
RNA 
(mRNA) 
variable Protein coding (15, 41) (195, 196) (197-209) 
 
Ribosomal 
RNA 
(rRNA) 
~120-5,000 Translation (210-212) (213) (208) 
 
Signal 
Recognition 
particle RNA 
300 Translation (108) (214)  
Housekeeping 
non-coding 
RNA 
Transfer RNA  
(tRNA) 
70-100 Translation (101) (215, 216)  
 
Small nuclear 
RNA (snRNA) 
60-450 Splicing (43)  (217) 
 
Small nucleolar 
(snoRNA) 
60-300 RNA editing (93) (218)  
 RNase P RNA ~500 tRNA maturation (106) (219)  
 
Telomerase 
RNA 
~400-1,300 
chromosome 
extension 
(220, 221) (222)   
 
Hepatitis Delta 
Virus (HDV) 
ribozyme 
~84 Unknown (70, 72, 223)   
 
Hammerhead 
ribozyme 
~100 Unknown (68, 69)   
 
MicroRNA 
(miRNA) 
20-24 
 
Post-
transcriptional 
gene silencing 
(140, 144, 149, 
150) 
(224-226) (136, 227, 228) 
Small 
 non-coding 
RNA 
(< 200-nts) 
Small 
interfering RNA 
(siRNA) 
20-24 
Post-
transcriptional 
gene silencing 
(144) 
 
(222, 226)  
 
DNA-damage 
response RNA 
(DDRNA) 
20-35 DNA repair (124, 125, 229)   
 
PIWI-
interacting 
RNA 
(piRNA) 
24-31 
 
Germline gene 
silencing 
(122, 230) (231)  
 
Circular RNA 
(circRNA) 
variable miRNA sponge (160, 161)   
 
Primal RNA 
(priRNA) 
22-23 
heterochromatin 
assembly 
(232)   
Mid-sized 
ncRNA 
<1 kb 
Promoter-
associated 
RNAs (PARs) 
variable 
Epigenetic gene 
regulation 
(172) (222)  
Long  
non-coding 
RNA 
(> 200-nts) 
Long non-
coding RNA 
(lncRNA) 
>200 
Epigenetic gene 
regulation 
(164) (225, 233, 234) (173, 235-237) 
 5’-UTR ~150 
mRNA regulatory 
element 
(79) (238)  
Cis-acting 
ncRNA 
3’-UTR ~300 
mRNA regulatory 
element 
(79, 119) (238)  
 Introns 
Variable (up 
to thousand) 
mRNA regulatory 
element 
(239) (240)  
 
†Representative references. Please refer to the text for a comprehensive list.   
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limited spot can be mathematically described by a point spread function (PSF) and 
approximated as a simple two-dimensional (2D) Gaussian function. The center of the 
Gaussian curve, which coincides with the intensity maximum of the diffraction limited spot, 
can be localized with accuracy similar to the size of the fluorescent emitter, effectively 
breaking the diffraction barrier. Recent advancements in instrumentation have thus 
facilitated our ability to visualize single molecules under ambient conditions in situ at 
nanometer spatial resolution (193, 241, 242), previously accessible only to biologically 
invasive techniques such as electron microscopy. 
However, the application of intracellular SMM presents a unique pair of challenges: 
(i) The need to reach an appropriately low sample concentration to delineate individual 
molecules within the dense and complex milieu of a cell; and (ii) the requirement to detect 
photons (signal) from individual molecules within the uneven background (noise), 
contributed mostly by both autofluorescence and signal from out-of-focus molecules, with 
minimal phototoxic effects on the cell. The former is specifically difficult to control when 
probing endogenous biomolecules, especially RNA, whose intracellular abundance can 
vary from a few to several (tens of) thousand(s) of molecules per cell. The latter, 
especially autofluorescence that is primarily contributed by fluorescent intracellular 
metabolites, cofactors and pigments, is omnipresent. Put together, these obstacles 
render the successful implementation of intracellular SMM non-trivial. Nevertheless, a 
careful choice of labeling strategies and imaging conditions can make this seemingly 
daunting task relatively seamless. For instance, titratable reporters (243), controlled 
delivery of labeled probes (136, 244, 245) and ultra-high resolution microscopy methods 
that systematically probe only a subset of all labeled probes at any given time (193, 242, 
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246) have judiciously tackled the concentration challenge, whereas improved optical 
configurations (illumination sources, strategies and detectors) and fluorescent probes 
have successfully dealt with the latter. In this section, we will review and present a 
“panorama” of the fluorescent probes, labeling strategies and imaging schemes that have 
been employed to achieve in cellulo single RNA/RNP molecule detection, along with their 
respective advantages and disadvantages.  
 
1.3.1  Fluorescent Probes 
During the early stages of intracellular single particle tracking (SPT) and single molecule 
microscopy large (0.25-2 µm), either fluorescent or non-fluorescent beads were popular 
as reporters (185, 247).  Their large size enabled convenient high-precision imaging 
without the risk of undesired signal photobleaching, even when using microscopes with 
unsophisticated optics. However, conjugating biomolecules to large beads comes with 
the caveat that the attachment of a bulky load may skew the molecule’s function, 
localization, and/or diffusion, or introduce other artifacts (247).  Moreover, limited options 
for multiplexing means that non-fluorescent beads cannot be used to probe multiple types 
of biomolecules simultaneously. Thus, small fluorescent probes, available in various 
colors, soon superseded beads as the primary choice of visual reporters in SMFM. 
Upon their discovery in the 1960’s (248) and cloning in the 1990’s (249), 
fluorescent proteins (FPs) quickly became a mainstay of intracellular fluorescence 
microscopy (250).  The ease with which FP genes can be expressed as fusions with 
cellular protein targets and the availability of a broad FP “color-palette” that spans the 
entire visible and near-IR part of the spectrum (251) make them attractive probes. One of 
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the main caveats of this labeling method is that protein fusions are often expressed 
exogenously, thus resulting in overexpression compared to endogenous levels, which 
jeopardizes physiological relevance. Additionally, overexpression typically increases 
intracellular particle density to an extent that it becomes refractory to single molecule 
visualization. Using weak promoters, inducible expression systems, controllable viral 
transduction or creating/selecting for stable cell lines with low expression are a few 
adaptations that can be employed to mitigate the effects of overexpression (204, 252).  In 
addition, recent genome editing technologies using Zinc-finger nucleases (ZFNs), 
transcription activator-like effector nucleases (TALENs) and clustered regulatory 
interspaced short palindromic repeat (CRISPR)/Cas-based methods have emerged as 
powerful tools that can function to regulate endogenous expression of FP fusions and 
thus, future implementation of these technologies may help circumvent the above hurdles 
(253).  Despite suffering from frequent intensity fluctuations (blinking) and limited 
photostability,(254) FPs are still preponderant in intracellular single molecule microscopy 
of RNA due to the ease of creating and delivering them as genetically encoded 
fluorescence markers. Even otherwise deleterious blinking properties have found 
compelling applications in super-resolution imaging (246, 255, 256), enhancing our ability 
to image samples of high probe density. The emergence of photoactivatable, 
photoconvertible and fluorescent dimer FPs (251, 257) has further improved super-
resolution imaging schemes (246) and tremendously aided in photosynchronization 
experiments (258).  Moreover, a majority of current RNA labeling schemes invoke the 
binding of multiple FPs per RNA (209), wherein a few well-folded FPs compensate for the 
blinking or photobleaching of a subset of others within the complex.  
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Organic fluorophores (of the rhodamine, cyanine, oxazine, bodipy, perylene and 
other structural scaffolds) are typically preferred over FPs in intracellular SMM for their 
small size and superior photophysical properties, i.e., they don’t blink as often, typically 
emit more fluorescence photons prior to photobleaching, and their undesired 
photophysical properties can be suppressed using several additives (as discussed in 
3.1.1). In further contrast to FPs, organic dyes are predominantly conjugated to 
biomolecules ex vivo, via several well standardized conjugation chemistries (259-262).  
This labeling scheme often mandates the careful purification of probe labeled molecules 
from unlabeled molecules and unbound dye impurities, and for intracellular imaging, the 
specific delivery of tagged molecules to cells. Such hurdles are potentially overcome by 
the use of various genetically encodable tags that form a covalent adduct with organic 
dye substrates, such as SNAP® tags (NEB), Halo® tags (Promega) and tetracysteine 
motif bearing peptides (Invitrogen). These labeling strategies effectively combine the 
elegance of intracellular labeling via genetic engineering with tagging photophysically 
superior organic dyes. The development of bioorthogonal labeling strategies (263, 264) 
and fluorogenic photoaffinity probes (265, 266) has further broadened the scope of in 
cellulo labeling methods.  
Fluorescent beads and quantum dots (QDs) have several favorable photophysical 
properties, as they are typically brighter, more photostable and the latter specifically have 
narrower emission spectra than organic fluorophores (267).  However, akin to non-
fluorescent beads, these probes are typically large (similar in size to a protein or small 
RNA) and have a high propensity to affect the intracellular physicochemical 
characteristics and function of the conjugated biomolecule. Their large size additionally 
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inhibits efficient intracellular delivery and imposes steric constraints during target binding 
of QD/fluorescent bead labeled probes. Additional limitations of QDs include the potential 
for cytotoxicity of the composite transition metal ions and tendency for frequent blinking 
(268), where the latter is a bane for both single molecule counting (as it confounds 
intensity values that are used to measure copy number) and particle tracking (as it 
introduces difficulty in assigning contiguous tracks when particles temporarily vanish from 
observation).  
 
 1.3.1.1 Photophysical Properties Required for Detecting Single Fluorescent 
Probes 
A fluorophore suitable for intracellular SMM should have high quantum yield (i.e., ratio of 
the rate of fluorescence to the sum of all relaxation rates; reflects the net efficiency of 
fluorescence), high brightness (i.e., measure of photon output calculated as the product 
of a fluorophore’s extinction coefficient and quantum yield), favorable photophysical 
properties and sufficient inertness so that the label does not interfere with the function of 
the molecule to be tagged. Among these, brightness and inertness are inherent 
characteristics of the probe’s chemical nature, and the brightness in particular is 
significantly influenced by the immediate chemical environment of the probe. It is thus 
critical to evaluate several probes and choose an appropriately bright fluorophore, such 
that the fluorescent signal is significantly more intense than the cellular autofluorescence. 
This cellular background is caused by naturally fluorescent molecules present inside cells, 
such as NADH, FADH and heme. Two ways to circumvent such background is to use: (i) 
cell culture media devoid of any naturally fluorescent molecules, especially vitamins 
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(269); and (ii) fluorophores that absorb light and fluoresce in the far-red visible or NIR part 
of the electromagnetic spectrum where cellular components show minimal emission (254, 
270, 271).  Another dye and environment dependent, important photophysical property of 
fluorophores is their fluorescence lifetimes, i.e., the time taken for an excited singlet 
electron to transition back to the ground state and concomitantly release a photon (Figure 
1.2). As fluorophore excitation (at femtoseconds, or fs) occurs much faster than photon 
emission (at nanoseconds, or ns) (Figure 1.2), excited singlet states have a propensity 
for electronic saturation, limiting the maximally possible yield of photons.  
In contrast to its intrinsic brightness, undesirable photophysical processes 
affecting a given fluorophore, such as large intensity fluctuations and photobleaching, to 
an extent can be controlled extrinsically. Intensity fluctuations are typically characterized 
by reversible changes of the fluorophore between bright and dark states (i.e., blinking), 
whereas photobleaching signifies an irreversible switch to a dark state (Figure 1.2). Both 
processes markedly affect the quality and length of single molecule recordings. Blinking 
is predominantly induced by intersystem crossing (ISC, Figure 1.2), wherein fluorophore 
excitation populates electronic triplet states instead of singlet states. Relaxation back to 
the ground state from triplet states, which is a prerequisite for further cycles of electronic 
excitation and subsequent fluorescence, is quantum mechanically forbidden and takes 
~1,000-fold longer than relaxation from singlet states so that probes are temporarily 
rendered dark. Blinking and photobleaching may also occur due to the chemical reaction 
of excited state molecules with radical species, induced by the excitation light or provided 
by the chemical environment of the dye. In certain cases, the excitation light may itself 
suffice to transform a fluorescent dye into its dark state in a phenomenon termed 
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photochromism. However, several chemical agents such as cyclooctatetraene (COT), 
trolox, ascorbic acid, mercaptoethylamine (MEA), 4-nitobenzyl alcohol, 1,4-
diazabicyclo[2.2.2.]octane (DABCO) and n-propyl gallate can be used to quench triplet 
states and radical species and, thus, reduce blinking and increase fluorophore longevity 
(254, 272-274).  It is noteworthy that the quenching action of some chemical agents is 
dye specific, for instance, MEA has proven to effectively quench triplet states of 
Rhodamine 6G (275) but increase blinking in cyanine dyes like Cy5 (272).  Although it is 
still unclear, this detrimental action of MEA is attributed to its function as a reducing agent, 
especially considering that other reducing agents such as dithiothreitol (DTT), β-
mercaptoethanol (BME) and tris(2-carboxyethyl)phosphine (TCEP) also induce such 
deleterious effects. This effect, termed redox blinking, can be induced by oxidants such 
as methyl viologen as well. Regardless of whether they enhance photophysical 
characteristics, the addition or removal of any of these chemical agents should be 
contingent upon their tolerability by and the viability of cells, especially in live cell imaging, 
whereas such stringency is not required for imaging fixed cells, where the choice of 
reagents can be purely dye-based. Another chemical that has been widely attributed as 
the cause of photobleaching, presumably via photooxidation of the fluorophore, is 
molecular oxygen and related species. Especially during intracellular imaging, excited 
fluorophores can react with molecular oxygen within cells, resulting in the accumulation 
of phototoxic free radicals that can compromise sub-cellular compartments or even the 
entire cell’s livelihood (276).  Enzymatic oxygen scavenging systems (OSS), such as 
those containing glucoseoxidase and catalase (GODCAT),(277) protocatechiuc acid and 
protocatechuate-3,4-dioxygenase (PCA/PCD) (272) or attributed 
 
30 
 
 
 
 
 
 
 
 
 
Figure 1.2. Photophysical properties of fluorophores. (A) Simplified Jablonski diagram 
representing excitation (Ex), fluorescence (Fl) emission, internal conversion (IC), vibrational 
relaxation (VR), non-radiative decay (NR), intersystem crossing (ISC), phosphorescence (Ph) and 
photobleaching (PB), and the respective timescales at which these processes occur. S0, singlet 
ground state; S1, singlet excited state; T1, triplet state. (B) A simulated intensity trajectory of a 
single molecule with two blinking events (orange arrow) and a single photobleaching step (dotted 
grey arrow).  Reprinted with permission from ref (46).  Copyright 2014 American Chemical 
Society. 
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as the cause of photobleaching, presumably via photooxidation of the fluorophore, is 
molecular oxygen and related species. Especially during intracellular imaging, excited 
fluorophores can react with molecular oxygen within cells, resulting in the accumulation 
of phototoxic free radicals that can compromise sub-cellular compartments or even the 
entire cell’s livelihood (276).  Enzymatic oxygen scavenging systems (OSS), such as 
those containing glucoseoxidase and catalase (GODCAT) (277), protocatechiuc acid and 
protocatechuate-3,4-dioxygenase (PCA/PCD) (272) or Oxyfluor© (278) utilize molecular 
oxygen as a substrate in enzymatic reactions, thereby effectively depleting it. These OSS 
prevent fast photobleaching and oxygen induced free radical production, resulting in 
increased signal longevity. However, it is critical to reduce the exposure of cells to OSS 
as they may lead to hypoxic shock (279), as well as to include good buffering agents in 
the imaging solution to overcome harmful effects of pH changes induced by certain OSS 
(280).  As molecular oxygen is also an efficient quencher of triplet states, addition of OSS 
may increase fluorophore lifetimes at the cost of increased blinking rates (281).  Thus, it 
is mandatory to include triplet state quenchers in imaging solutions that also contain OSS. 
Other deleterious photophysical effects, such as light induced free radical production and 
phototoxicity, are reduced by striking a balance between the excitation laser power (and 
wavelength) and the time over which the sample is illuminated while maintaining single 
molecule sensitivity. 
 
1.3.2  Labeling Strategies of RNA for Intracellular Single Molecule Fluorescence  
Microscopy RNA labeling strategies may be crudely divided into two main categories, 
indirect and direct labeling schemes. The former employs sequence-complementary 
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oligonucleotides (Figures 3 and 4) or fluorophore labeled RNA binding probes, such as 
RNA binding proteins, RBPs (Figure 1.5), which associate with appropriate RNA motifs 
to (indirectly) tag RNA with fluorophores. Conversely, direct labeling schemes exploit 
chemically reactive functional groups or structural motifs within the RNA, naturally present 
or introduced by chemical synthesis or RNA modifying proteins, for fluorophore 
conjugation (Figure 1.6). Currently, indirect labeling schemes are more predominant in 
intracellular SMM of RNA as they have the capability to probe endogenous targets, in 
addition to exogenous constructs, thereby finding widespread application in in situ gene 
expression profiling with single molecule sensitivity (21).  Below, we will focus on well-
established RNA labeling schemes used in intracellular SMM, but also describe a few 
methods that have strong potential. A majority of these labeling strategies has been 
optimized to probe mRNAs; however, applications to the world of ncRNAs are slowly 
emerging. 
 
1.3.2.1  Labeling by Fluorescence in situ Hybridization (FISH): An Early Glimpse 
at the Power of Intracellular SMM 
Labeling target RNAs by hybridizing sequence complementary oligonucleotides in situ 
upon fixing and permeabilizing a cell was one of the earliest strategies to reach single 
molecule sensitivity. The method quickly gained widespread use because of its ability to 
probe the sub-cellular distribution and abundance of endogenous RNA and led to the 
inception of single cell gene expression analysis, the importance of which is underscored 
by the ubiquitous occurrence of cell-to-cell variations in gene expression (21, 282, 283).  
For instance, tumors that are often considered as a single lump of cells are comprised of 
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many distinct cell types, each bearing distinct gene expression programs (284).  
Furthermore, the microenvironment of such tumors influences gene expression (284); for 
example, a cell in the center of a tumor or tissue expresses a different set of transcripts 
than one in the periphery. As an additional layer of complexity, gene expression is 
spatially organized even within individual cells (285-287).  Such heterogeneities are often 
hidden within the averaged measurement or statistical error of an ensemble method (such 
as Northern blotting, quantitative reverse transcription PCR (qRT-PCR), microarray or 
deep-sequencing), traditionally used to quantify gene expression at high-throughput on a 
genomic scale. Techniques to access these important heterogeneities, such as single-
cell RNA sequencing, microfluidics aided single-cell qRT-PCR, microdissection, 
fluorescence activated cell sorting and sub-cellular fractionation, are slowly emerging as 
attractive technologies for single cell transcriptome analysis (288, 289),  but are still not 
very efficient and/or introduce quantification or sequence biases through amplification 
steps in the protocol. Moreover, these ensemble methods still do not provide critical 
information on the spatiotemporal distribution of transcripts within tissues or individual 
cells. Therefore, it is becoming increasingly important to complement bulk measurements 
with techniques that characterize gene expression within individual cells in situ to 
decipher the stochastically driven, essential dispersities of gene expression within 
complex genetic networks. Progress in solid state synthesis of fluorophore labeled 
oligonucleotides and imaging/image analysis technology coupled with incessant 
advances of sequencing and bioinformatics analysis are now culminated in our ability to 
probe – in principle – any transcript, coding or non-coding, within the entire transcriptome 
at single molecule resolution in cellulo.  
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 Traditionally used for DNA profiling and later modified for RNA detection (290), in 
situ hybridization (ISH) protocols generally entail a sequence of fixation, permeabilization, 
hybridization of long (>100 nt) oligonucleotide probes to their corresponding 
complementary sequences, thorough washing to remove unbound probes, and image 
acquisition. Oligonucleotides are either directly labeled with fluorophores (fluorescence in 
situ hybridization, or FISH) in a stochastic fashion via enzymatic reactions (for example, 
transcription, 3’-end extension, nick translation and ligation; Figure 1.6B) or coupled to 
haptens, such as biotin or digoxigenin. In the latter case, the sample is then treated with 
avidin or antibody to digoxigenin, which are either directly labeled with fluorophores or 
coupled to chromogenic enzymes like alkaline phosphatase (AP) or horseradish 
peroxidase (HRP) whose enzymatic products yield an amplified light signal. Alternatively, 
secondary antibodies specific to avidin or primary antibody to digoxigenin are fluorophore 
or enzyme labeled to further amplify the signal from a single hybridization event. Even 
though these protocols are extremely useful in providing qualitative information on gene 
expression and localization patterns, they lack quantitative detail due to three main 
reasons: (i) Random distribution of fluorophores within oligonucleotides often results in a 
heterogeneously labeled population of probes and sometimes even localizes 
fluorophores close enough to mutually quench each other, both of which shroud intensity 
measurements that are critical for calculating the molecule copy number; (ii) long probes 
are poorly cell-permeable and thus result in incomplete labeling of RNA in situ; and (iii) 
this original protocol suffered from low sensitivity due to high background caused by 
unbound and non-specifically bound probes not removed by the washing. To overcome 
these caveats, multiple short oligonucleotide probes complementary to adjacent 
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sequences within an RNA of interest effectively have now replaced long probes when 
performing FISH at the single molecule level (291, 292) (Figures 3 and 4). Each of these 
short oligonucleotide probes, small enough to surpass the permeability issue, are labeled 
with multiple (291) or single fluorophores (292) and designed such that the distance 
between fluorophores within individual hybridization probes and between different probes 
minimizes proximity mediated fluorescence self-quenching. Moreover, the fluorophore is 
attached to a specific nucleotide within the probe, resulting in more homogeneous 
labeling. The collective fluorescence arising from the binding of multiple such probes to a 
single RNA molecule is much higher than the fluorescence from a single labeled 
oligonucleotide, effectively delineating specific signal from unbound, non-specifically or 
sub-optimally bound oligonucleotides and cellular autofluorescence. In an alternative 
experimental scheme, endogenous transcripts containing multiple repeats of a specific 
sequence (202) or exogenous transcripts tagged with such a repeat sequence array (197, 
293), are labeled with multiple copies of a single fluorophore tagged oligonucleotide 
sequence, essentially mitigating oligonucleotide synthesis costs. Following the basic 
principle of signal amplification, other modifications to the ISH procedure include the use 
of molecular beacons (197, 293), modified nucleic acid backbone (294, 295), padlock 
probes (296), branched DNA oligonucleotides (297) or multivalent RNA hybridization 
probes (244).  With the appropriate calibration controls, instrumentation and image 
analysis methods (described below) such modifications to the traditional ISH protocol 
result in single RNA molecule sensitivity. 
Singer and coworkers spearheaded single molecule FISH (smFISH) methods by 
using five or more short (~50 nt) oligonucleotide probes that bound complementary 
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sequences within an RNA of interest (291) (Figure 1.3A, (i)). Each probe was labeled with 
3 or 5 fluorophores at predefined positions and had a GC content of ~50%, suitable for 
optimal hybridization at relatively low temperatures (37-47 oC). Probes were then 
independently imaged in vitro at different concentrations to derive a calibration curve, 
which was consequently used to confirm the identity of individual fluorescent particles as 
single RNA molecules. To this end, various dilutions of the fluorophore labeled 
oligonucleotide were imaged in vitro in a sample chamber of known volume, using the 
same microscope settings as during intracellular imaging. A calibration curve of 
fluorescence signal versus number of oligonucleotide molecules (calculated from the 
concentration and sample holder volume) per voxel (a 3D pixel element) was plotted and 
the intensity of individual oligonucleotides was extrapolated from this curve. The authors 
found that the number of dye labeled oligonucleotide probes within individual fluorescent 
particles in a deconvolved image, as computed by dividing the particle signal by the signal 
of a single oligonucleotide, coincided with that expected to bind to a single mRNA (291, 
298).  This method has been employed by several groups for spatial annotation of 
transcripts and counting (199, 299-301); however, it suffers from one major drawback – 
high variability in the number of oligonucleotide probes bound per target (291, 292, 298).  
More specifically, >50% of all fluorescent spots contain only one or two of the possible 
five or more oligonucleotide probes, which complicates the reliable distinction of specific 
over non-specific binding. As each oligonucleotide probe has 3-5 dye labeling sites, 
incomplete labeling and inefficient separation of fully from partially labeled probes may 
result in the false annotation of probe density per transcript and thus have an impact on 
the quantification accuracy. 
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Figure 1.3. Fluorescently labeling RNA by hybridization of labeled probes. (A) Hybridization 
probes that do not employ signal amplification strategies. Represented here are schematics of 
the Singer approach using few multiply labeled probes (i), the Tyagi method of many singly 
labeled probes (ii), competitive hybridization (iii), and inherently quenched molecular beacons (iv). 
Green and red circles are spectrally distinct dye molecules and shaded grey circles are 
quenchers. Schematics iv–v and vii represent hybridization methods that have been widely used 
in ensemble imaging of intracellular RNA, with immense potential in single molecule imaging. 
Side-by-side probes(302) (iv) are designed to bind target RNAs at adjacent positions, such that 
the binding configuration brings fluorophores on the two probes into close proximity to enable 
FRET. In a variant of this scheme, called quenched-autoligation(303, 304) (v), the probe 
containing the FRET donor also contains a quencher to suppress the fluorescence from unbound 
oligonucleotides. Once the functionalized probes bind side-by-side, they self-ligate, removing the 
quencher from the vicinity of the donor probe, thereby resulting in unquenched FRET. Another 
variant of the side-by-side scheme consists of dual molecular beacon FRET probes(305, 306) 
(vii); here signal specificity is enhanced by two beacons, one containing the FRET donor and 
another containing the FRET acceptor, which bind at adjacent locations to generate a FRET 
signal. Each probe contains a quencher to reduce fluorescent background from unbound probes. 
(B) Signal amplification in hybridization probes. Schematics representing the ELF approach (i), 
padlock probes (ii) (Reprinted with permission from ref. (296). Copyright 2010 Nature Publishing 
Group.), and the HCR approach (iii). Reprinted with permission from ref. (307). Copyright 2010 
Nature Publishing Group. RCP, rolling circle product.  
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Tyagi, van Oudenaarden and coworkers modified Singer’s protocol by targeting a 
single transcript with 48-96 oligonucleotide probes, each spanning ~17-22 nt and labeled 
at the 3`end with just one fluorophore to allow for the efficient purification of labeled from 
unlabeled oligonucleotides, thereby improving labeling homogeneity of the target (Figure 
1.3A, (ii)) (292).  Such short probes also require less stringent conditions for hybridization 
and washing: compare 28-37oC and 10% formamide (292, 308) to 37-47oC and 50% 
formamide (291, 298) in the Singer protocol or 65oC and 50% formamide (309) in 
traditional FISH. Less harsh conditions allow for combining FISH with 
immunofluorescence or immunohistochemistry to probe both RNAs and (associated) 
proteins, frequently referred to as immunoFISH (310).  Probes are designed to bind 
adjacent sequences on a single transcript such that the minimum spacing between them 
is 3 nt, thus minimizing self-quenching. Compared to the Singer approach, this strategy 
results in an increased fluorescence enhancement from individual transcripts, to an extent 
that even transcripts bound by endogenous RBPs or partially degraded are more 
efficiently detected. By contrast, signal arising from the non-specific binding of just one or 
two probes is typically insignificant enough to avoid false positives. The single molecule 
sensitivity of this method was validated by multiple complementary approaches (292, 308, 
311). The method’s sensitivity and inherent simplicity have led to its rapid 
commercialization (Biosearch Technologies ©) and to the availability of intuitive websites 
for probe design (http://www.singlemoleculefish.com) for any RNA target. However, the 
approach cannot be employed to detect short transcripts and small ncRNAs. In an effort 
to overcome this caveat, Shepherd et al. developed a competitive hybridization based 
approach (Figure 1.3A, iii) (312, 313).  Herein, double-stranded probes contain a 
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fluorophore on the 5’-end of the strand complementary to target and a quencher on the 
3’-end of the other probe strand such that the former probe strand’s fluorescence is 
quenched as long as the two oligonucleotides remain in the duplex (314). The target 
gradually replaces the quencher strand to bind the fluorophore labeled probe strand, 
leading to loss of quenching. Shepherd et al. exploited this property to reduce background 
fluorescence from free probe. To probe smaller RNAs, they additionally reduced the 
number of probes (5-10 compared to 48-96) and relaxed several probe design criteria, 
including requirements for ~50% GC content and large separation between probes. 
However, this method also suffers from variability in the number of probes bound per 
target, largely due to reduced stringency in probe design. Inefficient labeling due to poor 
kinetics of probe strand separation is another possible drawback. One solution is to make 
the fluorophore labeled, target-binding strand longer than the quencher strand, such that 
the overhang of their duplex is complementary to the target RNA. This allows for a more 
rapid removal of the quencher by strand displacement (313).  Sunney Xie’s group has 
reportedly overcome these drawbacks by probing single mRNA molecules with a single 
fluorophore labeled oligonucleotide in E. coli (315).   
The use of probes bearing a modified oligonucleotide backbone that allows them 
to hybridize more stably to RNA has enabled the detection of short transcripts with high 
specificity. Hybridization is sensitive enough to distinguish single nucleotide differences 
and detect single RNA molecules with just a single probe. These properties were 
exploited by Lu and Tsourkas (295) to detect miRNAs in situ at single molecule sensitivity 
using locked nucleic acid (LNA or 2′-O, 4′-C-methylene-linked ribonucleotide) probes 
aided by enzyme labeled fluorescence (ELF) based signal amplification (Figure 1.3B, i). 
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The LNA oligonucleotide probe is labeled with digoxigenin at its 3’-end to be recognized 
by an anti-DIG-AP chimeric antibody. ELF is achieved by the cleavage of a pro-
luminescent substrate by AP (or HRP). Precipitation of the product and multiple turnover 
by the enzyme result in a fluorescent spot at the site of enzyme activity that is 20- to 40-
fold brighter than a single fluorophore. The authors confirmed single molecule sensitivity 
based on the similarity in copy number distribution of ectopically expressed control 
transcripts that were detected by either standard smFISH or LNA-ELF-FISH (295).  
Probes with other backbone modifications, such as peptide nucleic acids (PNA), have 
been used to detect telomeres and assess their length in situ (294). 
The possibility of fluorescent ELF amplification products diffusing away during 
washing or detection has spurred the development of other signal amplification methods. 
Initially standardized for DNA, Larsson et al. (296, 316) developed “padlock” probes to 
detect single nucleotide polymorphisms (SNPs) in RNA, i.e., distinguishing transcripts 
that differ only by a single nucleo base, via enzyme independent signal amplification. 
They first reverse transcribed the RNA to cDNA using LNA primers, RNase H treated to 
degrade any portion of the RNA complementary to the cDNA, hybridized linear padlock 
probes to the target such that the 5’- and 3’-ends are juxtaposed, enzymatically ligated 
the ends and used them as templates (and the cDNA as the primer) for rolling circle 
amplification by Phi29 DNA polymerase (Figure 1.3B, ii) (296).  A single-stranded DNA 
containing tandem repeats of the padlock probe was thus created at the mRNA 
localization site, to which fluorophore labeled detection oligonucleotides were hybridized 
to yield a bright fluorescent spot. The specificity of LNA hybridization contributes to the 
initial specificity in targeting transcripts and tethering the cDNA to the intracellular 
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transcript location, whereas the target dependent padlock probe ligation aided SNP 
detection. Another signal amplification approach uses branched DNA hybridization (297, 
317).  Here, a single gene specific probe contains flanking sequences that hybridize to a 
pre-amplifier probe, which in turn binds multiple amplifier oligonucleotides. Each amplifier 
oligonucleotide binds multiple detection oligonucleotides, thereby resulting in bright 
fluorescent spots, especially when multiple gene specific probes target a single transcript. 
This technology has been commercialized as QuantiGene ViewRNA (Affymetrix ©), with 
the advantage of using universal pre-amplifier, amplifier and detection oligonucleotides 
for any gene specific set of probes. A related system, named hybridization chain reaction 
(HCR(307)), uses flanking sequences on gene specific probes (initiator oligonucleotide) 
to initiate self-assembly of metastable fluorescent RNA hairpins into large amplification 
polymers (Figure 1.3B, iii). All of these protocols improve signal quality and quantity, yet 
they have a major drawback of amplifying false positive signals as well, necessitating 
stringent probe design criteria. 
Although multiplexing has been achieved with many of these methods by using 
distinct fluorophore colors, conventional optics and broad emission spectra typically limit 
the number of simultaneously detectable transcripts to three, beyond which non-specific 
excitation and spectral bleed-through confound signal identification. To overcome this 
limitation, Singer and colleagues developed an approach they termed “spectral 
barcoding” (318) wherein gene specific probes are divided into groups labeled with 
spectrally distinct fluorophores. Hybridization of these groups of probes with their cognate 
transcripts and careful registration of multiple fluorescent channels results in fluorescent 
spots that are multi-colored. With each gene designed to bind probes with a specific color 
42 
 
combination, one can, in theory, have 2n – 1 color combinations of n spectrally resolvable 
fluorophores, effectively multiplexing and increasing throughput. Recently, Levesque and 
Raj (200) doubled the number of simultaneously detected transcripts (from 10 to 20) in 
an adaptation of Singer’s method they called intron chromosomal expression FISH 
(iceFISH). The authors took advantage of the fact that most introns are unstable upon 
their removal from a pre-mRNA by splicing near their site of transcription and labeled 
introns to thus probe chromosomal structure (Figure 1.4A). 
A majority of smFISH approaches are not extendible to living cells because it is 
difficult to deliver such a large number of probes into cells by methods other than 
irreversible membrane permeablization. Moreover, FISH protocols rely on hybridization 
under (mildly) denaturing conditions and multiple wash steps to remove unbound probes, 
both of which are difficult to accomplish in living cells. Tyagi and coworkers (293) 
addressed these drawbacks by microinjecting molecular beacon probes (Figure 1.3A, vi) 
into live cells. Molecular beacons are designed to have small complementary sequences 
on either end such that they adopt a (weak) hairpin structure (with a small stem and a 
large loop), bringing a fluorophore at the 5’-end close to a quencher at the 3’-end for 
effective quenching of fluorescence from unbound probes. Upon target hybridization, the 
hairpin stem is disrupted and the fluorophore becomes unquenched. 2`-O-methyl (2OMe) 
oligonucleotides were used instead of DNA probes to alleviate RNase H mediated 
cleavage of RNA within DNA-RNA hybrids and to prevent probe degradation by cellular 
nucleases. For fluorescence enhancement from individual transcripts, the authors 
created an exogenous transcript that binds 96 copies of the probe, thereby requiring only 
a single probe sequence for target hybridization. To demonstrate that each fluorescent 
43 
 
spot contained a single RNA, the group prepared in vitro transcribed RNA containing 16, 
32, 64 or 96 probe binding sites, pre-hybridized the probes in solution and microinjected 
them into cells. As expected, the intensity of particles was proportional to the number of 
binding sites, the intensity distribution of particles was well represented by a single 
Gaussian, and the average particle counts per cell coincided with qRT-PCR results. The 
establishment of live cell single RNA detection allowed the group to understand nuclear 
trafficking of RNPs. A similar approach was used by Kubitscheck and colleagues to probe 
endogenous Balbiani ring (BR) 1 and 2 mRNPs. The group used a fluorophore labeled 
oligonucleotide that sub-stoichiometrically targeted a stretch of repeat sequences (~80 
repeats) within the mRNA (202).  Ishihama and Funatsu similarly used microinjection to 
track the diffusive behavior of polyA-tailed ftz mRNA, pre-hybridized with QD labeled 
oligonucleotide U(22), within the nucleus of mammalian cells (319).  
As microinjection may lead to the passive transport of probes into the nucleus and 
consequently hamper cytoplasmic RNA labeling, Santangelo and coworkers (244) used 
a combination of reversible permeabilization by streptolysin O (SLO) for intracellular 
delivery and a unique set of hybridization probes called multiply labeled tetravalent RNA 
imaging probes (MTRIPs) (Figure 1.4B). Individual detection probes were created by 
binding streptavidin to 2’-O-methyl RNA-DNA chimera that contained a 5’-biotin and 3-5 
well spaced internal fluorophores. As streptavidin contains four biotin binding sites, a 
tetravalent probe forms with a four-fold fluorescence enhancement over a single probe. 
SLO allowed for the delivery of such large probes into the cells. Single molecule sensitivity 
was supported by assessing intensity distributions of single probes immobilized to glass 
and those in cells and further confirmed by comparisons of the signal from monovalent  
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Figure 1.4. Recent techniques for fluorescently labeling RNA by hybridization of labeled 
probes. (A) A pseudocolored scheme for spectral barcoding in iceFISH to simultaneously detect 
20 transcripts (left panel). The right panel contains a representative cell with the transcriptional 
activity of 20 genes spatially annotated. Reprinted with permission from ref. (200). Copyright 2013 
Nature Publishing Group. (B) Schematic of the MTRIPs labeling method.  Reprinted with 
permission from ref (46).  Copyright 2014 American Chemical Society. 
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with that of tetravalent probes and the intracellular distribution of scrambled with that of 
specific probes. Major advantages of this method include the need for fewer tetravalent 
probes (2 - 3) per RNA and the ability to visualize the dynamics of endogenous (as 
opposed to engineered) RNA. Recently, the same group replaced streptavidin with multi-
armed PEG (320) covalently attached to fluorescent oligonucleotides to reduce toxicity 
from spurious binding of streptavidin to endogenous biotin, and to increase the number 
of oligonucleotides, and thus fluorophores, per MTRIPs. 
RNA labeling via hybridization, although popular, still suffers from several 
drawbacks. The cross-linking of RBPs to RNA during fixation and tightly formed 
secondary structures severely affect probe accessibility and binding (321), which may 
compromise imaging sensitivity. Additionally, accurate RNA counting within large, 
intracellular aggregates, such as transcription sites or RNA-protein aggregates is seldom 
straightforward and often error-prone. Another concern pertains to RNA probing in live 
cells, wherein hybridization of oligonucleotides, especially a large number of them, may 
compete with endogenous RBP binding or regulatory RNA elements vital to RNA function 
or trigger antisense or RNA silencing responses that degrade the RNA. Moreover, the 
translation machinery and other RNA helicases may denature probe-RNA hybrids, 
resulting in reduced sensitivity. Probes should therefore be designed within the UTRs of 
RNA, specifically selecting binding sites that do not affect RNA function. Finally, the 
abundance of unbound probes (that cannot be washed away) can contribute to high 
background and false positive signal in live cells.  
 
1.3.2.2  Labeling with RNA Binding Proteins 
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Since proteins can be easily appended with FPs, labeling RNAs using FP tagged proteins 
that bind them, rather than using oligonucleotide probes, is a logical extension. This 
method has allowed for the real-time detection of RNA localization and trafficking, and 
has provided valuable information on the temporal signature of gene expression in living 
cells, complementary to transcript counting in fixed cells (322).  As a result, it promises 
the possibility of investigating the entire life cycle of an RNA, from transcription, transport 
and translation to degradation, in a single experiment, a feat that is difficult to achieve 
with smFISH. The labeling strategy entails the intracellular expression of the RNA of 
interest as a fusion with multiple copies of an RNA motif that binds a specific protein. 
RBP-FP chimeras are simultaneously expressed and the binding of many copies of these 
fusion proteins to the RNA labels the target above background (Figure 1.5). Both the 
target RNA and the RBP, or just the RBP, are genetically engineered into plasmids that 
are either transiently transfected or stably integrated into the cellular genome for 
intracellular synthesis. The binding of multiple FP-tagged-RBPs (RBP-FP) through a 
repetitive RBP binding sequence (RBS) renders a single RNA molecule much brighter 
than a single FP molecule so that it becomes well distinguishable from unbound RBP-FP 
molecules and cellular autofluorescence (209).  Additionally, certain schemes favor 
fluorescence enhancement by confinement of individual nucleic acid bound FPs (323).  
Here, the experiment is designed such that unbound RBP-FPs are highly expressed and 
diffuse much faster than the time resolution of image acquisition, constituting a 
fluorescent blur spread over the entire cell. Once RBP-FPs associate with slow moving 
or immobile RNAs via their cognate RBS, they are confined to the extent that acquisition 
time is not a limiting factor. Fluorescence from such slowly diffusing complexes 
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supersedes that of the unbound probes and can be detected as distinct diffraction limited 
spots, effectively enhancing the signal-to-background ratio for single molecule detection. 
However, in either case unbound RBP-FPs still contribute significant background 
fluorescence, especially when over-expressed. To mitigate this issue, a nuclear 
localization signal (NLS) needs to be tagged to the RBP-FP gene as a means to 
concentrate unbound RBP-FPs in the nucleus and improve the sensitivity of (m)RNA 
detection in the cytoplasm (209).  Alternatively, fluorescence recovery by reconstitution 
of split GFP fragments can be employed (324).  Here, two distinct RBPs are fused to the 
non-fluorescent N-terminal and C-terminal halves of GFP. Binding of both RBPs to their 
respective, adjacently located RBS’s brings the two fragments in close proximity to 
promote association, resulting in a fluorescent protein. In this fashion, unbound and 
singularly bound RBP probes are effectively rendered non-fluorescent. To robustly label 
the RNA, it is essential that the RBP binds the RBS with great specificity and affinity 
(preferably with a KD of <10 nM), and that fluorescence recovery from the assembled 
fragments is reasonably efficient.  
One archetypical high-affinity protein-RNA tethering system, pioneered by Singer 
and coworkers, consists of the MS2 coat protein (MCP) and matching MCP binding 
sequence (MBS, Figure 1.5A) (209).  Derived from the MS2 bacteriophage (or its closely 
related R17 bacteriophage), the MCP is an ~13.7 kDa regulatory RBP that readily 
dimerizes in solution, whereas the MBS is an ~21 nt RNA fragment that spontaneously 
adopts a stem-loop structure (325).  Other viral protein-RNA tethering systems that have 
been derivatized for tagging RNA with FPs include a system derived from the PP7 
bacteriophage, an evolutionary cousin of the MS2 bacteriophage, which infects P. 
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aeruginosa (326, 327).   As in the MS2 system, two copies of the PP7 coat protein (PCP) 
bind one copy of the stem-loop structure of the PP7 RNA binding site (PBS) with high 
affinity (KD = ~1 nM) (326).  Despite the functional similarity, the PCP bears only ~15% 
sequence identity to the MCP and the PBS differs from the MBS in both size and 
nucleotide composition. This feature results in orthogonality between the PP7 and MS2 
systems, i.e., the PCP does not recognize the MBS and vice versa (326).  Another 
orthogonal system comprises the 𝜆N peptide, which spans ~22 amino acid (aa), and its 
corresponding ~15-nt long RNA binding motif, box B (325, 328, 329), derived from lambda 
bacteriophage (Figure 1.5B). In the virus, the 𝜆N protein (12.2 kDa and 107 aa), which 
contains the 𝜆N peptide at its N-terminus, binds box B stem-loop motifs in a 1:1 
stoichiometry and  with equal specificity and affinity (KD = ~1.5 nM) as the full-length 
version (325).  These three orthogonal protein-RNA tethering systems provide the 
opportunity to simultaneously image up to three different mRNAs (329) or probe three 
discrete segments of a single mRNA. Furthermore, they have evolved in nature to 
minimize non-specific interactions with other proteins or RNAs so that they can be 
expected to serve as “inert” tags for probing the intracellular localization and dynamics of 
target RNAs. 
In its earliest manifestation, 24 copies (24x) of the viral RBS were appended to an 
RNA, resulting in the binding of up to 48 molecules of FP labeled RBPs (209), although 
versions that utilize lower (330) or significantly higher (331, 332) number of RBS repeats 
have also been reported.  mRNA labeling via these large appendages is typically 
achieved by incorporating the RBS into the 5’- or 3’-UTR such that the tag does not affect  
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Figure 1.5. RNA labeling by various protein-RNA tethering approaches. A detailed 
description is provided in section 1.3.  Reprinted with permission from ref (46).  Copyright 2014 
American Chemical Society. 
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the transcript’s translation or UTR-mediated regulation (209).  Nevertheless, control 
experiments need to be performed to test whether a tagged RNA retains its biological 
function. Additional control experiments should be performed to verify that individual 
intracellular fluorescent particles represent single RNA molecules (205, 209).  To this end, 
Singer and coworkers used a combination of FP titration and cross-validation by smFISH 
(205, 209). The FP titration aided calibration curve was constructed similar to that 
discussed in segment 3.2.1, with purified FPs replacing fluorophore labeled 
oligonucleotides. This measurement was complemented with smFISH, performed on the 
same set of RBP-FP expressing cells, to exclude the possibility that clusters of sub-
optimally labeled mRNAs were misidentified as single mRNAs. Colocalization of smFISH 
probes with FP labeled particles and calibrations curves that identified the number of 
oligonucleotide probes bound per RNA (as also described in segment 3.2.1) further 
supported the FP titration data. 
Both the MS2 and PP7 systems have been well characterized, yet similar 
characterizations of the 𝜆N:boxB pair have so far been lacking. Notably, such 
characterizations have shed light on surprising anomalies and led to the development of 
improved MCP and PCP probes (333).  Anomalies included incomplete and 
heterogeneous occupancy of MBS by MCP (205, 209, 333), i.e., the observations that 
only a subset of the 24 or so MBS is bound by FP tagged MCPs and that MBS or PBS 
tagged mRNAs were not uniformly labeled across different cells or sometimes within the 
same cell. Especially the latter undermines the ability of this labeling method to quantify 
gene expression at single molecule sensitivity. For instance, a single RNA-containing 
particle that is half as bright as another owing to non-uniform labeling may be scored as 
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harboring half the number of RNA molecules even though the two are stoichiometrically 
identical. These limitations were attributed to the expression-level dependent dimerization 
of MCP or PCP (333).  At low RBP abundance, dimerization as a prerequisite to RBS 
binding is compromised and results in incomplete RBS occupancy. As the RBP 
expression increases, extent of dimerization and hence occupancy increases, but 
saturates based on the number of RBS repeats and concomitantly increases background 
fluorescence from unbound RBP-FPs. In an alternative strategy, Singer and coworkers 
created tandem dimers of MCP (tdMCP) or PCP (tdPCP) conjugated to an FP, wherein 
two copies of the RBP are engineered in tandem with a flexible linker in the middle (333).  
This scheme promotes concentration independent intramolecular dimerization, thus 
effectively resolving issues of expression level mediated non-uniform labeling. While 
maximum occupancy is achieved with the PCP-PBS system (~48 copies of the PCP or 
24 copies of tdPCP bound to 24x PBS), the MCP-MBS pair always shows sub-
stoichiometric labeling (only ~26 MCPs or 13 tdMCPs associated with 24x MBS), for 
reasons still unknown (333).  
Regardless of their widespread use and efficacy, the protein-RNA tether labeling 
strategies discussed so far are only useful to probe genetically engineered constructs. 
Recently, two groups independently developed distinct methods capable of labeling both 
engineered and endogenous RNAs with single molecule sensitivity (194, 202, 334, 335).  
Both methods exploit the binding of fluorophore labeled RBPs to specific RNA sequences, 
rather than structured motifs. In the first technique, Ozawa and coworkers (194, 334, 335) 
utilized the RNA binding properties of PUMILIO, a protein that mediates eukaryotic 
posttranscriptional gene regulation (Figure 1.5C) (336).  This protein binds RNA via the 
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Pumilio homology domain (PUM-HD), which contains an array of eight modular elements 
that specifically recognize the RNA sequence UGUANAUA (337, 338) (where N is any 
nucleotide), also termed PumBS. As each module recognizes a single RNA base (337), 
the binding specificity of PUM-HD can be altered by simply changing the base recognizing 
amino acid residues within each element such that is matches a specific sequence within 
an RNA of interest. Notably, just a single base mutation within the first half of the 
consensus sequence results in an ~100- to 3,000-fold loss in affinity for the wild-type 
PUM-HD that can be rescued by appropriate PUM-HD mutants (337, 338).  This modular 
RNA binding feature was exploited to create FP labeled tandem PUM-HD probes, 
wherein each engineered PUM-HD recognizes a distinct, yet closely located sequence 
within an endogenous target (194, 334, 335) (Figure 1.5C). This tandem binding approach 
utilizes two different 8-nt PumBS’s located adjacent to each other and can theoretically 
distinguish one among 416 (~4.3 x 109) transcripts, unique enough to identify a specific 
target RNA within a single cell. In one version, endogenous mitochondrial ND6 (334) or 
β-actin mRNA (339) were visualized by the split-GFP approach. Here, the two mutants of 
PUM-HD (mPUM1 and mPUM2) were fused to the non-fluorescent N-terminal and C-
terminal segments of GFP, respectively; binding of both PUM-HDs to their respective 
PumBS reconstituted GFP. A variant of this strategy was employed to image β-actin 
mRNA (194), in which a single RBP-FP fusion was constructed by bridging GFP between 
two PUM-HDs. In contrast to the split-GFP approach, this version necessitates the 
construction and intracellular delivery of only one RBP-FP probe (as opposed to two) and 
overcomes limitations of slow GFP reconstitution. The loss of the background reduction 
through the split GFP, however, had to be compensated by targeting unbound RBP-FP 
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to the nucleus, and imaging sensitivity was further improved by fluorescence 
enhancement via confinement. Both versions of this technique utilize tags that are 
significantly smaller than viral RBS-RBPs, a preferable trait, and can use single-step 
photobleaching of FPs to confirm detection of single RNAs. The system, however, suffers 
from diminished fluorescence enhancement and short observation windows, as the RNA 
is labeled with just one fluorescent RBP that binds its cognate RBS only for a limited 
amount of time. Disappearance of signal in a single step, often assumed to be 
photobleaching, can also occur by dissociation of the RBP from the RBS or from the 
abrupt diffusion of the RNA out of the focal plane. Additional limitations are related to the 
‘metastability’ of the reconstituted GFP, wherein the reconstructed probe persists beyond 
the dissociation or degradation of the RNA that nucleated assembly of the split GFP, often 
leading to false-positive signal. 
The second endogenous RNA probing technique exploits the binding of hrp36, an 
hnRNPA1-like protein found in C. tetans, to hrp36 binding sites in BR2 mRNA (Figure 
1.5D, shown is a general labeling scheme) (202, 206).  Although the hrp36 binding site is 
found in other mRNAs, its copy number in BR2 mRNA is significantly higher. Thus, at any 
given moment a larger number of hrp36 molecules bind BR2 mRNA than any other 
mRNA, allowing for selective fluorescence enhancement (202, 206).  In these studies, 
organic dye labeled hrp36 was used instead of FP for three reasons: (i) It was difficult to 
genetically manipulate primary cells extracted from C. tetans salivary glands; b) 
overexpression of FP labeled hrp36 was expected to result in high background of hrp36 
free or bound to other mRNAs; and c) intracellular delivery and density of labeled hrp36 
could be controlled by microinjection. Orthogonal in its approach, multiple repeats of the 
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hrp36 binding site can be tethered to any exogenous RNA, although the system has 
limited application in probing other endogenous mRNAs. Additional protein-RNA tethering 
system labeling approaches include the use of PABP (340), two split eIF4A domains 
(341), and MCP-zipcode binding protein (ZBP) (342), none of which have yet been utilized 
for intracellular SMM. 
Although a majority of these FP-based labeling schemes has the foremost 
advantage of genetic tractability, they suffer from a few drawbacks. First, the relatively 
high molecular weight of protein-RNA tethering systems limits their application to large 
RNAs. mRNAs in particular are bound by endogenous RBPs and the translation 
machinery, and therefore exist as bulky messenger ribonucleoprotein complexes 
(mRNPs); thus, the molecular weight of large mRNAs does not appreciably change upon 
introduction of a few tethered RBPs, but these can adversely affect the mobility of smaller 
mRNAs. Second, the inclusion of the NLS to the RBP-FPs may affect the labeled RNA’s 
function and localization by increasing the propensity of NLS-RBP-FP bound cytoplasmic 
RNAs to localize within the nucleus. Third, the presence of unbound RBP-FPs in the 
cytoplasm, mediated by their overexpression and/or their limited binding affinity and 
resulting significant dissociation from the target RNA, results in significant background 
noise the removal of which often requires image processing algorithms such as 
deconvolution (209).  Fourth, single molecule counting is not straightforward and entails 
the painstaking construction of fluorescence calibration curves (205, 209), as well as 
requires the implementation of other complementary methods like fluorescence in situ 
hybridization (FISH) (205, 209).  Fifth, non-uniformity of labeling further confounds 
counting (discussed above), but strategies to overcome this issue are slowly emerging 
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(333).  Sixth, RBPs – especially PumHDs – are not strictly specific to their corresponding 
RBS and can generate spurious signal by non-specifically binding to other RNAs. 
Nonetheless, the reliability of these well-standardized labeling schemes is evidenced by 
the availability of general methods to tag and image any mRNA with the MCP-MBS 
system in both lower eukaryotes, such as yeast (330), and complex mammals like mice 
(252).  The transgenic mouse model (252) in particular allows for probing the intracellular 
distribution of any mRNA over different cell types, tissues and even whole animals.  
Another approach to overcome some of the drawbacks of FPs is to reduce the 
protein in size to its chromophore and bind it to a specifically in vitro selected aptamer 
incorporated into the target RNA. Early versions of this approach used malachite green 
as the fluorophore with an aptamer that modulates the dye conformation and increases 
its fluorescence (343, 344).  A more recent incarnation of the approach uses a GFP-
derived group of fluorophores bound by an RNA aptamer termed “spinach” that again 
enhances their fluorescence (345, 346).  Because of their relatively low binding affinity 
and rapid exchange with free dye, the GFP-derived chromophores appear to photobleach 
only slowly (345), but whether such comparably weak binding of small-molecule 
fluorophores will allow for single molecule detection of spinach-tagged RNA remains to 
be seen. 
 
1.3.2.3  Direct Labeling of RNA 
The direct, covalent coupling of fluorescent probes, typically organic dyes, to an RNA of 
interest can be achieved by several chemical and enzymatic methods (259-262, 347-354) 
(Figure 1.6). Generally, small RNAs (<100 nt) are chemically synthesized to contain 
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fluorophore labels or reactive functional groups, which in turn are conjugated to 
fluorophores (Figure 1.6A), at predefined positions. Larger RNAs are either labeled at 
random positions using modified NTPs during transcription or specifically labeled, mostly 
at the 5’- or 3’-end or internally through ligation, by chemical or enzymatic modification 
(Figure 1.6B). Even here, modified NTPs directly coupled to fluorophores or containing 
reactive functional groups can be used, however, the larger size of the former may inhibit 
labeling (355).  In any case, two critical steps in this labeling strategy are the removal of 
free dye from the sample and separation of labeled from unlabeled RNA. As the molecular 
weight of the free dye is much smaller than that of the RNA, the first purification step is 
easily and efficiently achieved by, for example, ultrafiltration, gel filtration, or gel 
electrophoresis. Size cannot be used, however, for the second purification step, as the 
difference in molecular weight between labeled and unlabeled RNA is often negligible. 
Small RNAs are efficiently purified by reversed-phase HPLC since labeled RNAs are 
more hydrophobic than their unlabeled counterparts (352); however, this difference 
becomes less for large RNAs. The ligation of unique sequences to large RNAs can aid 
purification of the product via beads coupled to complementary hybridization probes, 
whereas other enzymatic reactions require thorough and time-consuming standardization 
to achieve high labeling efficiencies (262).  Moreover, the incorporation of modified NTPs 
during transcription results in a heterogeneous population of labeled RNAs, with both 
varying location and number of modifications. Nevertheless, non-specific RNA labeling 
via transcription (356) or alkylating agents (357) has been used to incorporate multiple 
fluorophores within individual RNA molecules as a fluorescence enhancement strategy.  
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Figure 1.6. Chemical (A) and enzymatic (B) methods for direct fluorophore labeling RNA. 
(A) Direct labeling of RNA by chemical methods. Red circles are dye molecules. (B) Direct labeling 
of RNA by enzymatic methods. X represents appropriately modified NTPs that are either directly 
conjugated to fluorophores or contain functional groups for subsequent chemical conjugation of 
dyes. RNA pol, RNA polymerase; polyA pol, polyA polymerase; Capping Enz, 5` end capping 
enzyme; Klenow, Klenow fragment of DNA polymerase I from E. coli; Ligase, typically one of the 
two T4 RNA ligases (24).  Reprinted with permission from ref (46).  Copyright 2014 American 
Chemical Society. 
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Although intracellular delivery of directly labeled RNA has challenges, it also offers 
three main advantages over other labeling strategies. First, RNA counting by stochastic 
photobleaching of fluorophores, wherein the stepwise reduction in intensity of labeled 
particles is a proxy of molecular count, is more accurate and straightforward 
(136, 358, 359).  Other methods require calibration curves and read out the intensity with 
little ability to consider the broad distribution of intensity fluorophores typically exhibit 
(360).  Second, this method does not require any elaborate probe design or attachment 
of significant RNA extensions, only that fluorophores are appropriately positioned to not 
affect RNA function. Finally, particularly small ncRNAs such as siRNAs and miRNAs, 
which cannot be probed via conventional hybridization or protein-RNA tethering 
strategies, can be directly labeled and visualized in both live and fixed cells at single 
molecule resolution (136).  
 
1.3.3  Intracellular Delivery of Fluorophore Labeled RNA 
The choice of labeling strategy directly influences that of the intracellular delivery method. 
For instance, a majority of RBS-RBP labeling strategies largely employs chemical 
transfection (194, 209, 333-335) or viral transduction (205, 252, 333, 361). Plasmids 
encoding both the RBS and RBP are transiently expressed or stably integrated into the 
cellular genome using either of these delivery methods. Numerous transfection reagents 
are available in various chemical formulations – cationic lipids, polyethyleneimine, DEAE 
dextran, calcium phosphate and cationic or neutral dendrimers to name a few – and serve 
to neutralize the innately negatively charged DNA (or RNA), which allows for the efficient 
uptake of the resulting self-assembled particles through negatively charged cell 
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membranes, presumably via endocytosis. As transfection reagent-plasmid complexes are 
heterogeneous in size and distribution, each cell receives a different amount of the 
plasmid (or RNA). Thus, transient transfection leads to heterogeneous (over)expression 
of both the RBS and RBP, a major obstacle for uniform RNA labeling (333).  Creation of 
stably transfected cell lines may mitigate non-uniform expression. Transduction with a 
lenti- or adenovirus that harbors only a single copy of the DNA offers better control over 
intracellular delivery, but is often a laborious process. Furthermore, direct synchronization 
of experiments using any of these methods is difficult because self-assembly, 
endocytosis, exit from endocytosed vesicles, migration into the nucleus, and subsequent 
gene expression each take significant amounts of time that have a wide distribution 
across cells. In addition to these steps, viral transduction also requires virus production, 
which further adds to the lead time prior to RNA visualization. However, the presence of 
inducible expression systems (197, 204, 293, 329, 330, 341, 362-364) for plasmids can 
aid in defining a more precise experimental start time, albeit often accompanied by a 
basal level of “leaky” expression. 
RNAs labeled via other strategies are predominantly delivered by physical force 
(134-136, 197, 202, 206, 208, 217, 293, 319, 357, 365-367) or via cell membrane 
permeabilization (197, 199, 200, 204, 205, 244, 252, 292, 295, 296, 310, 320, 329, 361, 
364, 368-370).  The former includes electroporation and microinjection, whereas the latter 
utilizes pore forming peptides or detergents and organic solvents that partially dissolve 
the cell membrane. More specifically, pore forming peptides function by reversible 
permeabilization (244, 320, 368, 369), making them popular for intracellular SMM of 
hybridization-labeled RNA in live cells. SLO is a classic example of a pore forming 
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peptide, which is produced by gram-positive bacteria as a cytolytic toxin (371).  The 
addition of SLO, typically under serum free conditions, results in its binding to cholesterol 
on the cell membrane and subsequent oligomerization to form pores of ~25–30 nm 
diameter that permits the influx of hybridization probes or directly labeled RNA (372).  
Once the SLO containing medium is removed and replaced with fresh growth medium, 
SLO dissociates and the membrane reseals. However, based on a cell type’s cholesterol 
composition, the incubation temperature, time, cell number, and SLO concentration 
needs to be optimized and, as is the case for transfection, non-uniform delivery of probe 
and/or RNA across the cell population is commonplace, and SLO cannot per se be used 
for intranuclear delivery. Permeabilization of the cell membrane by detergents (Triton-
X100, NP40, deoxycholate, etc.) or organic solvents (acetone, ethanol, and methanol) is 
irreversible and is only used to mediate the delivery of hybridization probes into fixed 
cells.  
In contrast to membrane permeabilization methods, delivery methods employing 
physical force are amenable for the intracellular delivery of both plasmids and RNA 
without any additives and are often the method of choice in hard-to-transfect cells. Among 
them, microinjection offers maximal control over delivered amount and flexibility in 
experimental design, especially for RNA that is directly labeled (136, 208, 217).  The 
process is conceptually simple and uses a micromanipulator, which can traverse 
distances as low as ~10 nm, and an injector pump. First, injection samples are filled into 
glass capillaries whose openings are typically ~0.5-1 µm wide, small enough not to 
puncture cells. Microinjection is then achieved via three precisely timed steps that occur 
within a second: (i) assisted by the micromanipulator the capillary pierces the cell; (ii) the 
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pump applies a pre-set pressure (~10-150 hPa) to the capillary that allows for sample 
ejection; and (iii) the capillary is removed from the cell. In this fashion, cells are 
sequentially and uniformly microinjected with a few femtoliters of RNA solution, and 
controlled delivery is achieved by modulating the sample concentration and injection 
pressure. Furthermore, the ability to inject RNA selectively into either the cytosol or 
nucleus provides for the opportunity to evaluate RNA function in distinct cellular 
compartments and to study nucleocytoplasmic transport processes (373).  
Disadvantages of this technique include the requirement for expensive instrumentation 
and its applicability only to relatively large cell types (i.e., not bacteria), and that only a 
limited number of cells can be manipulated in a given time period. However, the latter has 
the advantage that different RNA types or concentrations, as necessary for titrating and 
measuring reaction kinetics, can be injected into small, spatially separated groups of cells, 
maximizing experimental throughput within a single culture dish. Compared to SLO and 
transfection mediated intracellular delivery that take ~30 min and >6 h, respectively, 
fluorophore labeled RNA can be visualized immediately after microinjection, allowing for 
precise temporal control. Additionally, transfection often leads to the entrapment of 
probes within endocytic vesicles and their degradation via the endosomal/lysosomal 
pathway (159).  Emerging alternatives employ CPPs (320, 374), such as HIV-Tat, that 
are transported across the cell membrane via cell surface receptors. Here, RNA is directly 
tagged with the CPP and the addition of this fusion molecule to cell culture medium results 
in close to quantitative intracellular delivery. 
 
1.3.4  Instrumentation 
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As with any ultrasensitive technique, intracellular SMM requires sophisticated 
instrumentation. However, the availability of a plethora of fluorescence enhancement 
strategies has made it possible to visualize single bright RNA molecules even with simple 
microscopes. In addition to the labeling strategy, the choice of excitation source, optics, 
illumination scheme and detector contribute towards single molecule sensitivity. In the 
following we provide a broad overview of available instrumentation options and, in Figure 
1.7, describe a typical single molecule fluorescence microscope.  
 
1.3.4.1  Light Source 
Lamps were initially popular light sources in both ensemble and single molecule 
microscopy. Due to their polychromatic light, a single lamp could be used to excite 
distinctly colored fluorophores by spectrally refining the excitation light with relatively 
inexpensive narrow-bandwidth filters. However, inefficient filtering is typical and leads to 
the leakage of other excitation light colors that either spuriously excites the sample or 
adds to the noise of the detector and severely compromises sensitivity. Additionally, most 
of these arc-based lamps suffer from limited lifetime and non-uniform illumination intensity 
over their spectral range of operation. Since lasers emit monochromatic, coherent and 
collimated light, they now have effectively replaced lamps as the primary light source in 
intracellular SMM.  To minimize phototoxicity, especially during live cell imaging, and to 
reduce photobleaching, lasers operating at 1 µW -100 mW power, with a power density 
(i.e., the light flux or number of photons per unit area) of 1 W/cm2 to 100 kW/cm2 is typical 
in intracellular SMM applications (375, 376).  The choice of illumination wavelength 
depends on the spectral properties of the fluorescent probe, but typically spans the visible  
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Figure 1.7. Schematic of our home-built single molecule microscope. Our Olympus IX81 
microscope is equipped with two high NA, 60x and 100x, oil-immersion objectives. The 
microscope also has low NA, 10x and 20x, objectives. It features an internal 1.6x magnification 
and is additionally equipped with a 1-4x magnification changer (Olympus). Thus, a maximum 
magnification of 740x (100x1.6x4) can be achieved. Samples are positioned on a nanometer-
precision piezo-controlled stage. The microscope also contains an infrared laser based zero-drift 
control module (Olympus) to correct for focal drift. Solid state lasers with wavelengths of 405 nm, 
488 nm, 532 nm and 640 nm are directed through an acousto-optical tunable filter (AOTF) and 
split into separate fiber-optic cables within a laser launch system. The AOTF allows for computer-
guided selection of the appropriate laser wavelength for illumination and modulation of laser 
intensity. AOTF coupling also enables sub-millisecond switching between multiple laser 
wavelengths, forming the basis for alternating or interlaced excitation schemes. Alternatively, a 
broadband super-continuum laser capable of emitting multiple wavelengths of excitation light in a 
pulsed fashion (ns-ps) can replace the multi-laser system. The fiber-coupled laser beams are 
directed into a cell-TIRF laser-combining module (Olympus). All laser beams are focused on the 
back-focal plane of the objective and aligned to travel parallel to the optical axis such that the 
incident angle of illumination at the dish-medium interface can be controlled electronically by 
changing the distance of the beam from the optical axis at ~0.01o angular resolution using the 
cell-TIRF module. Fluorescence from the sample is detected typically via an MCCD. For multi-
color imaging, the emitted light is split onto two different detectors using a single beamsplitter or 
onto two regions of the same detector. The former strategy can be used even with a point detector 
such as an APD or PMT, whereas the latter requires a large detector area and can be 
implemented only with a CCD. Appropriate mirrors, filters and dichroic beamsplitters are used to 
guide and spectrally filter the light source and emitted light. QB, Quadband. Cells grown on dishes 
(Bioptechs) are maintained at 37 oC on the microscope stage while imaging using a stage 
incubator. The micromanipulator of a microinjection system (Eppendorf Femtojet) is attached to 
the microscope for intracellular probe delivery.  Reprinted with permission from ref (46).  Copyright 
2014 American Chemical Society. 
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part of the electromagnetic spectrum (~400-700 nm) because transmission properties of 
available optics are best in the visible range and the best-documented fluorophores emit 
within this regime. Imaging at wavelengths greater than ~500 nm is preferred to overcome 
cellular autofluorescence and to increase sample penetration depth via reduced 
scattering so that far-red and near-infrared (NIR) probes and lasers are slowly gaining 
popularity. Ultraviolet (UV) light is not suitable for imaging living cells as it induces DNA 
damage and apoptosis (377). 
 
1.3.4.2 Optics  
At the heart of a microscope lies the objective lens. It transmits light from the illumination 
source and collects (fluorescent) light from the sample to create a focused image on the 
detector. Two important parameters, the numerical aperture (NA), an indirect measure of 
photon collection ability, and the magnification together define objectives. High NA (1.25 
– 1.65) and optimal magnification (60x – 150x) are preferred to collect as many photons 
as possible, especially under the low light conditions of single molecule experiments. 
Notably, a further increase in magnification without a corresponding increase in the 
brightness of the light source reduces the number of photons collected per unit square 
area of the detector, thoroughly compromising the visibility of single molecules. A good 
objective additionally minimizes chromatic aberrations (distortions in an image caused by 
differential focusing of different wavelengths of light). Thus, achromat or apochromat 
versions of objectives are mandatory for multicolor imaging. Downstream of the objective 
lens are other optical elements that mediate spectral selection/filtering, important aspects 
of intracellular SMM and multicolor imaging. These include dichroic beamsplitters and 
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emission filters, whose choice is based on the spectral characteristics of the light source 
and the fluorescent probe. The former is oriented at an angle of 45o with respect to the 
illumination or emission light to spectrally separate them, typically reflecting the light 
source and transmitting fluorescence from the sample (in which case it is called as a long-
pass dichroic). This property is also used in multicolor imaging to separate colors above 
and below the dichroic’s wavelength cut-off. Emission filters placed further downstream 
are oriented orthogonal to the incoming light to selectively transmit only the fluorescent 
light and effectively block other stray radiation, including a significant amount of excitation 
light that leaks past the dichroic.  
Although the basic optical elements (objective, other focusing lenses, 
beamsplitters, filters, etc.) suffice for intracellular SMM of RNA over the lateral (x,y) plane 
of the sample, 3-dimensional (3D) motion inherent to all biomolecules including RNA is 
not captured. To extract such axial (z) information, certain optical accessories, such as 
astigmatic lenses can be used. First introduced by Kao and Verkman,(378) and later 
modified by Zhuang and coworkers (379), the method uses a cylindrical lens in the optical 
path to adjudicate axial localization based on the intensity profile of the sample under 
investigation – particles in focus have evenly distributed radial intensity profiles whereas 
particles just above or below the focal plane have elliptical/ellipsoidal intensity profiles 
elongated along different major axes. Recently, Moerner and coworkers used the 
combination of achromatic lenses and a spatial light modulator in a so-called 4f imaging 
system to extract 3D diffusional information of mRNPs in yeast (380, 381) at 25 nm lateral 
and 50 nm axial accuracy. In this case, the PSF of each single molecule is bi-lobed, 
whose relative position varies with the particle’s axial position, essentially carving out the 
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backbone of a DNA double helix through the axial movement of the particle; hence the 
eponym double helical PSF (DH-PSF). Other accessories such as a defocusing lens 
(382) and wedge prisms (383) have also been used to resolve 3D diffusion of particles 
and hold promise in 3D SPT of RNA.  
 
1.3.4.3 Illumination Geometry  
In intracellular SMM, far-field illumination geometries are typically used, wherein the 
distance between the objective lens and sample is at least an order of magnitude greater 
than the wavelength of illumination light (Figure 1.8). There are primarily two types of far-
field illumination: wide-field (WF) and narrow-field (NF) illumination. The main difference 
between the two types of illumination geometry arises in the sample area (the field of 
view, or FoV) they excite: >100 µm2 of the sample is illuminated in WF illumination, 
whereas it is <1 µm2 in NF illumination.  Examples of WF illumination include epi-, total 
internal reflection (TIR), highly inclined and laminated optical sheet (HILO, also termed 
near-TIR), and various other forms of selective plane illumination (SPI), whereas 
examples of NF illumination include confocal and single point edge excitation sub-
diffraction (SPEED) schemes (Figure 1.8).  
Simplest to implement, WF epi-illumination (Figure 1.8A) is widely used in 
intracellular SMM of RNA, largely due to several fluorescence enhancement strategies 
that render single RNA molecules significantly brighter than the cellular background. 
However, excitation light passes through the entire depth of the sample and out-of-focus 
fluorescent molecules contribute towards significant background noise, limiting the 
method to samples with molecules sparsely distributed over all three spatial dimensions.  
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Figure 1.8. Various types of illumination geometries. (A) Wide-field, (B) TIRF, (C) HILO/VAEM 
with a field diaphragm to reduce illumination light diameter, (D) SPI with LSFM (left) and RLSM 
(right) with a magnified view of the illumination plane. Although the geometry is similar for the two 
approaches, the dimensions of the illumination plane are very different. (E) Standard narrow-field 
illumination, with a blow-up of the illumination spot. Pinholes for the excitation (Ex.) light and 
emitted (Em.) light are used to reduce excitation volume and decrease background from out-of-
focus fluorescence, respectively.  Reprinted with permission from ref (46).  Copyright 2014 
American Chemical Society. 
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In contrast, only a thin lamina of ~150 nm at the sample surface is illuminated using TIR 
fluorescence microscopy (TIRF, Figure 1.8B), effectively reducing background 
fluorescence from outside regions (384).  This scheme is based on Snell’s law, wherein 
light that is transmitted through a medium of higher refractive index (ni; e.g., coverglass) 
into one of lower refractive index (nr; e.g., water), is totally reflected within the first medium 
at incident angles (θi) greater than the critical angle given by θc = sin-1(nr/ni). Because of 
the wave properties of light, TIR creates a thin lamina of “evanescent” wave within the 
aqueous phase, only exciting molecules that are within ~150 nm of the coverglass-sample 
interface. TIR is rarely used in intracellular SMM of RNA because it only excites the basal 
plasma membrane and ~100 nm of the adjacent cytoplasm, whereas most RNAs are 
present also throughout the cell and in cellular compartments (such as the nucleus) that 
the evanescent wave cannot penetrate. To achieve greater penetration into the sample 
without significantly compromising the signal-to-noise ratio, HILO microscopy (HILO, 
Figure 1.8C), also termed variable angle epi-fluorescence microscopy (VAEM) or near-
TIR fluorescence microscopy (near-TIRF), was developed (385, 386).  Here, θi < θc so 
that the light is refracted into the sample at high inclination from the optical axis, thus 
illuminating an angled layer within the sample and reducing illumination of molecules not 
in focus. A field diaphragm that maintains the laminar width of the beam controls the width 
of this illuminated layer within the sample. The excitation beam path for epi-illumination, 
through-objective (or objective-type) TIRF and HILO are so similar that a single 
microscope can be used to implement all three schemes (Figure 1.7).  
Several alternative SPI methods have been developed to further increase the 
penetration depth of illumination and restrict sample excitation to the focal plane, such 
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that single molecules can be visualized within tissues or even whole organs, a realm that 
is not accessible to WF-epi, TIRF or HILO. One such advancement is called light sheet 
based fluorescence microscopy (LSFM, Figure 1.8D) (202, 206, 387-389).  In its most 
recent embodiment (206), the method uses two perpendicular objectives, one with low 
NA (~0.3) and the other with higher NA (>1) for illumination and detection, respectively. 
Such a configuration allowed focusing the illumination light as an ~3 µm thick, elliptical 
sheet, which can be moved across the z-axis of the specimen for optical sectioning. Depth 
of imaging is only limited by the working distance of the detection objective. A possible 
alternative to LSFM is reflected light sheet microscopy (RLSM, Figure 1.8D) (376).  In this 
method a small disposable mirror, such as an aluminum coated tipless AFM cantilever, is 
attached at an angle of ~45o to a high (0.8) NA illumination objective, positioned to face 
the detection objective with a slight lateral offset. The mirror reflects the light sheet from 
the illumination objective by 90o and projects it horizontally across the sample, thus 
attaining optical sectioning capabilities. The upright geometry allowed for imaging 
samples mounted on standard sample holders and results in a light sheet thickness of ~1 
µm (FWHM). However, the positioning of the mirror and the shape of the light sheet 
introduce a gap between the surface and light sheet that cannot be illuminated. The RLSM 
illumination geometry holds promise for optical sectioning of thick specimens, but so far 
has been primarily used to image cultured cells (376).  
A majority of NF illumination schemes aims to increase spatial resolution by 
physically reducing the focal volume to a small, typically ellipsoidal or spherical, spot 
rather than a large plane (Figure 1.8E). In this fashion, only a few molecules are excited 
within this small volume element, typically ~500 nm wide and ~1 µm deep. Conventional 
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confocal microscopes are augmented by more sophisticated optical configurations, such 
as spot-scanning 4Pi microscopy (4PiM) (390) and other reversible saturable optical 
fluorescence transitions (RESOLFT) techniques (391), which achieve significantly higher 
spatial resolution by further reducing the illumination volume by at least an order of 
magnitude. Unlike WF illumination, throughput is minimal with NF illumination, i.e., the 
sample is illuminated only one volume element at a time and has to be scanned, but NF 
illumination has advantages of superior spatial (axial) resolution. Modifications to the 
standard confocal setup, such as the spinning-disc or Nipkow-disc confocal microscopy 
(392), significantly improve scanning rates and throughput by simultaneously illuminating 
distinct regions of the sample. Recently, Ma and Yang (393) increased the FoV of NF 
illumination by incorporating oblique angle illumination (projected onto the sample at an 
angle of 45o with respect to the optical axis) and an ~400 µm wide pinhole in the excitation 
path within a standard WF microscope, in what they termed SPEED microscopy. This 
modification results in an inclined ellipsoid excitation volume, tilted at an angle of 45o with 
respect to the optical axis, that selectively illuminates ~320 nm of the sample in all three 
dimensions, leading to ~6-fold larger lateral FoV and ~3-fold smaller axial FoV than 
standard confocal microscopy. By restricting the acquisition area on an EMCCD camera, 
the time resolution of acquisition was improved to ~1 ms (393), which is ~20-to 100-fold 
better than standard WF imaging using the entire CCD chip.  
 
1.3.4.4 Detectors 
Illumination geometry dictates the choice of detector. Intensified charged coupled devices 
(ICCDs) or electron multiplying CCDs (EMCCDs), which feature a relatively large 
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detection area (~8x8 mm2), are the detectors of choice in WF illumination. For NF 
illumination, where photons are collected from only a small region of the entire sample, 
point detectors like avalanche photodiodes (APDs) or photomultiplier tubes (PMTs) are 
used. Almost unlimited in time resolution, APDs and PMTs are sensitive enough to detect 
and accurately count single photons in the sub-millisecond regime, showcasing the 
superior sensitivity and better time resolution of NF imaging (with the caveats of low 
throughput and the need for scanning a larger sample). Although current CCDs also have 
photon counting capabilities, they still suffer from limited time resolution (millisecond time 
regime) and spectral range of detection. The complementary metal oxide semiconductor 
(CMOS) is an emerging technology that promises faster acquisition rates for WF imaging, 
but suffers from lower quantum efficiency (the ratio of detected photons over total photons 
that reach the detector) than CCDs.  
 
1.3.4.5 Specialized Illumination Schemes 
Once a specific illumination geometry is chosen, several illumination schemes can be 
employed to enhance sensitivity and spatiotemporal resolution. For instance, alternating 
excitation (ALEX) schemes (394) have been routinely used in multicolor imaging to 
spectrally and temporally separate photon acquisition from multiple fluorophores by 
sequential imaging. Other multicolor acquisition schemes rely on spatially separating 
fluorescence signals from distinct fluorophores onto different regions of the same detector 
or onto multiple detectors, adding to the cost of instrumentation, whereas ALEX is useful 
in multicolor imaging on a single detector. ALEX is especially useful in reducing 
background associated with simultaneous multicolor illumination and in fluorescence 
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resonance energy transfer (FRET) applications to confirm the presence of both the donor 
and acceptor fluorophores through the course of image acquisition. Another illumination 
scheme, termed stroboscopic illumination (247, 395), can be employed to detect rapidly 
moving single particles that typically look blurry under slow CCD frame rates. Here, high-
powered laser pulses, much shorter than the camera integration time, are used to briefly 
excite the sample. During this excitation period, single particles do not move over large 
distances and appear as distinct PSFs. In this fashion, the temporal resolution of 
acquisition is controlled by the duration of the pulse, however, at the cost of very high 
laser intensity that may be phototoxic to cells. The method also relies on relatively slow 
moving particles distributed at a very low density, such that it is easy to track the position 
of a single particle over time despite the pulse train’s dark periods and the presence of 
other proximal particles, which can obscure particle identity. Finally, when 
photoactivatable or photoconvertible probes are used, tandem excitation schemes of 
photoactivation followed by sample excitation can be used to execute stochastic optical 
reconstruction microscopy (STORM) or photoactivation localization microscopy (PALM) 
and attain ~10 nm-scale spatial resolution, even within densely populated samples (193, 
246).  
 
1.3.5  Single Molecule Observables 
A single intracellular SMM experiment allows the user to monitor a multitude of 
observables, each of which provides information about the molecule under study and its 
immediate surroundings (193).  Experiments are typically performed on one of two distinct 
sample types, live cells or fixed cells, where each provides mutually complementary 
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information. Among the two, live-cell intracellular SMM or SPT experiments shed light on 
the dynamic aspects of cellular function, such as the mobility of individual molecules and 
the extent of interaction between multiple distinct sets of molecules. Although 
fluorescence recovery after photobleaching (FRAP) (396) and fluorescence correlation 
spectroscopy (FCS) (134, 135, 367, 397) have been traditionally used to extract such 
dynamic information, they only measure ensemble-averaged properties and probe a 
small sub-cellular section at any given time, frequently missing variations in molecular 
motion that occur over the entirety of the cell. SPT microscopy by WF illumination 
overcomes this caveat by accounting for almost all fluorophore labeled molecules within 
a cell in a sequence of images (or video). Individual particles are localized in each frame 
of the video at nanometer-scale accuracy and this position is linked between frames to 
construct particle trajectories. Several well-established methods are available to execute 
both of these steps (186, 398-401) whose choice is dependent on the signal-to-noise ratio 
for the former and the ratio of particle density to interframe displacement for the latter. 
Mobility of RNA is then expressed in the form of velocity and a 1D, 2D or 3D diffusion 
coefficient (the average spatial unit a molecule traverses per unit time given any 
constraints on its movement). Particle velocity and displacement are physical properties 
that provide valuable insight into the processivity and overall directionality of motion, 
which are important, for example, in the characterization of motor protein-mediated RNA 
transport (402).  Diffusion coefficients encode information about the molecular mass of 
the mRNPs or the nature of its surrounding milieu, in terms of sub-cellular viscosity and 
the presence of potential interaction partners (403, 404).  Furthermore, the diffusive 
pattern (Brownian, biased, corralled, or stationary) can be used to predict the role of motor 
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proteins or the nature and amount of obstacles in the path of a diffusing molecule (209).  
For instance, prolonged observation and analytical methods like velocity autocorrelation 
(381) have shown that the diffusive pattern of a single RNP often varies even within an 
individual trajectory (209, 381), highlighting the different intracellular interactions a 
molecule experiences through its lifetime. More specific interactions are revealed by 
simultaneous tracking and colocalization dwell times of molecules that are labeled with 
spectrally distinct fluorophores (205, 369) in two-color imaging schemes. Concordant 
motion adds another layer of confidence to traditional colocalization studies that often 
obfuscates non-interacting particles bearing similar x,y coordinates but distinct z-
positions with physical association (complex formation). The protein-RNA,(205, 209) 
hybridization by molecular beacons (293) or MTRIPs (244, 368, 369), and direct labeling 
systems (136) have all been used in SPT of RNA in living cells; however, the protein-RNA 
tethering systems are particularly popular among cell biologists because of their arguably 
easier and gentler conditions for delivering probes, which may better preserve cell 
integrity.  
Sub-cellular localization and counting of individual mRNA molecules yields single 
cell gene expression data and thus has revolutionized our understanding of cellular 
homeostasis and the effects of deviations from it (21, 136, 405-407).  Stoichiometry 
measurements by stepwise photobleaching, which assess the number of molecules 
within individual, not further resolved fluorescent particles, increase the accuracy of 
counting and are useful in discerning the ubiquitous assembly/disassembly of molecular 
complexes (136, 358) and in functionally annotating sub-cellular localizations (310, 369).  
However, the abrupt change in intensity by the diffusion of particles out of the focal plane 
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in conventional 2D imaging confounds single molecule counting and stoichiometry 
measurements in live cells. FCS is useful in such cases, wherein the diffusion of 
molecules through a well-calibrated focal volume results in intensity bursts whose 
frequency is used to measure intracellular concentration. This method, however, has the 
inherent disadvantage of having to assume a homogeneous distribution of the molecule 
throughout the cell or, conversely, requires the slow, sequential probing of different 
regions within the cell to correct for heterogeneity. Molecule counting and stoichiometry 
analysis are more reliable in fixed cells, where particles are easily tractable and spatially 
confined. A majority of single molecule counting experiments of RNAs, especially 
mRNAs, has been achieved by smFISH. 3D image stacks of probe-treated cells are 
acquired and individual particles are detected by image processing steps that include 
image enhancement and intensity thresholding (292, 311).  Gaussian fitting,(186) 
deblurring by deconvolution (244, 291, 298) and image convolution by high-pass filtering 
(292, 308), such as a Laplacian of Gaussian (LoG) filter, are a few image enhancement 
strategies that have been applied to particle detection via smFISH. Molecular 
stoichiometry in fixed cells can be measured either by particle counting in smFISH images 
or by stochastic photobleaching of fluorophores (136, 358).  The latter is more effective 
when single RNA molecules are labeled with relatively few fluorophores, typically 
achieved by direct labeling schemes. Photobleaching of RNPs decorated with a large 
number of fluorophores, as in the case for most protein-RNA tethering and hybridization 
labeling schemes, yields non-discernible and frequently overlapping photobleaching 
steps that yield incorrect molecular count (359).  In such cases, calibration curves are 
constructed by imaging (free) fluorescent probes (291, 298) at various concentrations, 
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from which the intensity of a single probe is extrapolated. The number of probe repeats 
per RNA is considered in calculating the approximate intensity of a single RNA molecule, 
which is then used to compute the molecular copy number within individual particles. 
Alternatively, the mean intensity value of smFISH-detected particles is used as a measure 
of molecular count (292, 311).  Although stoichiometries extracted from these curves are 
often either error-prone or approximate, they are useful in observing trends. Overall, both 
live and fixed cell imaging are powerful in discerning the spatiotemporal organization of 
intracellular RNAs.  
In the next section, specific recent examples of characterizing the biological 
function of RNAs and the mechanisms of their biogenesis, transport, regulation and 
turnover through single molecule observation are presented. 
 
1.4  RECENT APPLICATIONS OF SINGLE MOLECULE APPROACHES TO RNA 
IN CELLULO  
Earlier, RNA was introduced in its various forms as a highly versatile molecule, coding for 
proteins, serving as structural scaffold, performing enzymatic functions, and regulating 
gene expression. To perform such widespread functions, RNA production, maturation, 
interactions, and spatial distributions require tight regulation, which in turn is the 
foundation of cellular homeostasis and survival. Intuitively, the bulk properties observed 
of such processes and others are potentially the sum of all single molecule events. For 
example, ensemble experiments have convincingly shown that a significant fraction of β-
actin mRNA localizes to the leading edge of a cell (285, 408), while a majority of 
transcripts still seems to be spread throughout the cytoplasm. Yet only with the aid of 
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intracellular SMM it could be resolved that their diffuse cytoplasmic distribution is a 
cumulative result of individual transcripts either remaining stationary or undergoing: (i) 
Brownian diffusion; (ii) corralled motions; and (iii) active transport (209, 368).  It was 
additionally found that transcripts are not in a constant diffusive state, but rather switch 
between multiple modes of movement (209).  Despite the fact that only ~9-20% of all 
transcripts exhibit biased motion, interrupting active transport significantly alters 
intracellular distribution and almost abolishes localization at the leading edge (209, 285, 
368, 408).  Thus, intracellular SMM has been indispensable for understanding 
mechanisms of cellular RNA localization and the underlying kinetic parameters controlling 
them. To fully appreciate these findings, this section will detail the results of select studies 
performed over the last fifteen years and how they have contributed to our understanding 
of cellular biology. By necessity, this selection will be incomplete, due to the rapid and 
accelerating progress in intracellular single molecule fluorescence studies of RNA. 
 
1.4.1  Nuclear Diffusion of RNA 
Regardless of the relative distances between the transcription and pre-mRNA processing 
sites, RNA must eventually traverse the nucleoplasm to reach the nuclear envelope for 
exportation. Active transcription sites are not always located at peripheral regions of the 
nucleus, but can occur in chromatin dense regions (409, 410).  Transcribed RNA 
molecules in these regions traverse chromatin free tracks towards the nuclear envelope 
(411), sparking the hypothesis that RNA may be actively transported via motor proteins 
along the nucleoskeleton as a more efficient means of RNA delivery to processing centers 
and the NPC. An electron microscopy study was the first to demonstrate that BR mRNAs 
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in C. tentans salivary glands are randomly distributed throughout the nucleoplasmic 
space, suggesting that they move primarily via simple diffusion and not active transport 
(412).  Siebrasse et al. labeled and tracked the movements of single BR mRNA 
molecules, labeled with fluorophore-conjugated DNA or 2’-O-methyl-RNA 
oligonucleotides, or with recombinant fluorescent hrp36 (an hnRNP protein), in living C. 
tentans salivary gland cells (202) to corroborate the EM findings. Mean square 
displacement (MSD) analyses of the SPT data demonstrated deviations from linearity, 
and thus from Brownian diffusion behavior, with increased lag time, suggesting corralled 
motions (202, 413).  This behavior is potentially mediated by the binding of BR transcripts 
to cellular factors or by general crowding effects that occur in the dense milieu of the 
nucleus. Nucleoplasmic diffusion coefficients of BR mRNA were significantly slower than 
those of similarly sized dextran molecules (D = 2.2 µm2/s). These data coupled with Monte 
Carlo simulations suggested that BR mRNA may be slowed as the result of a series of 
transient interactions with nuclear components. These results effectively strengthened 
claims from prior ensemble microscopy experiments performed in chromatin bearing 
mammalian cells, where mobility of mRNPs was found to involve passive diffusion and 
ATP-dependent processes (340, 414).  
Shav-Tal et al. employed the MCP-MBS labeling system to selectively label stably 
integrated and inducible exogenous genes in mammalian cells and, using SPT, studied 
a significant part of their lifecycle, from transcription to nuclear export (203).  Labeled 
RNA diffused throughout the nucleoplasm avoiding regions occupied by large nuclear 
structures (chromatin, nucleolus, etc.), with 58% of the tracks Brownian in nature and 
42% exhibiting corralled motion (Figure 1.9) (203, 204).  Motions were most confined or 
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immobile when in close proximity to the TS (203, 293).  Outside the transcription site, 
RNA molecules were not observed to stall or stop, implying that they do not make stable 
interactions with sub-nuclear compartments. Under hyper-osmolar conditions, corralled 
motions of mRNPs were enhanced due to the entrapment of transcripts within dense DNA 
regions and their sequestration into speckle domains, a process that is reversible upon 
returning the cells to isotonic conditions. Vargas et al. obtained similar results with 
temperature reduction or ATP depletion (293), strongly suggesting a (perhaps indirect) 
role for DNA dynamics in modulating RNP diffusion. 
The diffusion coefficients of MCP-MBS labeled mRNPs are much smaller than 
those reported in ensemble mRNA experiments (428, 242).  To test if this effect is due to 
particle size or transient RNP interaction with other proteins, Mor et al. designed seven 
constructs of increasing size or bearing the same size but different numbers of introns 
(Table 2) (204).  2D and 3D SPT of these transcripts showed trends of diffusion 
coefficients decreasing with RNA size, eventually reaching a saturation point for the three 
largest mRNAs tested (Table 2). Cytoplasmic diffusion coefficients of the smaller 
transcripts correlated well with their nuclear diffusion coefficients, however, the larger 
transcripts diffused more slowly in the nucleoplasm. 3D tracking of mRNPs in cells with 
Hoechst 33342-stained DNA suggested that the larger RNAs exhibit more corralled 
motions in the narrow inter-chromatin spaces than the smaller RNA, contributing to their 
small diffusion coefficients. Thus, the three largest mRNAs have equal nuclear diffusion 
coefficients but divergent, faster cytoplasmic diffusion coefficients simply due to the 
strong (and non-discriminating) sieving effects of the comparably narrow inter-chromatin 
channels they traverse in the nucleus (204). 
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Figure 1.9. Single particle tracking of mRNPs in mammalian cells. (A) Schematic of the 
mRNA constructs with 24xMS2 binding sites used in this study. Nuclear diffusion data for each 
construct are summarized in Table 2. (B) Deconvolved time-series images of nuclear Cerulean-
½ Mini-Dys + intron mRNP diffusing in the nucleoplasm (green tracks). (C) Complete track of the 
nuclear Cerulean-½ Mini-Dys + intron mRNP. (D) MSD analysis of single nuclear mRNPs 
displaying Brownian (green) or corralled (red) motions in the nucleoplasm. Corralled motions 
deviate from linearity at longer lag times. Scale bar represents 1 µm. Reprinted with permission 
from ref. (204). Copyright 2010 Nature Publishing Group. 
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Labeling of particles with spectrally distinct fluorophores facilitates colocalization 
and co-tracking during the assembly of biomolecular complexes. A two-color approach 
was used to study the interaction of snRNPs with nuclear speckles, in an effort to 
understand the interaction of splicing factors with these largely elusive nuclear foci. To 
this end, Grunwald et al. microinjected non-specifically labeled U1 snRNP-Cy5 
conjugates into the cytoplasm of HeLa cells expressing ASF/SF2-GFP, a protein that 
concentrates in nuclear speckles (217).  Upon nuclear import, the snRNPs distributed into 
three sub-populations: immobile (77.5%), slowly diffusing (15%, with average diffusion 
coefficients of 0.51 ± 0.05 µm2/s), and fast diffusing (7.3%, with 8.2 ± 3 µm2/s). 
Interestingly, not all immobile snRNPs were observed to colocalize with fluorescent 
markers of nuclear speckles (217) where splicing occurs and most spliceosomal snRNPs 
are thought to reside. Notably, those snRNPs that did colocalize remained in speckles 
over periods ranging from milliseconds to seconds with a double-exponential time 
distribution, suggesting that their binding mechanisms are complex (217).  In another 
study, it was observed that spliceosomal components are not stored in nuclear speckles, 
but rather splicing proteins are found diffusing throughout the nucleus and collide 
randomly and transiently with pre-mRNAs (415). 
 
1.4.2  Cytoplasmic Localization of RNA 
Much like proteins, the sub-cellular localization of RNAs is critical to their function and 
regulation (416).  Localization can be diffuse, wherein RNA molecules move in a manner 
that allows equal sampling of the cytoplasmic space, or polarized, where the RNA is 
directed to and localized in or near unique sub-cellular features. For instance, certain  
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Table 1.2. Nuclear diffusion characteristics of RNAs of varying length. Data taken from ref. (204) 
Reprinted with permission from ref (46).  Copyright 2014 American Chemical Society. 
 
Gene Name 
mRNA 
length (kb) 
Diffusion 
(μm2/sec) 
Percent 
Corralled 
Percent 
Brownian 
Full-Dys 14  0.005 60% 40% 
Mini-Dys 8  0.005 75% 25% 
½-mini-Dys 4.8  0.005 50% 50% 
½-mini-Dys + 1 intron 4.8  0.004 45% 55% 
E1 1.7  0.009 NA NA 
E3 2.1  0.010 NA NA 
E6 2.3  0.023 NA NA 
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neuronal mRNAs are enriched in select dendritic regions for their local and rapid 
production of proteins that control potentiation, a process necessary for cellular memory. 
These asymmetric RNA distributions were alternatively hypothesized to result from: (i)  
continuous active transport; (ii) active transport and anchoring; (iii) diffusion and 
anchoring; and/or (iv) increased stability in sub-cellular distributions. However, it is still 
unclear if these processes simply occur to varying degrees or if different RNAs follow 
distinct localization pathways. Live cell, single molecule experiments are an ideal tool to 
provide answers to these questions. 
The first recorded experiment utilizing the MS2 RNA labeling system was designed 
to probe the mechanism of mother-to-daughter (bud) Ash1p mRNA delivery and 
sequestration in yeast (207).  SPT of Ash1p mRNA revealed directional movements at 
velocities concordant with that of myosin-mediated transport (320 nm/s), strongly 
suggesting active transport of these mRNPs on the actin cytoskeleton. Ash1p mRNA 
stably resides at the bud cortex for periods of >1 min, suggesting an anchoring 
mechanism. It was later found that similar transport mechanisms mediate the asymmetric 
distribution of other yeast RNAs (329, 417).  RNA transport mechanisms were found to 
be widespread in higher eukaryotes such as Drosophila (305, 418-420), C. elegans (421), 
chicken fibroblasts (422), and human cells (194, 208, 368, 423, 424).  
Although individual actively transported mRNPs are large and typically contain the 
transport and translation machinery among others, they primarily entail only single 
molecules of mRNA (208, 423-426).  In lieu of single RNP transport, the packaging and 
co-transport of multiple RNPs as large granules have also been observed, in both 
individual cells and multicellular embryos (329, 420).  In either case, RNA in route to its 
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destination can oscillate between anterograde and retrograde transport (305, 425, 427), 
and the extent of bidirectionality can be stimulus dependent. For instance, Rook et al. 
used the MS2 system to demonstrate that the dendritic localization of CaMKIIα mRNA is 
increased by cell depolarization (427). 
In cellulo single molecule imaging has also shed light on novel RNA transport 
mechanisms. Specifically, Fusco et al. (209) used the MS2 labeling strategy to 
demonstrate the heterogeneous and probabilistic movement of individual mRNPs in living 
COS cells (209).  They found that mRNPs exhibit either a multitude of diffusive behaviors 
(biased, corralled and Brownian) or remain stationary and frequently switch between 
different diffusive patterns (Figure 1.10A and B), a phenomenon observed by other 
groups as well (368, 428).  Importantly, the authors demonstrated a sequence specific 
bias of mRNPs towards select motion types by being able to increase the propensity for 
directed motion in RNPs tagged with a zipcode sequence contained in the 3’-UTR of β-
actin mRNA (Figure 1.10C) (209).  Other cytoskeleton independent RNP transport 
processes were also found in complex multicellular systems, wherein transport is 
mediated by fluid flow within the organism and localization can either be actin dependent 
or independent (419, 429). 
 
1.4.3  Translation of mRNA 
As discussed earlier, transcription can be a highly variable process that will lead to 
changes in cellular mRNA levels. Correlating transcript number to protein output further 
defines the stochastic nature of translation and its overall contribution to noise in gene 
expression (430).  Notably, spatiotemporally controlled, localized mRNA translation is a 
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ubiquitous phenomenon, where proteins are synthesized at their site of activity, thus 
reducing the need for macromolecular transport - a prototypical example is that of actin 
mRNA translation at the leading edge of cells (431).  Tatavarty et al. probed the 
translational output of individual mRNAs in neuronal cell dendrites by taking advantage 
of the facts that mRNPs are typically transported within relatively slow moving granules 
along dendrites and that translation is primarily localized to the dendritic spine (208).  In 
essence, the authors had a priori knowledge of the location of translation and could 
visualize both the mRNA and translated protein at the temporal resolution of their 
microscope. To this end, they non-specifically labeled the mRNA coding for the Venus 
FP with Cy5 by incorporating Cy5-UTP during in vitro transcription and microinjected the 
labeled mRNA into the perikaryon of cultured hippocampal cells. They used an 
appropriate concentration of labeled RNA such that a single granule had at most a single 
RNA. Correlating mRNA signal with that of translated Venus FP presented evidence for 
Poissonian (sporadic) or super-Poissonian (Bursting) translation, where bursting was 
hypothesized to result from polysome formation (mRNA bearing >1 ribosome) (208).  The 
authors demonstrated that polysome formation occurs less frequently than monosome 
formation and that its extent is controlled by receptor mediated elongation or initiation 
inhibition and excitation (208).  Intriguingly, there was no correlation between mRNA 
number and fluorescent protein output in E. coli (315), which the authors attributed to 
factors extrinsic to translation, like mRNA degradation, or to the static nature of the 
smFISH technique (315).  Stress conditions can also alter the extent of translation of a 
given gene (432).  During bacterial stress, a protein called RelA synthesizes alarmones 
(signaling molecules synthesized solely under harsh conditions), such as ppGPP and  
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Figure 1.10. Cytoplasmic mRNP dynamics. (A) Movements of an MCP-FP labeled LacZ-hGH 
mRNA. Overlay of a 200-frame video (left image). The scale bar located in the bottom right corner 
represents 10 µm. Magnifications of select regions of the projection image are shown in the right 
images. The scale bar here represents 2 µm. Green lines represent the tracks the particles 
traverse. (B) Movements of an MCP-FP labeled Lacz-SV mRNA, imaged similar to panel A. (C) 
Distributions of LacZ-SV mRNP motions with and without a -actin 3’-UTR. Reprinted with 
permission from ref. (209). Copyright 2003 Elsevier. 
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pppGppp to suppresses translation, among other cellular processes. English et al. 
discovered that both RelA and the ribosomal 70S subunit have the same diffusion 
coefficient (~0.5 µm2/s) at normal growth conditions, possibly due to their association 
(432).  Upon heat shock or starvation, RelA’s diffusion coefficient increases 25-fold, 
suggesting its release and diffusion throughout the cytoplasm, in a reversible fashion. 
Taken together, the authors were able to demonstrate that RelA will ‘hop off’ the ribosome 
under stress conditions in order to induce the cellular adaptation response pathway, 
consequently inhibiting bacterial translation (432).  
 
1.4.4  Post-Transcriptional Control of Gene Expression 
The proper development, growth, and regeneration of multicellular organisms require tight 
spatiotemporal control of gene expression. Any deviation from the norm, in terms of the 
number and spatiotemporal localizations of specific RNAs, can contribute to phenotypic 
changes that are either necessary or deleterious to the organism. Defining these RNA 
parameters provides mechanistic insight into functional and dysfunctional differentiation 
processes. Single molecule, particularly smFISH, tools have been used extensively to 
characterize RNA expression profiles in multicellular, asynchronous and heterogeneous 
cell populations, such as tissues and developing embryos (296, 433, 434).  For example, 
Saffer et al. used smFISH to demonstrate the impacts of genetic mutations in synMuv 
genes on cellular lin-3 RNA distribution and the consequent influence on vulva 
development in C. elegans (435).  A three-color smFISH study by Itzkovitz et al. 
discovered the location of specific stem cells in mouse intestines by probing for cell 
specific genes (406).  Their findings revealed that two distinct populations of stem cells 
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are harbored in intestinal crypts, each exhibiting a unique expression profile for stem-cell 
specific genes that changes as a function of age and active regeneration (406).  Lionnet 
et al. developed a transgenic mouse that co-expresses an endogenous MCP-FP fusion 
protein together with a -actin mRNA carrying MBS repeats that can be used to study 
mRNA expression in any tissue (252).  In addition to coding mRNAs, smFISH techniques 
have been utilized to probe miRNA expression patterns (227, 228).  Neely et al. utilized 
the Direct miRNA assay to characterize the expression patterns of 45 miRNAs in as many 
as 16 different tissue types (227).  Finally, Li et al. utilized miRNA In Situ Hybridization 
(MISH) coupled with enzyme-labeled fluorescence (ELF) to show reduced quantities of 
miRNA-375 expression in esophageal squamous cell carcinoma cell lines relative to 
normal tissue (228).  Collectively, these single molecule RNA counting assays have and 
will continue to provide much needed spatial and temporal information of gene regulation 
in asynchronous and heterogeneous cellular systems.  
The cell has developed a multitude of mechanisms to control gene expression and 
prevent infection through the sequestration and degradation of both endogenous and 
exogenous parasitic RNAs. Mechanistic and kinetic analyses of RNA decay processes 
reveal important parameters to understand and predict their cytoplasmic spatial 
distributions and lifetimes. In cellulo single molecule counting is ideal when aiming to 
quantify changes in RNA levels within a single cell or a heterogeneous sample. Trcek et 
al. counted cytoplasmic mRNA using smFISH and uncovered a cell cycle specific mRNA 
decay mechanism in yeast (436).  They deduced that these mRNAs are stable from the 
S to the G2 phase (halftime, t½ > 66 min), but are more rapidly degraded during mitosis 
(t½ < 2 min). Additionally, these effects were found to be dependent on the promoter 
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sequence and nuclear protein factors that bind them (Dbf2p and Dbf20p) (436).  Together, 
this data presents a model of degradation wherein co-transcriptional events dictate an 
mRNA’s lifetime.  
Single particle tracking is ideal for measuring kinetic parameters of rapid processes 
and measuring temporal changes in diffusion patterns. Pitchiaya et al. used a unique 
blend of SPT, photobleaching analysis and microinjection (in a technique termed 
intracellular single-molecule, high resolution localization and counting, or iSHiRLoC) to 
elucidate the spatiotemporal behaviors of microinjected, cyanine dye labeled miRNAs in 
HeLa cells (Figure 1.11) (136).  The authors found that a majority of miRNAs begins to 
diffuse slowly enough for observation with a 100-ms camera integration time about an 
hour after microinjection, suggesting that association with target mRNAs occurs on this 
timescale. Analysis of stepwise photobleaching trajectories in fixed cells indicated little 
multimer assembly (more than one miRNA per focus) up to this time (Figure 1.11C and 
D), supporting the conclusion from live cell imaging (136).  Two hours after microinjection 
and beyond, miRNAs are visible as individual particles with a fluorescence signal 
enhanced by confinement or binding within comparatively large endogenous mRNPs.  
These particles exhibit four different types of diffusive motion, Brownian, corralled, 
directional, and slow Brownian/immobile, and distribute into (at least) two Gaussian 
distributions of diffusion constants that mimic the diffusion observed for mRNPs (0.26 
µm2/s) and the mRNA degrading P-bodies (0.034 µm2/s; Figure 1.11B). Photobleaching 
analysis revealed time dependent formation of miRNA multimers (foci containing >1 
labeled miRNA), whose temporal evolution fits with a double-exponential function (Figure  
 
 
90 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11. iSHiRLoC of miRNAs. (A) Representative pseudocolored images of live HeLa cells 
injected with Cy3 (green) or Cy5 (red) labeled let-7-a1 miRNAs and representative single particle 
tracks showcasing the multitude of diffusive patterns these miRNAs exhibit. Scale bars represent 
10 µm. (B) Distribution of diffusion coefficients of miRNPs at various time points. (C) 
Representative pseudocolored and background subtracted image of a fixed HeLa cell 
microinjected with Cy5 labeled let-7-a1 miRNA. Below, two representative photobleaching 
trajectories of particles in the image. (D) Fraction of monomers and multimers as a function of 
time. (E) Unifying model of the RNA silencing pathway consistent with the experimental data. 
Reprinted with permission from ref. (136). Copyright 2012 Nature Publishing Group. 
 
 
91 
 
1.11D) and correlates well with the changes in miRNA diffusion coefficients (136).  An 
artificial miRNA with much fewer endogenous targets does not show any temporal change 
in assembly, unless endogenous mRNA target is co-microinjected (Figure 1.11D). Taken 
together, the authors concluded that miRNA bind and sequester their targets into mRNA 
degrading P-bodies within the first 2 h (k1 = 1.2 ± 0.2 h-1), which are slowly (k2 = 0.14 ± 
0.08 h-1) released back to the cytoplasmic pool, likely after target degradation, over the 
remaining 32 h period. These results correlate with the timing of colocalization between 
smFISH probed RNA and various immunostained P-body components (310) and support 
a unifying two-stage RNA silencing mechanism where translational repression is 
kinetically followed by mRNA degradation (136). 
Stress granules (SGs) are membrane-less cytoplasmic foci that form when cells 
are exposed to environmental stress, and their formation is accompanied by global 
translation arrest of housekeeping transcripts (437).  These foci are composed of the non-
canonical, translationally silent 48S pre-initiation complex (containing the small ribosomal 
subunit-associated early initiation factors eIF4E, eIF3, eIF4A, eIFG as well as PABP), 
several mRNA binding proteins that regulate mRNA translation and decay and proteins 
involved in RNA metabolism (437).  P-bodies, by contrast, are cytoplasmic foci 
predominantly enriched in RNA processing and degradation enzymes, which are present 
in healthy cells as well. Although SGs and P-bodies are often seen in proximity to each 
other during stress and both have common protein components, they are distinct cellular 
granules, with the former functioning to store and aggregate translationally inactive 
mRNAs and the latter representing RNA decay sites (437).  While the two types of foci 
have been well characterized, their interactions with native mRNAs are still poorly 
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understood. To probe this interaction, Zurla et al. used hybridization based MTRIPs to 
visualize the interaction of actin and other polyA sequence containing mRNAs with 
immunostained SGs and P-bodies in fixed cells (369).  They observed that under stressed 
conditions <5% of all transcripts colocalized with SGs, whereas <1% colocalized with P-
bodies, and that the extent of P-body localization was similar between stressed and 
unstressed conditions. Stress induced specifically by translation inhibition changed the 
localization pattern of the transcripts and moved them closer to the nucleus. By co-
imaging the mRNA and tubulin, and by disrupting the cytoskeletal network, the group 
found that microtubule integrity was necessary for actin mRNA localization to both these 
foci and the exosome (369). 
 
1.5  SUMMARY 
Above, describes numerous RNAs that are found in particularly the eukaryotic cell and 
have provided a detailed summary of the single molecule tools available to study RNAs 
intracellularly. A large fraction of single molecules studies published so far have been 
used to characterize protein-coding mRNAs. However, as we have highlighted in Section 
2, the majority of RNAs found in the eukaryotic cell do not code for protein, but rather 
regulate gene expression via post-transcriptional gene silencing or epigenetic gene 
regulation. Intracellular single molecule techniques offer an unparalleled means to 
investigate the behavior of these emerging classes of ncRNAs.  
 Rapid recent advances in single molecule tool development are likely to further 
facilitate analysis of the multitude of cellular RNA functions. For example, more pervasive 
implementation of super-resolution techniques may be necessary to dissect the functions 
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and mechanisms of ncRNAs within densely populated samples (193).  In addition, 
enhanced spatiotemporal resolution using, for example, SPEED microscopy (89), more 
observables, and an increased field of view will likely facilitate studies of intracellular 
single molecule RNA dynamics. We anticipate a bright future for discoveries using 
intracellular single molecule fluorescence microscopy as applied to RNA. 
 
1.6   THESIS OVERVIEW 
RNA plays a fundamental, pervasive role in cellular physiology, through the 
maintenance and controlled readout of all genetic information, a functional landscape we 
are only beginning to understand.  In particular, the cellular mechanisms for the 
spatiotemporal control of the plethora of RNAs are still poorly understood.  Intracellular 
single-molecule fluorescence microscopy provides a powerful emerging tool for probing 
the pertinent biophysical and biochemical parameters that govern cellular RNA functions, 
including those of protein-encoding mRNAs.  Yet progress has been hampered by the 
scarcity of high-yield, efficient methods to fluorescently label RNA molecules without the 
need to drastically increase their molecular weight through artificial appendages that may 
result in altered behavior.  Herein we employ and systematically test the biological 
consequences of three distinct labeling strategies in intracellular single-molecule 
fluorescence microscopy assays.   
Chapter 2, describes my attempts to explore the intracellular spatiotemporal 
behaviors of microinjected Cy5-labeled miR-21 in cancer versus primary cells.  Given that 
microRNA-21 (miR-21) is predicted to have low target engagement in primary versus 
immortalize cancer cells (438),  we hypothesized that microinjected fluorescent miR-21 
94 
 
should diffuse measurably faster in the various cell lines.  Yet during our analysis we 
identified off-target/ non-specific intracellular distribution patterns of microinjected 
fluorescent miR-21 that largely convoluted their movement behaviors.  These anomalous 
particles were identified as LAMP-1 containing compartments (lysosomes) which we 
hypothesize to be sites of sequestered degraded miRNA or uncoupled fluorophore.  
Furthermore, we were able to disprove our original hypothesis by demonstrating a miR-
21 dependent repression of luciferase reporter genes bearing miR-21 microRNA 
regulatory elements (MRE) in primary mesangial cells.   
Chapter 3 discusses the use of yeast poly(A) polymerase (yPAP) and T7 RNA 
polymerase to incorporate either 2’ azido-2’-deoxyadenosine-5’-triposhpate (azido-ATP) 
or Cyanine5-Aminoallyluridine-5’-triphosphate into one of three distinct regions of the 
RNA chain: throughout the body (5’ UTR, coding sequence & 3’ UTR), between the body 
and poly(A) tail (BBT), or throughout the poly(A) tail (Tail).  The positions of each label 
are then tested for their impact on the protein-coding functions of the RNA molecule 
through in vitro translation, in vivo luminescence and immunofluorescence assays; a feat 
only successfully accomplished by BBT and tail labeling strategies.  Additionally, the 
extent of 3’ UTR accessibility to regulatory molecules was tested by comparing the extent 
of repression of FLuc RNA, bearing one or more microRNA regulatory elements (MRE), 
in the presence or absence of labeling.  This was further explored by two-colored 
intracellular single-particle tracking experiments, the extent of colocalization of a 
fluorescent RNA with DCP1a-EGFP – processing body (p-body) marker – with and 
without microRNA; all three labeling strategies were largely accessible to microRNA 
mediated repression.  Collectively, BBT and tail modified strategies represent the most 
95 
 
minimally invasive of the three techniques that render the RNA capable of coding for 
protein and miRNA mediated regulation. 
Chapter 4 discusses the intracellular single-particle behaviors of microinjected 
labeled RNA (as described in chapter 3) using the intracellular single-molecule high-
resolution localization and counting (iSHiRLoC) assay.  These labeling strategies prove 
superior for real-time particle tracking and counting of fluorescent RNA than by traditional 
labeling approaches (230, 232, 427).  Single-colored particle tracking and counting 
experiments were difficult to interpret and showed largely indiscernible movement 
characteristics from free dye or partially degraded fluorescent RNA.  Despite these 
caveats, two-colored live-cell tracking experiments demonstrate clear instances of 
functionally relevant interactions between fluorescent RISC components and messenger 
RNAs; thus poising us for success to address relevant questions about miRNA target 
engagement in a cellular context. 
Chapter 5 discusses the implementation of a new intracellular assay designed to 
measure the long-term interaction kinetics of fluorescently labeled molecules, termed: 
gene-actin tethered intracellular co-tracking Assay (GATICA).  Herein, we wield the use 
of either biotinylated phalloidin or actin protein to tether streptavidin coupled, biotinylated 
fluorescent RNA to f-actin fibrils within the cell.  Microinjected complexes, both phalloidin 
and actin tethered, demonstrated clear instances of slowed diffusion and colocalization 
with fluorescent actin fibril marker.  However, the use of biotinylated actin has the 
additional benefit of localizing the properly complexed RNA through directed motion to 
the leading edge of the cell, which assists in the identification of single-particles.  Only in 
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its preliminary stage, this assay is a nice complement to our previous two chapters in 
studying interaction kinetic differences for fluorescent miRNA and its target genes.   
Overall, this body of work systematically tests the functional impacts of fluorescent 
labels on short and long RNA molecules in our in-house single molecule assays:  
iSHiRLoC and GATICA.  Lessons are learned herein about the functional consequence 
of fluorescently labeling both short and long RNA in vitro, namely: anomalous diffusional 
behaviors and slow clearance rates of degraded fluorescent RNA, sequestration of 
fluorescent RNA with lysosomal components and even inhibition of protein translation.  
Optimization of the RNA labeling design and implementation of two-colored iSHiRLoC 
assay largely circumvented the aforementioned caveats, by closely studying only those 
particles that interact with one another.  Poised for success, fluorescent mRNA and RISC 
component interactions can now be extensively studied inside the cell at the single-
molecule level.  
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Chapter II 
Testing the miR-21 Target Engagement Hypothesis: Comparing Immortal and 
Primary Cells 
 
2.1  INTRODUCTION: 
MicroRNAs (miRNA) are small ~22 nucleotide (nt) RNA molecules that, when loaded into 
one of four Argonaute proteins (Ago1-4), serve as a template sequence for the miRISC 
machinery to silence their messenger RNA (mRNA) targets.  miRNAs recognize their 
targets by the partial annealing of the first eight nucleotides on their 5’ end, the so-called 
seed sequence, with a complementary sequence (miRNA binding site) in the mRNA 3’ 
untranslated region (UTR) (439, 440).  Once recognized, miRNA-mRNA loaded Ago 
recruits other miRNA Induced Silencing Complex (RISC) components to induce 
translational initiation inhibition followed by mRNA 5’ to 3’ decay (441-443).  Over 1,500 
endogenous miRNA have been discovered, which have been observed to target over 
60% of the mammalian genome (444).  Of these mammalian genes, half have been 
implicated in human disease (445).  The dysregulation of miRISC components or the 
mRNA target can cause a systemic imbalance manifesting into disease (445).  Therefore, 
a detailed understanding of the mechanisms through which miRISC function may obviate 
a disease cause and potentially lead to its treatment. 
miRNA expression profiles can vary dramatically in cancer cells relative to their 
healthy counterparts (446, 447).  These changes within the miRNA expression profile 
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have been implicated in both the cause (448, 449) and pathogenesis of cancer (450, 451).  
Considering that over 52% of miRNA genes are located in regions of the genome that are 
highly prone to epigenetic modification, rearrangement, or deletion (452), that is, cancer-
associated gene regions (452), there is little surprise that a number of miRNAs are 
classified as tumor suppressors or oncogenic.   Overexpression of various oncogenes or 
mutations in various miRNA biogenesis proteins (such as Dicer1 and Drosha) (453) or 
their effector proteins (TARBP2 & XPO5) (454, 455) have also been implicated in altered 
miRNA expression levels, often leading to poor patient prognosis.  Ablation of miRNAs 
implicated in the silencing of pro-apoptotic genes (450, 456) or, alternatively, 
overexpression of select miRNAs (457, 458) that silence specific oncogenic genes, lead 
to regression of the cancer phenotype.  Data from these experiments suggest that 
targeting miRNA is an effective therapeutic tool.  One particular oncogenic microRNA 
(oncomiR) that is most frequently dysregulated in tumors is microRNA-21 (miR-21) (459).   
miR-21 is has been observed to be over expressed in numerous cancer cell types 
relative to their surrounding healthy tissue (446, 450, 460-466).  This overexpression has 
been connected with the activation of miR-21 promoter binding transcription factors (AP-
1 and STAT3) (467-469) and an increase in the affinity of Drosha and Dicer – proteins 
involved in miRNA biogenesis – for pri- and pre-miR-21 processing (470, 471).  
Overexpression of miR-21 (naturally or artificially) leads to a cancer phenotype in cell 
culture: increased colony formation and proliferation, cell migration, and invasion (468, 
472-475).  The use of synthetic anti-miR-21 agents reverses the effects of miR-21 in 
cancer cells leading to reduced colony size, proliferation, invasiveness and increased 
apoptosis (473, 474, 476-478).  This is easily explained by the finding that miR-21 has 
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been predicted (438) and directly shown (438, 473, 474, 479-482) to regulate numerous 
genes associated with apoptosis and stress.  Taken together, it is clear that miR-21 is 
intrinsically oncogenic.   
Human hepatocellular carcinoma (HCC) is considered one of the most common 
cancers worldwide and its prognosis is often poor (473, 483-487), making it a highly 
sought after disease target (488).  In HCC, miR-21 is found to be overexpressed >10 fold 
relative to a corresponding healthy primary hepatocyte (483); similarly, HCC cell lines 
(Huh7, HepG2, and SMMC-7721) have been observed to have an ~4 fold increase in 
miR-21 levels relative to normal liver (483).  More generally, miR-21 is a top-10 most 
abundant miRNA in human and mouse liver samples (438, 489, 490).  Validated miR-21 
targets in HCC have been identified to be PTEN, PDCD4, and RECK; of these only PTEN 
and PDCD4 were directly linked to the survival, proliferation, and invasiveness of the HCC 
phenotype (483, 491).  Interestingly, in HCC cell lines and tumors dosed with and without 
anti-miR-21 demonstrated a miR-21 dependence on protein expression of its validated 
targets without significant loss in mRNA (483, 491).  A follow-up study conducted by 
Androsavich et al had also shown that miR-21 showed little target binding in healthy 
mouse liver samples relative to a human cervical cell line (HeLa); these data were 
explained by a potential low thermodynamic stability of the mRNA:miRNA duplex caused 
by AU-rich seed sequence in miR-21 (versus a high GC-rich seed sequence) and the 
potential presence of non-coding RNAs that may act as a miRNA sponge (438, 492).  
While it is not quite understood precisely why the high levels of miR-21 in healthy liver 
samples have little binding to validated targets, there have been theories of sequestering 
agents in the cell capable of removing miR-21 from the targetome pool (493-496). 
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If miR-21 were to engage higher molecular weight complexes in cancer cells, 
relative to primary, as in those bound to poly-ribosomal complexed targets, then 
diffusional properties of the complexes would be measurably different between the two 
cell lines.  For example, translating messenger RNA (mRNA) diffuse 4x slower than those 
disengaged from ribosomes (497), thus miR-21 bound by polysomal complexes should 
move comparatively slower than those bound to non-coding transcripts (i.e. sponges or 
pseudogenes).  Exploiting this phenomenon, the live-cell portion of our in-house single 
molecule assay – intracellular single-molecule high-resolution localization and counting 
(iSHiRLoC) – can measurably track microinjected fluorescent miRNA particles that are 
engaged on high-molecular weight targets, but not those that were bioinformatically 
predicted to have few potential targets (136, 498).  Thus by injecting fluorescently labeled 
miR-21 duplex into primary versus cancer cell lines, we can look for changes in diffusion 
and localization behaviors and systematically test the cause of observation.   
Herein I injected and single-particle tracked miR-21 into representative cancer 
(HeLa and U2OS) and primary (mouse primary mesangial cells, wild-type and miR-21 
double knockout) cells.  Cell lines were predominantly selected based on availability, cell 
shape – flat and strongly adherent are ideal for iSHiRLoC assay design – and culturable.  
To our dismay, we discovered miR-21 particles are trackable in PMC in as large of a 
quantity and diffusing at a similar rate as those in HeLa cells.  Furthermore, those that 
diffused the slowest, in both cancer and primary cells, predominantly colocalized with 
LAMP1-GFP foci, in a RISC independent fashion.  Lastly, ensemble luciferase repression 
assays indicate that both mouse PMC and Fibroblasts repress reporters bearing one or 
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more microRNA Repression Elements (MRE), indicating that poor miR-21 target 
engagement is unlikely a primary cell phenomenon, but more cell-type specific.   
 
2.2  MATERIALS & METHODS 
2.2.1 Preparation of Fluorescent microRNA Duplexes 
All labeled and unlabeled microRNA guide and passenger strands were ordered from 
Integrated DNA Technologies (IDT, Supplemental Figure 4.4B).  For all combinations of 
guide and unlabeled passenger strand, each RNA molecule was modified to contain a 5’ 
phosphate and, in the case of the labeled guide strand, a 3’ NHS-ester linked Alexa Fluor 
647 or Cy5 fluorophore.  Guide and passenger strands were HPLC purified by IDT, and 
their size and purity verified by denaturing, 8M urea, 20% polyacrylamide gel 
electrophoresis.  For the Alexa Fluor 647 and Cy5 labeled guide strands, > 90% of the 
RNA was found to be singly-labeled as determined by quantifying the molar ratio of 
fluorophore to RNA through UV-Visible absorbance measurements.  Duplex formation 
between guide and passenger strand were performed at a 1:1.5 ratio in 1x Phosphate 
Buffered Solution (PBS, Gibco, Cat# 70011) to a final concentration of 10 M.  Duplex 
formation was assessed by electrophoretic mobility shift assay on a non-denaturing 20% 
polyacrylamide gel in 1x Tris/Borate/EDTA buffer.   
 
miR-21 Guide Strand:                 5’   p-UAGCUUAUCAGACUGAUGUUGA – Alexa 647 
miR-21 Passenger Strand:         5’   p-CAACACCAGUCGAUGGGCUGU 
Let-7a-1 Guide Strand: 5’   p-UGAGGUAGUAGGUUGUAUAGUU – Cy5 
Let-7a-1 Passenger Strand: 5’   p-CUAUACAAUCUACUGUCUUUCC 
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2.2.2  Cell Culture and Lamp1-GFP Transduction 
HeLa (CCL-2, ATCC), Ago2-GFP stably transfected HeLa (499), primary mouse 
mesangial (PMC, Wild Type (WT) and miR-21 knockout(KO)), Primary mouse Fibroblast 
miR-21 KO, and DCP1a-EGFP stably transfected U2OS cells were grown in an incubator, 
held at 37 oC and in an atmosphere with 5% CO2 and 95% relative humidity.  HeLa cells 
were maintained in DMEM media (GIBCO, Cat# 11995); PMC (WT & KO) and Fibroblast 
cells were all maintained in RPMI 1640 media (GIBCO, Cat#11875093); U2OS cells in 
phenol red free McCoy’s 5A, with L-Glutamine, media (GE Health, Cat# SH30270.01).  
For all cell lines, with exception to the PMC, the medium was additionally supplemented 
with 10% (v/v) fetal bovine serum (FBS) and 100 U/mL Penicillin-Streptomycin 
(ThermoFisher Scientific, Cat# 15140122).  PMC cells were supplemented with 20% (v/v) 
FBS, 100 U/mL Penicillin-Streptomycin, and Insulin-Transferrin-Selenium (Gibco, Cat# 
41400045).  In select instances, lysosomes are fluorescently labeled by transducing 
adhered cells with LAMP1-GFP gene.  To do this, cells were transduced by CellLight® 
Lysosomes-GFP, BacMam 2.0 (ThermoFisher Scientific, Cat# C10596) per the 
manufacturer’s instructions.  In short, 24 uL of reagent were added to 1 x 105 cells 16 h 
prior to microinjection. 
 
2.2.3  Repression Assays 
To validate that miR-7 increasingly regulate mRNA in a MRE number dependent process, 
dual luciferase reporter plasmids, bearing no site, 1 PTEN miRNA site, or 1 perfectly 
complementary site (siRNA site) to miR-21 in the FLuc 3’ UTR, were co-transfected with 
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unlabeled miR-21 duplex into HeLa, Ago2-GFP HeLa, HuH-7, PMC WT, PMC KO, 
Fibroblast KO, and DCP1a-EGFP stably transfected U2OS cells.  To do this, a 96-well 
plate was seeded with 15,000 cells per well and allowed to adhere for 24 h.  Next, half of 
the cell medium was replaced by an equivalent volume of transfection mixture.  For each 
well, the transfection mixture was comprised of 60 ng of the dual luciferase reporter, 
containing the appropriate number of miR-7 MRE in the FLuc 3’ UTR, 100 nM of either 
duplexed miR-21 or control miRNA, 0.4 L of Lipofectamine 2000, diluted to a total of 10 
L with Optimem media (Gibco, Cat# 31985070).  Upon the addition of the transfection 
mixture, samples were allowed to incubate for a period of 6 h, where the cells were given 
fresh media.  After a 24 h period, the cells were washed thrice with 1x PBS, lysed and 
analyzed for total RLuc and FLuc luminescence per the instructions of the Dual-
Luciferase Reporter Assay System (Promega, Cat# E1910) and analyzed on a 
luminometer (Lmax Molecular Devices Luminometer Reader, BERTHOLD 
Luminescence).   
 
2.2.4  DCP1a – EGFP Stably Transfected U2OS Cell Line Generation 
U2OS cells were stably transfected with our DCP1a-EGFP plasmid using a protocol 
described elsewhere (500).  In short, U2OS cells were seeded to a density of 5 x 105 cells 
in a 6-well plate and allowed to adhere overnight.  Into each well, a mixture of 2 g of 
linearized DCP1a-EGFP containing plasmid DNA, 4 L of FuGENE® HD (Promega, Cat# 
E2311) to a total 50 L with Optimem minimal media is added.  After 6 h, fresh cell media 
was placed into each well and cells were allowed to continue to incubate for an additional 
18 h.  Following a 24 h period, cell media is supplemented with 0.5 mg/mL G418 selection 
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marker.  Cell media was replaced every 2 to 3 days to ensure a high concentration of 
selection marker.  After cell colonies become large enough, cells were split, the cell 
density was counted and seeded onto a 96 well plate at a density of approximately 1-cell 
per well.  After cells reach ~ 80% confluency, cells were tested for phenotypic EGFP 
expression.  Furthermore, EGFP-DCP1a expression was tested further by western blot 
analysis using an Anti-DCP1a (C-terminal) antibody (Sigma, Cat# D5444).   
 
2.2.5  Microinjection 
All cell-lines were seeded (1.5 x 105 cells) onto Delta T Culture Dishes (Bioptechs, Cat# 
04200417C) 24 h prior to treatment.  Just prior to injection, cells were washed once and 
immersed in minimal HEPES buffered saline (HBS) solution, containing 20 mM HEPES-
KOH (pH 7.4), 135mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2 and 5.6 mM glucose.  
Injection solutions comprised of 1 M fluorescent miR-21 or Let-7a-1, 1 mg/mL Cascade 
Blue® 10 kDa Dextran (Life Technologies, Cat# D-1976), with and without 0.1 ug/uL 
DCP1a-RFP plasmid, and 1x PBS to a total volume of 30 L.  Samples were spin filtered 
in a 0.22 m pore sized Ultrafree-MC GV Centrifugal Filter (EMD Millipore, Cat# 
UFC30GV00) to remove any large particulates from clogging the microinjection needle, 
and kept on ice until further used.  Femtotip micropipette (Eppendorf, Cat# 930000035) 
was loaded with 4 L of injection solution and cells were injected using a Femtojet pump 
and Injectman NI2 micromanipulator (Eppendorf) for 0.5 s at 100 hPa with 20 hPa 
compensation pressure.  Once completed, microinjected cells were returned to complete 
medium and incubated at 37 C and in an atmosphere with 5% CO2 and 95% relative 
humidity.  Prior to microinjection, select dishes of cells were treated with either 0.1 mg/mL 
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emetine (Enzo Life Science, Cat# ALX-350-092-M050), 100 mg/mL puromycin (Sigma, 
Cat# P9620) 10 – 15 minutes prior to imaging (501), 2 M Geldanamycin (InvivoGen, 
Cat# ant-gl-5) 4 h prior to injection (502), or 100 uM Chloroquine (Sigma-Aldrich, Cat# 
C6628-25g) 2 h prior to injection (503).  At the designated time point, cells washed twice 
and immersed in BSS media (live-cell imaging), or thrice with warm 1x PBS solution, fixed 
in 4% (w/v) paraformaldehyde solution in PBS for 20 min, washed twice with PBS, and 
stored overnight in 70% ethanol. 
 
2.2.6 Stress Granule Immunofluorescence Assays 
Four hours prior to fixation, cells were immersed in either complete medium, 2.5% FBS 
containing medium, or 2.5% FBS followed by 15 minutes of BSS media treatment.  In 
select instances, the cells will receive 1 mM Sodium Arsenite (Sigma Aldrich, Cat# 35000-
1L-R) into their media 15 min – 1 h prior to antibody staining.  Fixed cells were ethanol 
permeabilized, next washed twice with 1x PBS, then blocked in a solution of 5% mouse 
serum (Jackson ImmunoResearch, Cat# 015-000-120) in 1x PBS for 45 min at 25 oC.  
Blocked cells were then immersed in a 1:200 diluted elF3 primary antibody (Santa Cruz 
Biotechnology, Inc., Cat# sc-16377) in 5% blocking solution for 1 h at 25 oC.  
Subsequently, cells were washed twice in 1x PBS (5 – 10 min/wash) and soaked in 
1:1000 diluted AffiniPure mouse anti-goat IgG, Cy3 conjugated, (Jackson 
ImmunoResearch Laboratories, Inc., Cat# 205-165-108) in blocking solution for 1 h at 25 
oC.  Cells were washed thrice with 1x PBS and imaged for Cy3 fluorescence at either 20x 
or 60x magnification.    
 
106 
 
2.2.7  Single-Molecule Imaging 
Microscopy imaging was conducted, similar to before (504, 505), on a home-built IX-81 
Olympus microscope with a 60x, 1.49NA oil immersion objective (Olympus), 2x 
magnification wheel, P-545.3C7 capacitive piezoelectric x-y-z stage (Physik 
Instrumente), IXon 897 (Andor) EMCCD camera, and a Cell-TIRF module (Olympus).  
Cells were illuminated using solid-state lasers with wavelengths of 405 nm (0.8 mW at 
the objective) and 640 nm (8 mW at the objective).  Highly inclined laminar optical sheet 
(HILO) microscopy was used to achieve sufficient illumination depth while minimizing 
background.  A quadband dichroic (Chroma) 405/488/532/647 was used to detect miR-7 
fluorescent particles and cell boundaries.  Cells were maintained at 37 oC on the Delta T 
open dish system (Bioptechs).  All videos were acquired at 100 ms camera exposure time 
for 50 - 200 frames.   
 
2.2.8 Live and Fixed Cell Imaging of RNA 
All cell-lines were seeded (1 – 1.5 x 105 cells) and allowed to adhere for 1 day.  Prior to 
microinjection, cells were immersed in 1x HBS (see above).  Microinjection solutions 
comprised of 1 mg/mL Cascade Blue ® 10 kDa dextran with 1 M of Cy5 Let-7a-1 or 
Alexa 647 labeled miR-21 guide strands duplexed with unlabeled passenger strand, and 
1x PBS to a total volume of 30 L.  Injection solutions were spin filtered (0.22 m pore 
size) and stored on ice until injection.  Femtotip micropipette is filled with 2 – 4 L of 
injection solution and cells were injected using a Femtojet pump and Injectman NI2 
micromanipulator (Eppendorf) for 0.5 s at 100 hPa with 20 hPa compensation pressure.  
Once completed, microinjected cells were returned to complete medium and incubated 
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at 37 oC and in an atmosphere with 5% CO2 and 95% relative humidity.  Cells were 
allowed to incubate for the delegated time, post-injection, where they were subsequently 
washed thrice in HBS media and live cells were either immediately imaged or 4% 
formaldehyde fixed (20 min) and subsequently imaged in Oxygen Scavenger System (5 
mM protocatechuic acid (PCA), protocatechuate – 3,4 – dioxygenase (PCD), and 2 mM 
Trolox (6 – hydroxyl – 2,5,7,8 – tetramethylchroman – 2 – carboxylic acid)).   
All live-cell videos were then tracked using the tracking module of Imaris (Bitplane) 
software.  Brownian micro-diffusion coefficients were calculated from the first 3 data 
points of a mean squared displacement plot (MSD): 
MSD = <r2> = 4Dt + offset 
Offset is a parameter that assesses the localization error as a result of image drift during 
an experiment.  Thus it is a parameter of precision of localization around a particle in a 
fixed cell.  From previous studies, this value varied by an average of 50 nm with a 
standard deviation of 30 nm (504, 505).  Particles persisting for more than 9 frames were 
considered for MSD analysis, as the accuracy of the calculated diffusion coefficient 
begins to exceed 50% error (506).  In-house MATLAB routines were then used to 
calculate the MSD and diffusion coefficients for all particle tracks, as described elsewhere 
(504, 505).  Colocalization between any two fluorescent particles was identified as those 
that persist within a 4-pixel radius (536 nm) of one another for more than 9 frames and 
exceed a threshold of > 100 arbitrary units (a.u.) using a custom in-house ImageJ routine. 
 
 
2.3  RESULTS 
2.3.1  Live-Cell Single-Particle Tracking of miR-21 
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Previous reports indicate that Argonaute loaded miR-21 engages high molecular weight 
targets in cancer but not in primary cells (438).  Taking this into consideration, it is 
expected that the relative diffusion coefficients of miR-21 in cancer versus primary cells 
should be differentiable.  To test this hypothesis, we microinjected fluorescent miRNA into 
HeLa and mouse primary mesangial, miR-21 double knockout, cells (PMC KO) and using 
the single particle tracking (SPT) portion of our in-house single molecule assay 
(iSHiRLoC), we compared the differences in their MSD calculated diffusion coefficients 
(Figures 2.1 and 2.2). 
Alexa-647 labeled miR-21 particles, microinjected into HeLa cells, were tracked at 
0.5, 1, 2, 4, 6, 9, 12, 14, 18, 22, and 24 h post-injection, as described elsewhere (504, 
505).  From the representative images, clear patterns of large, bright, and perinuclear 
localized fluorescent particles are apparent, as early as 30 min post-injection (Figure 
2.1A).  Mean square displacement plots from trajectories of each fluorescent particle were 
converted into diffusion coefficients.  Since the calculated diffusion coefficient becomes 
exponentially error prone as tracks shorten, we measured only particles persisting within 
the focal plane for >9 frames.  Diffusion coefficients for each particle were calculated on 
the assumption that all particles moved in a Brownian fashion.  Diffusion coefficients for 
each time-point (n > 8 cells per time point) were plotted into a single histogram (Figure 
2.1B) and broadly fitted (black line) with two Gaussians, each representing the primary 
diffusing populations: slow (green) and fast (red).  Of the 15 - 200 trackable Alexa-647 
labeled miR-21 particles discovered (across all time-points), the fractions of slow and fast 
changed in an oscillatory fashion (slow to fast, and back) over time (Figures 2.1B and C).  
The same pattern was also observed when the data were plotted as a cumulative 
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distribution of all diffusion coefficients (Figure 2.1D).  Unclear about the mechanistic 
cause of this finding, we hypothesize that this might be the result of a changing 
transcriptome throughout the cell cycle and thus a changing number of miR-21 targets 
available for it to engage.   
  Microinjecting fluorescent miR-21 into PMC KO cells resulted in similarly patterned 
fluorescent particle distributions as was observed in HeLa cells (Figure 2.2A).  Our 
analysis of the diffusion coefficients for miR-21 in PMC KO uncovered a larger proportion 
(~81.6%) of trackable, non-background, particles relative to HeLa (Figure 2.2B).  Of 
those, 55% more were slower diffusing than in HeLa, for time-points earlier than 9 h; 
although this may be due to the oscillatory nature of these diffusing populations (Figure 
2.2C), a finding that is confirmed by plotting the data as a cumulative distribution (Figure 
2.2D).  However, because of the oscillations observed, the magnitude of the difference 
between these fast and mobile populations between the cell lines can vary greatly 
depending on time-point (Table 2.1).  Thus, more exploration is required to better 
understand the nature of the number of particles and their time-dependent shifts in 
movement characteristics.   
 
2.3.2  Single-Particle Tracking of Let-7a-1 in HeLa Cells 
To ask whether the miR-21 findings were cell specific, I repeated the live-cell Let-7a-1 
single-particle tracking experiment previously performed (504).  Similar to the above, a 
Cy5 labeled Let-7a-1 duplexed miRNA was injected into HeLa cells and analyzed at the 
relevant time points found in the previous paper.  Representative images of injected cells 
revealed a similar pattern of large and bright fluorescent peri-nuclear puncta, similar to 
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the miR-21 experiment (Figure 2.3A).  Particles from cells injected 2, 4, and 8 h post-
injection (504) were tracked and their MSD calculated diffusion coefficients were plotted 
into histograms per time-point (Figure 2.3B).  Comparing these data to those previously 
published (136), we see generally similar trends, albeit not exactly, as the fraction of slow 
particles increased from 23% to 41% between 4 h and 8 h.  However, the difference 
between the two data sets lies largely in their average diffusion coefficients.  From my 
data, I calculated the diffusion coefficients for both distributions to be 0.178 (fast) and 
0.01 m2/ s (slow), which are 32% (fast) and 71% (slow) faster than what was observed 
elsewhere (504). 
To better understand how significant these differences in diffusion coefficients 
were, I plotted the data from each cell within a given time-point as a cumulative distribution 
(Figure 2.3C).  Qualitatively, it is obvious that the spread, particularly on a log scale, is 
quite large, suggesting that intra-experimental variability easily accounts for these 
variations in diffusion coefficients between my data and what was observed elsewhere 
(504).  The spread in intracellular diffusion coefficients can also account for the oscillatory 
behavior observed for miR-21 (Figure 2.1C &D and 2.2C & D) and for Let-7a-1 (data not 
shown).  The variability between the data sets can possibly be attributed to differences in 
cell shape or size, the changing number of miRNA targets throughout the cell cycle, or 
the accuracy in miRNA trajectory analysis, as the shorter the track, the less accurate the 
calculated diffusion coefficient (506).  
 
2.3.3  Colocalization of miR-21 with P-Body Marker DCP1a-EGFP 
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Contrary to our original hypothesis, the SPT portion of the iSHiRLoC assay still unveiled 
an unexpectedly high number of trackable miR-21 in PMC KO, compared to HeLa cells.  
One potential explanation for this finding is that miR-21 is largely being sequestered away 
from the translating pool, a hypothesis that would explain the diffusion characteristics of 
miR-21 and still render them incapable of binding their targets.  P-bodies – sites of miRNA 
dependent target destabilization – are one potential site for sequestration of the miR-21 
particles.  While these granules are largely perceived to be sites of active degradation, 
one possible explanation is that they might also be sites of sequestration of miR-21 that 
prevent them from binding actively translating products in the cytoplasm.  To test this 
hypothesis, I microinjected Alexa-647 labeled miR-21 into U2OS cells, stably expressing 
transfected DCP1a-EGFP (507) – an essential RISC decapping protein – and co-tracked 
the two populations at 2, 4, or 9 h post-injection (Figure 2.4A).  Diffusion coefficients 
calculated from miR-21 trajectories displayed similar movement behaviors in these 
DCP1a-EGFP cells as observed in HeLa and PMC KO (Figure 2.4B), with average 
diffusion coefficients of 0.014 m2/ s (slow, green) and 0.186 m2/ s (fast, red).  
Interestingly, the trackable miR-21 particles seldom co-tracked with the large cytoplasmic 
DCP1a foci.  Regardless of the time point, fewer than 10% of both the total miR-21 and 
p-body pool were found colocalized (Figure 2.4C and Table 2.2), a number that 
decreased from 2 to 9 h.  With the slow populations representing 51.5%, 24.0% and 
59.4% of all miR-21 particles for the 2, 4 and 9 h time points, there was still a large 
proportion of the slow moving miR-21 particles that have not been characterized.   
 
2.3.4  miR-21 Does Not Colocalize with Stress Granules 
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Under stressful environments, the cell will reprogram itself to either adapt to its 
environment or terminate its existence.  One type of intracellular response to stress is the 
formation of stress granules, whereby Argonaute protein can relocate RNA targets from 
the translating pool into amorphous, membrane-less aggregates to facilitate rapid 
reprogramming of the cell through selective translation of non-targeted transcripts (507).  
Since stress granules represent another miRNA mediated process that could result in the 
appearance of large, slow diffusing aggregates of miRNA that would not colocalize with 
processing bodies, we decided to investigate if any portion of the iSHiRLoC process 
resulted in stress granule formation.   
Mechanical microinjection and exposure to imaging medium (reduced serum or 
HEPES Buffered Saline Solution (BSS)) both represent plausible sources of stress on a 
cell that could be induced during a typical iSHiRLoC experiment.  Thus, we wanted to 
investigate if injected Alexa-647 labeled miR-21 were sequestered into stress granules 
as a byproduct of the iSHiRLoC assay design.  First, we optimized our conditions for a 
variety of different primary and cancer cell lines (Figure 2.5A).  To achieve this, we used 
immunofluorescence microscopy (IF) to identify the appearance stress granule foci with and 
without sodium arsenite stress by eIF3 antibody detection.  As can be observed, the appearance 
of stress granules was only observed in the presence of the stress inducing sodium arsenite.  
Next, each cell line was immersed in either complete medium, reduced serum (~2.5% FBS), or 
reduced serum and subsequently soaked in BSS for 15 min prior to fixation.  In all three cases, 
except in the case of sodium arsenite treatment, cells did not express stress granules (Figure 
2.5B).    
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Figure 2.1:  Intracellular single particle tracking of Alexa-647 labeled miR-21 in HeLa cells.  (A) 
Representative single cell images of Alexa-647 labeled miR-21 microinjected into HeLa cells 
across all time-points.  (B)  Histogram plots of diffusion coefficients calculated from MSD plots for 
trackable particles – exceeding 9 frames – from over 8 cells, assuming Brownian behavior.  
Histograms were fitted (black line) to two distributions – slow (green line) and fast (red) – to 
demarcate changes in bulk properties of select subpopulations.  (C) Areas under each curve, for 
both slow (green) and fast (red) subpopulations, have been plotted relative to the time-point to 
demonstrate time dependent changes in each subpopulation.  (D)  Cumulative distribution plot of 
diffusion coefficients for all particles within a time-point to demonstrate the same pattern observed 
in (C).  The black, red, blue, pink, green and orange lines correspond to 0.5, 1, 2, 4, 6, and 9 h 
time-points. 
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Figure 2.2:  Intracellular single particle tracking of Alexa-647 labeled miR-21 in PMC KO.  (A) 
Representative single cell images of Alexa-647 labeled miR-21 microinjected into PMC KO across 
all timepoints.  (B)  Histogram plots of diffusion coefficients calculated from MSD plots for 
trackable particles – exceeding 9 frames – from over 8 cells, assuming Brownian behavior.  
Histograms were fitted (black line) with two distributions, slow (green line) and fast (red), to 
demarcate changes in bulk properties of select subpopulations.  (C) Areas under each curve, for 
both slow (green) and fast (red) subpopulations, have been plotted relative to the time-point to 
demonstrate time dependent changes in each subpopulation.  (D)  Cumulative distribution plot of 
diffusion coefficients for all particles within a time-point to demonstrate the same pattern observed 
in (C).  The black, red, blue, pink, green and orange lines correspond to 0.5, 2, 4, 9, 12, and 24 h 
time-points. 
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Table 2.1.  The diffusion coefficient area under the curve for each miR-21 subpopulation, for 
select time-points.   
 
  
Time Dependent AUC Changes in Subpopulation Diffusion 
Coefficients 
  
Time 
(h) 
0.5 2 4 9 12 24 
Slow 
Distribution 
HeLa 14 64.5 38.4 39.4 68.7 47.5 
PMC KO 21.5 74.2 86.2 31.5 52.6 83.5 
1Fraction Difference -35% -13% -55% 25% 31% -43% 
Fast Distribution 
HeLa 86 35.5 61.6 60.6 31.3 52.5 
PMC KO 78.5 25.8 13.8 68.5 47.4 16.5 
 
1 Fraction difference is calculated by dividing the difference between the slow HeLa from PMC KO AUC, by the 
PMC KO AUC value. 
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Figure 2.3.  Let-7a-1 live-cell particle tracking in HeLa Cells.  (A) Representative images of 
injected Cy5 labeled Let-7a-1 duplexed miRNA in HeLa cells at either 2, 4, or 8 h post-injection. 
(B) MSD calculated Let-7a-1 diffusion coefficient histogram plots from injected HeLa cells.  Data 
were fit (black line) into two subpopulations representing Let-7a-1 miRNA that move slowly 
(green) or fast (red).  Trajectories from particles that persisted in the focal plane for > 9 frames 
were used in the analysis.  Data was acquired from > 7 cells per time-point.  (C)  Cumulative 
distribution plot of the diffusion coefficients of Let-7a-1 particles in HeLa cells.  Each colored dot 
represents data collected for a single cell 2 h post-injection.   
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Figure 2.4.  Co-tracked Alexa 647 labeled miR-21 with p-bodies in DCP1a-EGFP stably 
transfected U2OS cells.  (A) Representative images of Alexa-647 labeled miR-21 injected cells 
(left panes, red), DCP1a-EGFP foci (middle panes, green) and merged images (right panes).  (B)  
MSD calculated diffusion coefficient histogram plots of trackable (> 9 frames) Alexa-647 miR-21 
particles in DCP1a-EGFP U2OS cells (n > 8 cells) 2, 4 or 9 h post-injection.  Histogram plots were 
fitted (black line) to two distributions that represent two subpopulations of moving miR-21:  slow 
(green) and fast (red).  (C)  Fraction of either miR-21 particles (n = 3 cells) sequestered by p-
bodies (dark grey) or DCP1a-EGFP particles that were occupied by miR-21 particles (light grey). 
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Table 2.2.  The extent of colocalization of microinjected Alexa-647 labeled miR-21 with DCP1a-
EGFP cytoplasmic foci in U2OS cells.  Fraction of colocalization either as a function of total 
miRNA or total p-bodies, average from 3 cells.   
 
 Alexa-647 miR-21 in DCP1a-EGFP U2OS Cells 
 Average (n = 3 cells) Colocalized 
Time (h) miRNA per Cell P-Body per Cell Fraction miRNA Fraction P-Bodies 
2 21.7 58.0 0.094 0.044 
4 28.7 50.3 0.057 0.051 
9 61.3 47.7 0.025 0.029 
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Due to the excessive background contributed by the antibodies used in the IF assay, we 
were forced to find an alternative means to determine if the microinjection process caused the 
appearance of stress granules.  Previously, Ago2-GFP stably transfected HeLa cells were used 
to monitor the assembly and disassembly of miRNA into and out from stress granules (499).  Due 
to a gracious donation from Phillip Sharp’s lab, we were able to utilize these cells to detect the 
appearance of non-p-body sequestered Ago2 in HeLa cells following microinjection (Figure 2.5C).  
Here, Alexa-647 miR-21 RNA and DCP1a-RFP containing plasmid were co-injected into the 
Ago2-GFP stably expressed HeLa cells and allowed to incubate for 16 h.  Cells were analyzed 
for the presence of globular Ago2-GFP foci that did not colocalized with cytoplasmic DCP1a-RFP 
foci following microinjection.  As observed, Ago2-GFP colocalized extensively with DCP1a-RFP 
foci after microinjection alone, unlike in sodium arsenite treated cells, where the appearance of 
stress granules (yellow arrows) occurred.  Furthermore, qualitatively, under both conditions, the 
bulk of the miR-21 was seldom found colocalized with either Ago2-GFP or DCP1a-RFP foci.  
Taken together, this suggesting that microinjection alone was not sufficient to induce stress 
granule formation, and therefore is not a significant cause of the large, slow moving fluorescent 
miRNA population. 
 
2.3.5  Inhibiting Translation Resulted in Unexplained miR-21 Changes in Diffusion 
Coefficients 
It has been demonstrated that miRNA are enriched on endoplasmic reticulum (ER) in unstressed, 
actively translating cells (508).  Inhibiting translation with puromycin, an aminonucleoside 
antibiotic that causes premature release of the nascent protein chain, results in the release of the 
mRNA transcript from polyribosomes, thereby decreasing its association with the ER and 
increasing its diffusion coefficient (509).  Thus, treating the cells with Puromycin should enhance 
RISC activity on targeted RNAs as they are often closely associated with increases in p-body size 
and number (510).  Microinjecting Alexa-647 labeled miR-21 RNA and DCP1a-RFP plasmid into 
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Ago2-GFP stably transfected cells, in the presence of puromycin, resulted in little change in the 
distribution of fluorescent miR-21 by comparison to untreated cells (Figure 2.6A).  Yet there was 
a corresponding increase, albeit slight, in p-body number and diminished total GFP and RFP 
fluorescence in treated vs untreated cells, suggesting that puromycin was inhibiting protein 
translation of the fluorescent Ago and DCP1a markers, thus demonstrating functionality. 
Alternatively, translation inhibition can occur by stalling the ribosome on the mRNA using 
either cycloheximide or emetine chemical inhibitors.  Considering that RISC targeted mRNA, still 
being actively translated, do not enter p-bodies, then treatment with either inhibitor should lead to 
decreased p-body number and size (510).  As expected, treatment of microinjected Alexa-647 
miR-21 RNA and DCP1a-RFP plasmid resulted in loss of p-body formation, but still left miR-21 
as bright perinuclear foci (Figure 2.6A).  If these RNA were engaged on their targets, one would 
suspect they would have left the ER surface with their target, thus the emetine data suggest that 
these fluorescent miRNAs are largely unengaged.  However, due to cell health issues in the HeLa 
population during the study, these data should be taken cautiously since only a few viable cells 
were available for imaging.   
To further understand this finding, I performed real-time SPT of injected fluorescent miR-
21 into HeLa cells in the presence of either puromycin or cycloheximide (Figure 2.6B) – used in 
place of emetine due to the extent of toxicity – and histogram plotted the diffusion coefficients 
from over 8 cells per time-point, 2 h post-injection (Figure 2.6C).  We hypothesized that 
microinjected Alexa-647 labeled miR-21 HeLa cells, treated with translational inhibitors that stall 
ribosomes, as opposed to those that cause polysome disassembly, should diffuse slower by 
comparison.  However, this was not the case.  Instead, we observed puromycin treated HeLa 
cells to have a larger proportion of slowest moving miR-21 population (70% of total) by 
comparison to the cycloheximide treated cells (56.5% of total).  Taken together, these peri-nuclear 
fluorescent miR-21 puncta are unlikely associated with mRNA targets on the ER membrane.   
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Figure 2.5.  iSHiRLoC processes do not induce, nor do miR-21 largely enter, stress granules.  
(A) Immunofluorescence (IF) experiment of fixed primary and cancer cell lines in the presence 
and absence of stress granule forming sodium arsenite.  This experiment is designed to 
demonstrate the phenotype for stress granule formation when detected by the elF3 antibody.  
(B) IF detection of stress granules that result from various iSHiRLoC imaging and incubation 
media, for both cancer and primary cells.  (C) Ago2-GFP stably transfected HeLa cells 
microinjected with Alexa-647 labeled miR-21 RNA and DCP1a-RFP plasmid and analyzed 16 h 
post-injection.  Cells were imaged in real-time and assessed for stress granule formation (yellow 
arrows) in the presence or absence of sodium arsenite. 
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Figure 2.6.  Chemical inhibitors of translation do not express the appropriate phenotype in HeLa 
cells.  (A) Ago2-GFP (green) stably transfected HeLa cells injected with Alexa-647 miR-21 RNA 
(red) and DCP1a-RFP (blue) are assessed for changes in colocalization patterns with p-body foci 
upon treatment with either puromycin or emetine, relative to untreated control. (B) Alexa-647 miR-
21 RNA (left panes) is microinjected into HeLa cells and single particle tracked 2 h post injection.  
Cell boundaries and injected cells are identified by the co-injection of cascade blue 10 kDa 
dextran.  (C) Histogram plots of MSD calculated diffusion coefficients from trajectories of Alexa-
647 labeled miR-21 particles in HeLa cells, treated with either puromycin or cycloheximide.  Data 
was generated from > 8 cells per time-point.  Histogram plots were fitted (black line) to 2 distinct 
diffusing populations: slow (green) and fast (red).   
A 
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Figure 2.7.  Fluorescent miRNA Colocalize with Lysosome Marker in RISC Independent Fashion.  
(A) Autofluorescent background particles (green), excited with 488 nm radiation, colocalized with 
slow moving population of microinjected microRNA (red), but not DCP1a-RFP foci (blue).  Cells 
were either microinjected with either Cy5-labeled Let-7a-1 or Alexa-647 labeled miR-21. (B) 
LAMP1-GFP (green) transduced HeLa cells, untreated (top), microinjected with Cy5-Let-7a-1 or 
miR-21 (middle panes) or Alexa 647 Alkyne dye (bottom) were assessed for extent of 
colocalization (merge).  (C) LAMP1-GFP (green) transduced HeLa cells were microinjected with 
either Cy5-Let-7a-1 or Alexa-647 labeled miR-21 (red) and treated with an autophagy inhibitor 
(Chloroquine).  (D) Geldanamycin treated HeLa cells, injected with Alexa-647 labeled miR-21 
(red) and analyzed real-time for colocalization of fluorescent miRNA with background particles 
(green).  Cascade Blue labeled 10 kDa dextran was used as an injection marker to identify which 
cells were treated, but also illuminate cell boundaries.   
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Figure 2.8.  Endogenous and exogenous miR-21 function to repress genes in a miRNA and 
siRNA capacity in both mouse primary and cancer cell lines.  (A) Dual luciferase reporter plasmid 
was transfected into two cancer (HeLa and Huh-7) and three mouse primary (PMC WT, PMC KO, 
and Fibroblast KO) cell lines, with Firefly Luciferase reporter genes bearing no or 1 miR-21 
partially or perfectly complementary sites.  Two primary cell lines were double knockout for miR-
21 (PMC (-,-) and Fibroblast (-,-)) and should not repress miR-21 containing reporters.  Partial 
complementary site was cloned from a validated miR-21 binding site found on the PTEN gene, 
the perfectly complementary site was engineered so miR-21 would behave like an siRNA when 
loaded into Ago2.  All data was normalized to the no-site containing control.  (B) Cancer cell line 
(HeLa) and three primary cell lines (PMC WT, PMC (-,-) and Fibro (-,-)) were all co-transfected 
with a dual luciferase reporter plasmid bearing one PTEN miR-21 miRNA recognition element 
and duplexed, unlabeled miR-21 at concentrations ranging from 0 to 100 nM.  All data was 
normalized to Renilla expression and further normalized to the 0 nM miR-21 concentration.   
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2.3.6 miR-21 Co-Localize Extensively with LAMP1-GFP Foci Independent of RISC 
Loading 
During my analysis, I had discovered, repeatedly, that the slowly diffusing fluorescent miR-21 and 
Let-7a-1 populations extensively colocalized with autofluorescent background in HeLa cells, but 
not with DCP1a-RFP p-body marker (Figure 2.7A).  Based on the pattern of the autofluorescent  
foci, and findings from literature (511), these background particles were presumed to be 
lysosomes.  To further test this, I transduced HeLa cells with LAMP1-GFP – lysosome marker – 
and co-tracked these particles with injected fluorescent miR-21 and Let-7a-1 miRNA (Figure 
2.7B).  As can be observed, both miR-21 and Let-7a-1 miRNA extensively colocalized with 
LAMP1-GFP lysosomal marker.  Considering that RNA are susceptible to RNase mediated 
degradation, it is possible that what sequesters into the lysosome is either the fluorophore or the 
fluorescent nucleoside.  To test this, Alexa-647 alkyne dye was injected into the LAMP1-GFP 
transduced HeLa cells and assed for the extent of their colocalization.  Surprisingly, a large 
amount of uncoupled fluorescent dye colocalized with the lysosome marker, suggesting that it is 
possible for degradants, uncoupled dye, or even fluorescent nucleotides to sequester there.   
Previous work suggests that under starvation conditions, Ago and Dicer associate with 
autophagosome components (512), which are known to merge with lysosomes (513), thus 
represents one possible mechanism for microinjected fluorescent miRNA to enter the lysosomal 
compartment.  To test this, LAMP1-GFP transduced HeLa cells were incubated in chloroquine to 
inhibit autophagosome merging with the lysosome compartment (Figure 2.7C).  Despite 
chloroquine, fluorescent miRNA was still observed to extensively colocalize with LAMP1-GFP 
marked lysosomes, suggesting that this is not the major route of lysosome entry.  Furthermore, 
lysosomal sequestration of the fluorescent miRNA is likely unrelated to RISC processes as 
inhibition of Ago loading by incubating Alexa-647 labeled miR-21 microinjected HeLa cells, treated 
with geldanamycin (514), still resulted in large perinuclear puncta (Figure 2.7D).   
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2.3.7  Mouse Primary Cells Do Have miR-21 Activity 
In our original hypothesis, we made the broad assumption that immortalized and primary cells 
differ in miR-21 activity.  The above data have demonstrated that testing this assumption using 
iSHiRLoC is challenging due to sequestration of fluorescent miR-21 into lysosome compartments 
following microinjection.  Thus, using ensemble based approaches, luciferase repression assays 
of select plasmid reporters were used to detect the extent of miR-21 mediated repression in 
primary versus cancer cell lines. Two human cancer cell lines (HeLa and HuH-7) and three mouse 
primary cell lines (PMC, PMC KO, and Fibroblast KO) were transfected with a dual luciferase 
plasmid reporter containing a Firefly gene bearing either no site, 1 mismatched site, or 1 perfectly-
complementary site (siRNA site) and a Renilla Luciferase gene for normalization purposes (Figure 
2.8A).  The mismatched site sequence was derived from a validated miR-21 site found on the 
PTEN gene.  In the instance of the perfectly complementary site, miR-21 will behave as an siRNA 
when loaded into Ago2.  The result of this assay demonstrated that PMC, wild type (WT), had a 
more robust miRNA and siRNA response than either of the two cancer cell lines (HeLa and HuH-
7).  Meanwhile, as negative controls, it can be observed that in the absence of miR-21 (Fibroblast 
and PMC double knockout for miR-21 (-,-)), there is little difference in expression between these 
cell lines and the no-site control.  Thus, endogenous miR-21 in primary cells do engage and 
repress targets.  Similarly, exogenously introduced miR-21 can also repress the miR-21 reporters 
in primary cell lines, including the double-knockout miR-21 cell lines, in a dose dependent fashion 
(Figure 2.8B).  Taken together, the low target engagement of miR-21 is likely unique to mouse 
liver tissue rather than a global primary versus immortal cancer cell difference.   
 
2.4  DISCUSSION 
Our goal at the beginning of this project was to tease out the mechanistic cause for miR-21 target 
engagement differences between cancer and primary cells as demonstrated by a previous lab 
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member (438).  To do this, we would employ our intracellular single-molecule high-resolution 
localization and counting (iSHiRLoC) technique.  Through this single-molecule approach, we 
expected to observe differences in miR-21 diffusion coefficients and extent of particle assembly 
(sequestration into p-bodies) between cancer and primary cell lines.  From there, we could adapt 
various biochemical means to tease out the likely source of the issue, however, we found that the 
data are convoluted by an experimental design caveat that we had not yet anticipated: our 
microinjected fluorescent particles sequester into lysosomal compartments found in HeLa cells 
and, by extension, U2OS and PMC.   
Ago-loaded microRNA has been detected to be as small as either 160 kDa to as large as 
2 MDa depending on whether it engages a poly-ribosomal bound mRNA target (515, 516).  The 
~10x difference in size corresponds to only a 60.6% difference in diffusion coefficient (13.7 m2/ 
s vs. 5.4 m2/ s), as measured by fluorescence correlation spectroscopy (517).  Considering that 
published data suggest that primary cell miR-21 has lower target engagement and largely resides 
in non-polysomal fractions in polysome profiling experiments (438), then there should be a large 
disparity between miR-21 diffusion coefficients in cancer vs. primary cells.  Yet, when we 
microinjected miR-21 into HeLa and mouse primary mesangial cells, doubly knocked out miR-21 
gene (PMC KO), we observed an inverse relationship from what we would have expected: primary 
cells have more slow moving, trackable particles than cancer cells (Figures 2.1 and 2.2, Table 
2.1).  Similar to prior reports (504), we were able to largely bin the total trackable miRNA 
population into two categories: slow (~ 0.01 m2/ s) and fast (~ 0.178 m2/ s) for all cell lines 
tested.  Based on previous findings, we attribute the slowest population to be sequestration of 
miRNA into processing bodies (p-bodies) – sites of miRNA mediated mRNA destabilization – and 
the faster of which are those engaged on polysomal bound mRNA targets.  However, the extent 
of colocalization between the miR-21 particles and p-bodies was less than 10% of the total 
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population, leaving anywhere between 10 – 70% of the slowest moving population readily 
uncharacterized and thus their movement behaviors unexplained (Figure 2.4C and Table 2.2).   
One possible explanation for the PMC KO finding is that these large moving foci represent 
a population that have been sequestered away from the translating pool, explaining the number 
of trackable particles despite low target engagement.  Considering that miRNAs are known to 
participate in stress granule formation and also have been known to assemble on endoplasmic 
reticulum (ER), we explored these as potential sites of miRNA sequestration and slow diffusion.  
However, our real-time imaging revealed that neither the injection nor imaging conditions resulted 
in stress granule formation, nor were they sequestered there after chemical induction of stress 
granule formation (Figure 2.5).  Additionally, inhibiting translation through polysome disassembly 
or stalling ribosomes on the mRNA surface did not render the expected outcome as observed 
elsewhere, largely suggesting that the bulk of these particles are not bound to the ER (Figure 
2.6).  However, what we did observe repeatedly is the bulk of the slowest population routinely 
colocalized with autofluorescent cellular organelles (Figure 2.7), the identity of which are 
lysosomes (Figure 2.8).    
It is widely known that select molecules are poised for uptake into select cellular 
compartments.  Thus, depending on the physiochemical properties of the molecule, salient 
features can alter the uptake and cellular localization of the fluorophore (518-520).  For example, 
lysosomes have been shown to actively uptake and sequester drugs into lysosomal 
compartments (521-523).  In select instances, these features have been exploited to selectively 
label lysosome compartments for research purposes (524, 525).  Thus, it is less surprising that 
we discovered large proportions of Cy5 and Alexa-647 labeled miRNA colocalized with lysosomal 
marker LAMP1-GFP.  Additionally, considering that the average diffusion coefficient for a 
lysosomal particle is measured to be 0.071 – 0.03 m2/ s (526), which overlaps nicely with our 
miRNA diffusion coefficients, and mammalian cells can have anywhere between 50 – 1,000 
lysosomes, it seems logical to suggest that a large proportion of these molecules are likely within 
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lysosomes.  Lastly, we discovered that colocalization between Cy5 or Alexa 647 with lysosome 
markers was not dependent on RISC loading or autophagy.  Considering that microinjected 
alkyne modified Alexa 647 also colocalized with lysosomal markers, it is clear that the extent of 
colocalization is likely dependent on miRNA integrity and Ago protection.  Taken together, this 
suggests that these particles should be excluded from the analysis as they are not RISC related 
and thus will convolute future findings. 
While lysosomal sequestration was one key insight from this study, a second was that 
while mouse liver tissue and HeLa cells may differ in miR-21 activity, the findings should not be 
broadly characterized into cancer and primary cells.  Fortunately, a dual-color iSHiRLoC 
approach, fluorescent miRNA microinjected into LAMP1-GFP expressing cells, is an easy means 
to sift out non-RISC related particles to study biologically significant processes.  Additionally, 
repression assays of reporter genes bearing both miRNA and siRNA sites for miR-21 revealed 
that not only can mouse primary mesangial cells repress these targets, but equally as proficient, 
if not better, as HeLa.  Taken together, not only were there single particle tracking hurdles to 
overcome, but our original hypothesis required restructuring to be able to utilize iSHiRLoC to 
understand the mechanisms of differential miRNA activity in vivo for these select instances. 
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Chapter III 
Designing and Labeling Long RNA for Intracellular Single-molecule Fluorescence 
Microscopy 
 
3.1  INTRODUCTION 
It has been hypothesized that Ribonucleic Acid (RNA) is the foundational molecule of the 
origin of life (527).  The most compelling argument for this was the discovery of 
intracellular RNA functions that extend beyond a messenger for protein production.  In 
fact, non-protein coding RNAs (ncRNA) represent > 90% of the total human transcriptome 
and play crucial roles in every facet of gene expression (172, 528); DNA replication, 
maintenance & repair (529); cellular defense (530) and various enzymatic functions (531).  
With over 80,000 ncRNA discovered to date (532), most of which are uncharacterized 
structurally and functionally, scientists are just beginning to understand their intracellular 
landscape.  Despite the overwhelming need for exploration in this field, there is an 
insufficient number of tools available for their study, by comparison to protein research 
(533).  This is in large part because RNA research accelerated only over the past two 
decades and thus trails protein research by at least half a century.   
Intracellular (“in cellulo”) single-molecule microscopy imaging of RNA is a powerful 
tool for measuring expression levels, kinetics of interaction between two molecules, 
molecular dynamics, cellular localization, and 3D architecture of assembled structures in 
its native environment (509, 533-536).  Given the stochastic nature of biochemical events 
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in a cellular environment, single-molecule assays are pivotal for not only probing 
biochemical mechanisms, but also how they are controlled spatiotemporally in the cellular 
context, ultimately deconvolving what separates disease from archetypical.  Some 
examples of intracellular single-molecule fluorescence techniques used to measure these 
phenomena are: super-resolution microscopy (3D structure) (537), fixed-cell stepwise 
photobleaching (subunit stoichiometry in aggregates) (538), single particle tracking 
(interaction kinetics & cellular localization) (539), fixed cell particle counting (expression 
levels) (540), amongst others (533, 534). 
A messenger RNA (mRNA) can canonically be divided into 4-major functional 
fractions: 5’ UTR (541, 542), coding sequence (543), 3’ UTR (544) and Poly(A) tail (545).  
A concern is that incorporating a fluorescent probe into any one of these segments may 
be deleterious to the RNA’s function, potentially resulting in spurious findings and 
incorrect conclusions.  For this reason, there is a great need for labeling schemes that 
can precisely incorporate a controllable number of fluorophores at exact locations in an 
RNA.  Additionally, the labeling method should require few steps, of high efficiency and 
yield, and use gentle, commercially available and non-cytotoxic materials.   
A diversity of intracellular and ex vivo/in vitro fluorescent labeling methods are 
available to the RNA scientist that meet the aforementioned idealized labeling conditions 
(546-551).  Intracellular labeling schemes, while quintessential in principle, are plagued 
by issues relating to cell-membrane permeability, non-specific binding, cytotoxicity, 
necessary modifications to the cell genome, high background, high molecular weight 
fluorescent appendages, and are often impractical for monitoring low-abundance and 
short transcript (552, 553).  Conversely, many of these problems are inconsequential for 
135 
 
ex vivo/ in vitro labeling strategies.  As an example, to account for the transient nature of 
non-covalent strategies, cells are typically immersed in a solution of probe to maximize 
the extent of labeling, unintentionally elevating the background noise and increasing the 
potential for non-specific binding events.  Uniquely imperfect, covalent strategies are 
caveated by challenges associated with their methods of delivery (552-555); this is 
something that is easily surmountable through proper control design and microinjection 
(505).  Focusing our attention on these covalent labeling strategies, we discovered that 
enzymes used in RNA transcription and maturation process – T7 RNA Polymerase and 
Yeast Poly(A) Polymerase – can be employed to either randomly or site-specifically insert 
modified nucleotides (nt) into the RNA chain (554, 556).  Coupling transcription and tailing 
processes with modification and labeling methods has the potential to additionally save 
time, money, and increase yields.    
Herein, we exploit T7 RNA polymerase and Yeast Poly(A) Polymerase (yPAP) to 
integrate modified nucleotides into one of three select regions of the RNA molecule: body 
(includes 5’ UTR, coding region and 3’ UTR), tail, and between body and tail (BBT).  In 
the case of the body labeling strategy, the modified nucleic acid is pre-coupled to the 
fluorophore, while in the remaining cases an additional coupling step must be 
incorporated into the protocol.  While the body labeling approach largely inhibited protein 
translation, BBT and tail modified strategies were as potent protein producers and their 
unlabeled counterparts.  Yet in all cases, the 3’ UTR was accessible to the RNA Induced 
Silencing Complex (RISC) machinery, demonstrating equivalent levels of miRNA 
mediated translation inhibition as its unlabeled counterpart, and sequestration into 
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degradation granules (processing bodies).  In Chapter 4, these labeled molecules will be 
assessed for intracellular single-particle capabilities.   
 
3.2  MATERIALS & METHODS 
3.2.1 Preparation of microRNA Duplexes 
All unlabeled microRNA guide and passenger strands ordered from Integrated DNA 
Technologies (IDT).  For all combinations of guide and unlabeled passenger strand, each 
RNA molecule was modified to contain a 5’ phosphate.  Guide and passenger strands 
were HPLC purified by IDT, and their size and purity verified by denaturing, 8M urea, 20% 
polyacrylamide gel electrophoresis.  Duplex formation between guide and passenger 
strand were performed at a 1:1.5 ratio in 1x Phosphate Buffered Solution (PBS, Gibco, 
Cat# 70011) to a final concentration of 10 M.  Duplex formation was assessed by 
electrophoretic mobility shift assay on a non-denaturing 20% polyacrylamide gel in 1x 
Tris/ Borate/ EDTA buffer.  
miR-21 Guide: 5’  p-UAGCUUAUCAGACUGAUGUUGA-OH 
miR-21 Passenger: 5’  p-CAACACCAGUCGAUGGGCUGU-OH 
miR-7 Guide: 5’  p-UGGAAGACUAGUGAUUUUGUUGU-OH 
miR-7 Passenger: 5’  p-CAACAAAUCACAGUCUGCCAUA-OH  
 
3.2.2  Plasmid Reporter Designs 
Dual luciferase reporter plasmid are variants of the pmiRGLO Dual-Luciferase miRNA 
Target Expression Vector (Promega, Cat# E1330).  Depending on the number of miR-21 
or miR-7 microRNA recognition element (MRE) cloned into the FLuc gene, pools of 5’ 
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phosphate containing primers (Table 3.1 & 3.2) are heat-annealed followed by T4 DNA 
Ligase treatment.  Both the annealed primers and the pmiRGLO vector were restriction 
enzyme digested using Xba1 and Sbf1 and purified using QIAquick PCR Purification Kit 
(Qiagen, Cat# 28104).  Restriction enzyme digested pmiRGLO vector were Antarctic 
Phosphatase treated and purified a second time using a QIAquick PCR Purification Kit.  
Purified primer pool and pmiRGLO vector were pooled at a ratio of 7:1 and ligated 
together using T4 DNA Ligase.  The reaction was QIAquick PCR purified and transformed 
into XL10-Gold® Ultracompetent Cells (Agilent, Cat# 200314).  Transformation mixture 
was smeared onto LB agar plates with 100 g/mL ampicillin to achieve single colonies.  
Colonies were PCR screened for the proper insertion of the miR-7 MRE into the FLuc 3’ 
UTR.  Selected colonies were grown in LB medium with 100 g/mL ampicillin to a cell 
density of approximately 3 – 4 x 109 cells/mL and the plasmid was purified using the 
QIAGEN® Plasmid Maxi Prep Kit (Qiagen, Cat# 12162).  Purified plasmid sequences 
were further characterized by the University of Michigan Sequencing Core via Sanger 
Sequencing.   
In order to transcribe FLuc modified RNA, we restriction cut the FLuc gene, with 
the appropriate number of miR-7 MRE, from the pmiRGLO plasmid into the pcDNA™ 3.1 
(-) Mammalian Expression Vector (Invitrogen, Cat# V795-20).  To do this, both plasmids 
were treated with PmeI (coding) or PspOMI (pseudogene) and Xba1 restriction enzymes, 
pmiRGLO vector was additionally Antarctic Phosphatase treated, and both were purified 
via QIAquick purified.  Purified pmiRGLO and pcDNA restriction digested mixtures were 
pooled 2:1 and T4 DNA Ligase treated and QIAquick purified.  The ligated mixture was 
then transformed into XL10-Gold® Ultracompetent Cells, smeared onto LB agar plates 
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containing 100 µg/mL ampicillin and single colonies containing the proper plasmid were 
PCR identified.  Selected colonies were grown in LB medium with 100 g/mL ampicillin 
to a cell density of approximately 3 – 4 x 109 cells/mL and the plasmid was extracted and 
purified using the QIAGEN® Plasmid Maxi Prep Kit (Qiagen, Cat# 12162).  Purified 
plasmid sequences were further characterized by the University of Michigan Sequencing 
Core via Sanger Sequencing. 
 
 
3.2.3  In Vitro RNA Preparation 
Plasmid templates, from which RNA are prepared, are first linearized using restriction 
enzymes.  Renilla Luciferase RNA is transcribed from the Not 1 restriction enzyme cut 
pRL-CMV Vector (Promega, Cat# E2261) plasmid.  FLuc RNA, bearing 0, 1, 3, 6, or 11 
miR-7 MRE sites, was transcribed from AFl III restriction enzyme cut pcDNA™ 3.1 (-) 
Mammalian Expression Vectors.  Linearized plasmids were further purified by QIAquick 
PCR Purification Kit. 
Unlabeled RLuc and FLuc RNA are first transcribed from 1 g – per reaction – of 
linearized plasmid, using MEGAscript® T7 Transcription Kit (ThermoFisher Scientific, 
Cat# AM1333), incubated at 37 oC for 6 h, and purified using MEGAclear™ Kit 
(ThermoFisher Scientific, Cat# AM1980).  RNA was capped using ScriptCap™ m7G 
Capping System (CellScript™, Cat# C-SCCE0610) and yeast poly(A) polymerase (yPAP) 
tailed using USB® Poly(A)Polymerase, Yeast kit (Affymetrix, Cat# 74225Y/Z) per their 
instructions, with a MEGAclear™ purification step following each treatment.  For body 
labeling, proportions of the total UTP pool were replaced with either 0.1, 0.5, 1.0, 5.0, or 
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10% Cyanine 5-Aminoallyluridine-5'-Triphosphate (Trilink Biotechnologies, Cat# N-5108).  
For modifying the RNA between body and tail (BBT), an additional yPAP tailing and 
purification step was inserted between cap and tail procedures.  In this instance, the RNA 
was yPAP treated with the total pool of ATP replaced with 2'-Azido-2'-deoxyadenosine-
5'-Triphosphate (Trilink Biotechnologies, Cat# N-1045), using standard kit conditions, but 
incubating only for 10, 20, 30, or 60 minutes.  The tail modified RNA procedure hijacked 
the yPAP poly(A) tailing step to co-integrate 2'-Azido-2'-deoxyadenosine-5'-Triphosphate 
into the poly(A) tail.  To do this, portions of the total ATP pool were replaced with 0.1, 0.5, 
1.0, 5.0, or 10% of 2'-Azido-2'-deoxyadenosine-5'-Triphosphate nucleic acid.   
2'-Azido-2'-deoxyadenosine-5'-Triphosphate modified, BBT and Tailed, RNA were 
fluorescently labeled using either Click-IT® Protein Reaction Buffer Kit (Life 
Technologies, Cat# C10276) with Alexa Fluor® Alkyne (Life Technologies, Cat# A10278) 
or Click-IT® Alexa Fluor® 647/555 DIBO Alkyne (Invitrogen, Cat# C10408 / C10406).  
Alkyne Alexa Fluor® 647, Click-IT® Alexa Fluor® 647 DIBO Alkyne, and Click-IT® Alexa 
Fluor® 647 were all dissolved in anhydrous DMSO to a stock concentration of 1 mM.  Cu-
based click chemistry using the Click-IT® Protein Reaction Buffer Kit & Alkyne Alexa 
Fluor® 647 were used as described per the manufacturer’s instructions, using a final RNA 
concentration of 1 M.  RNA labeled using the strained-promoted alkyne-azide 
cycloaddition (SPAAC) click reactions, 1 M of azide-ATP modified RNA is mixed with 
100 M Click-IT® Alexa Fluor® 647/555 DIBO Alkyne in 1x PBS for 2 h at 37 oC.  
Following all labeling procedures, the RNA was MEGAclear™ purified and EtOH 
precipitated overnight.  Precipitated RNA was dissolved in miliQ H2O to a final 
concentration of approximately 1 M.  RNA integrity was analyzed via either 4% 
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denaturing, 8 M urea, polyacrylamide or 1.2% denaturing, 1 M urea, agarose gel 
electrophoresis.  RNA is detected via SYBR® Gold Nucleic Acid Gel Stain (ThermoFisher 
Scientific, Cat# S11494) or GelRed™ (Biotium, Cat# 41003).   
 
3.2.4  Cell Culture and Transfection 
HeLa (CCL-2, ATCC), primary mouse mesangial (PMC, Wild Type (WT) and miR-21 
knockout(KO)), Primary mouse Fibroblast miR-21 KO, and DCP1a-EGFP stably 
transfected U2OS cells were grown in an incubator, held at 37 oC and in an atmosphere 
with 5% CO2 and 95% relative humidity.  HeLa cells were maintained in DMEM media 
(GIBCO, Cat# 11995); PMC (WT & KO) and Fibroblast cells were all maintained in RPMI 
1640 media (GIBCO, Cat#11875093); U2OS cells in phenol red free McCoy’s 5A, with L-
Glutamine, media (GE Health, Cat# SH30270.01).  For all cell lines, with exception to the 
PMC, the medium was additionally supplemented with 10% (v/v) fetal bovine serum (FBS) 
and 100 U/mL Penicillin-Streptomycin (ThermoFisher Scientific, Cat# 15140122).  PMC 
cells were supplemented with 20% (v/v) FBS, 100 U/mL Penicillin-Streptomycin, and 
Insulin-Transferrin-Selenium (Gibco, Cat# 41400045).  
 
3.2.5  DCP1a – EGFP Stably Transfected U2OS Cell Line Generation 
U2OS cells were stably transfected with our DCP1a-EGFP plasmid using a protocol 
described elsewhere (500).  In short, U2OS cells were seeded to a density of 5 x 105 cells 
in a 6 well plate and allowed to adhere overnight.  Into each well, a mixture of 2 g of 
linearized DCP1a-EGFP containing plasmid DNA, 4 L of FuGENE® HD (Promega, Cat# 
E2311) to a total 50 L with Optimem minimal media is added.  After 6 h, fresh cell media 
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was placed into each well and cells were allowed to continue to incubate for an additional 
18 h.  Following a 24 h period, cell media is supplemented with 0.5 mg/mL G418 selection 
marker.  Cell media was replaced every 2 to 3 days to ensure a high concentration of 
selection marker.  After cell colonies become large enough, cells were split, the cell 
density was counted and seeded onto a 96-well plate at a density of approximately 1-cell 
per well.  After cells reach ~ 80% confluency, cells were tested for phenotypic EGFP 
expression.  Furthermore, EGFP-DCP1a expression was tested further by western blot 
analysis using an Anti-DCP1a (C-terminal) antibody (Sigma, Cat# D5444).   
 
3.2.6  Repression Assays 
To validate that miR-7 increasingly regulate mRNA in a MRE number dependent process, 
dual luciferase reporter plasmids, bearing various FLuc 3’ UTR MRE site number (mutant 
and wild-type sequences) targeting miR-7 or miR-21, were co-transfected with either 
unlabeled microRNA duplex or control miRNA (Life Technologies, Cat# 4390843) into 
HeLa and DCP1a-EGFP stably transfected U2OS cells.  To do this, a 96-well plate was 
seeded with 15,000 cells per well and allowed to adhere for 24 h.  Next, half of the cell 
medium was replaced by an equivalent volume of transfection mixture.  For each well, 
the transfection mixture was comprised of 60 ng of the dual luciferase reporter, containing 
the appropriate number of miR-7 MRE in the FLuc 3’ UTR, 100 nM of either duplexed 
miR-7 or control miRNA, 0.4 L of Lipofectamine 2000, diluted to a total of 10 L with 
Optimem media (Gibco, Cat# 31985070).  Upon the addition of the transfection mixture, 
samples were allowed to incubate for a period of 6 h, where the cells were given fresh 
media.  After a 24 h period, the cells were washed thrice with 1x PBS, lysed and analyzed 
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for total RLuc and FLuc luminescence per the instructions of the Dual-Luciferase Reporter 
Assay System (Promega, Cat# E1910) and analyzed on a luminometer (Lmax Molecular 
Devices Luminometer Reader, BERTHOLD Luminescence).  In the instance of 
transfected mRNA, the same protocol was used, but substituting plasmid DNA with 100 
ng of RLuc mRNA and 100 ng of either fluorescent BBT or Tail modified FLuc mRNA, or 
unmodified control FLuc, cloned with 0, 1, 3, 6, or 11 miR-7 MRE.   
 
3.2.7  In Vitro Translation Assay 
Testing the functionality of the artificial pseudogene was performed in the TnT® 
Coupled Reticulocyte Lysate Systems (Promega, Cat# L4611).  All components were 
thawed and stored on ice prior to mixing.  Next 25 L of TnT® Reticulocyte Lystate was 
mixed with 2 L of reaction buffer, 1 L of RNA polymerase, 0.5 L of both minus Leucine 
and minus Methionine amino acid mixtures, 1 g of DNA (pseudogene, coding gene, or 
kit control) or 2 L of ddH2O (no DNA control), 2 L of FluoroTect™ GreenLys in vitro 
Translation Labeling System (Promega, Cat# L5001) – to detect protein – and diluted with 
ddH2O to a total of 50 uL.  After 90 min incubation at 30 oC, 5 L of sample was added 
to 10 L of 2x SDS gel-loading buffer & 10 L of ddH2O and heat denatured at 70 oC for 
3 min.  Samples were then run on a Novex™ Value™ 4 – 20% Tris-Glycine Mini Gel 
(ThermoFisher Scientific, Cat# XV04200PK20) and imaged using a Typhoon 9410 
Variable Mode Imager (GE Healthcare Life Sciences). 
The ability of labeled and unlabeled transcribed RNA to translate protein was 
tested using the Rabbit Reticulocyte Lysate System (Promega, TM232).  All components 
are thawed and stored on ice prior to mixing.  Next, 35 L of Rabbit Reticulocyte Lysate 
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was mixed with 0.5 L of each amino acid mixture, 2 g of the mRNA, and 2 L 
FluoroTect™ GreenLys in vitro Translation Labeling System (Promega, Cat# L5001) and 
diluted to final volume of 50 L with H2O.  Mixtures were incubated at 30 oC for 90 min.  
After 90 minutes, 5 L of sample was mixed with 5 L of miliQ H2O and 10 L of 2x SDS 
gel loading buffer, and heated to 70 oC for 3 min.  Sample was then loaded onto a Novex™ 
Value™ 4 – 20% Tris-Glycine Mini Gel (ThermoFisher Scientific, Cat# XV04200PK20) 
and imaged using a Typhoon 9410 Variable Mode Imager (GE Healthcare Life Sciences). 
 
3.2.8  Immunofluorescence of Firefly Luciferase 
HeLa cells (1.5 x 105 cells) were seeded onto Delta T Culture Dishes (Bioptechs, Cat# 
04200417C) 24 h prior to microinjection.  Just prior to microinjection, cells were washed 
once and immersed in minimal HEPES buffered saline (HBS) solution, containing 20 mM 
HEPES-KOH (pH 7.4), 135mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2 and 5.6 mM 
glucose.  Injection solutions comprised of 10 nM of labeled or unlabeled mRNA, 1 mg/mL 
Cascade Blue® 10 kDa Dextran (Life Technologies, Cat# D-1976) and 1x PBS to a total 
volume of 30 L.  Samples were spin filtered in a 0.22 m pore sized Ultrafree-MC GV 
Centrifugal Filter (EMD Millipore, Cat# UFC30GV00) to remove any large particulates 
from clogging the microinjection needle, and kept on ice until further used.  Femtotip 
micropipette (Eppendorf, Cat# 930000035) was loaded with 4 L of injection solution and 
cells were injected using a Femtojet pump and Injectman NI2 micromanipulator 
(Eppendorf) for 0.5 s at 100 hPa with 20 hPa compensation pressure.  Once completed, 
microinjected cells were returned to complete medium and incubated at 37 C and in an 
atmosphere with 5% CO2 and 95% relative humidity.  After 12 h, cells were washed thrice 
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with warm 1x PBS solution, fixed in 4% (w/v) paraformaldehyde solution in PBS for 20 
min, washed twice with PBS, and stored overnight in 70% ethanol.  Next, cells were 
washed twice with 1x PBS and blocked in a solution of 5% rabbit serum (Sigma, Cat# 
R9133), 0.02% sodium azide, and 1x PBS for 45 min at 25 oC.  Blocked cells were then 
immersed in a 1:50 diluted Anti-Luciferase pAb (Promega, Cat# G7451) in blocking 
solution for 1 h at 25 oC.  Subsequently, cells were washed twice in 1x PBS (5 – 10 
min/wash) and soaked in 1:200 diluted rabbit anti-goat IgG (H+L) Cross Adsorbed 
Secondary Antibody, DyLight 650 conjugated, (Pierce, Cat# SA5-10081) in blocking 
solution for 1 h at 25 oC.  Cells were washed thrice with 1x PBS and imaged for DyLight 
650 fluorescence at either 20x or 60x magnification.    
 
3.2.9 Fluorescence Microscopy 
Microscopy imaging was conducted, similar to before (504, 505), on a home-built IX-81 
Olympus microscope with a 60x, 1.49NA oil immersion objective (Olympus), 2x 
magnification wheel, P-545.3C7 capacitive piezoelectric x-y-z stage (Physik 
Instrumente), IXon 897 (Andor) EMCCD camera, and a Cell-TIRF module (Olympus).  
Cells were illuminated using solid-state lasers with wavelengths of 405 nm (0.8 mW at 
the objective) and 640 nm (8 mW at the objective).  Highly inclined laminar optical sheet 
(HILO) microscopy was used to achieve sufficient illumination depth while minimizing 
background.  A quadband dichroic (Chroma) 405/488/532/647 was used to detect miR-7 
fluorescent particles and cell boundaries.  Cells were maintained at 37 oC on the Delta T 
open dish system (Bioptechs).  All images were acquired at 100 ms camera exposure.   
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Table 3.1:  Primer list for cloning pmiR-Glo and pcDNA3.1 (-) miR-7 3’UTR containing constructs. 
miR-7 Primer List 
1 miR-7 Site  
Forward 
TCGAGTCTAGAGGTACCGGTTTTATTGTTATTCTGTCTTCCAGGAGCGGCCGC
CCTGCAGGCATGCAAGCT 
Reverse 
AGCTTGCATGCCTGCAGGGCGGCCGCTCCTGGAAGACAGAATAACAATAAAA
CCGGTACCTCTAGACTCGA 
 
2 miR-7 Sites 
 
Forward 
TCGAGTCTAGAGGTACCGGTTTTATTGTTATTCTGTCTTCCAGGTTTTATTGTTA
TTCTGTCTTCCAGGAGCGGCCGCCCTGCAGGCATGCAAGCT 
Reverse 
AGCTTGCATGCCTGCAGGGCGGCCGCTCCTGGAAGACAGAATAACAATAAAA
CCTGGAAGACAGAATAACAATAAAACCGGTACCTCTAGACTCGA 
 
3 miR-7 Sites 
 
Forward #1 
TCGAGTCTAGAGGTACCGGTTTTATTGTTATTCTGTCTTCCAGGTTTTATTGTTA
TTCTGTCT 
Forward #2 
TCCAGGTTTTATTGTTATTCTGTCTTCCAGGAGCGGCCGCCCTGCAGGCATGC
AAGCT 
Reverse #1 
GAATAACAATAAAACCTGGAAGACAGAATAACAATAAAACCGGTACCTCTAGAC
TCGA 
Reverse #2 
AGCTTGCATGCCTGCAGGGCGGCCGCTCCTGGAAGACAGAATAACAATAAAA
CCTGGAAGACA 
 
4 miR-7 Sites 
 
Forward #1 
TCGAGTCTAGAGGTACCGGTTTTATTGTTATTCTGTCTTCCAGGTTTTATTGTTA
TTCTGTCTTCCAGGTTTTAT 
Forward #2 
TGTTATTCTGTCTTCCAGGTTTTATTGTTATTCTGTCTTCCAGGAGCGGCCGCC
CTGCAGGCATGCAAGCT 
Reverse #1 
AACCTGGAAGACAGAATAACAATAAAACCTGGAAGACAGAATAACAATAAAAC
CGGTACCTCTAGACTCGA 
Reverse #2 
AGCTTGCATGCCTGCAGGGCGGCCGCTCCTGGAAGACAGAATAACAATAAAA
CCTGGAAGACAGAATAACAATAA 
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5 miR-7 Sites 
 
Forward #1 
TCGAGTCTAGAGGTACCGGTTTTATTGTTATTCTGTCTTCCAGGTTTTATTGTT
ATTCTGTCTTCCAGGTTTTATTGTTATTCTGTCT 
Forward #2 
TCCAGGTTTTATTGTTATTCTGTCTTCCAGGTTTTATTGTTATTCTGTCTTCCAG
GAGCGGCCGCCCTGCAGGCATGCAAGCT 
Reverse #1 
AGCTTGCATGCCTGCAGGGCGGCCGCTCCTGGAAGACAGAATAACAATAAAA
CCTGGAAGACAGAATAACAATAAAACCTGGAAGACA 
Reverse #2 
GAATAACAATAAAACCTGGAAGACAGAATAACAATAAAACCTGGAAGACAGAA
TAACAATAAAACCGGTACCTCTAGACTCGA 
 
6 miR-7 Sites 
 
Forward #1 
TCGAGTCTAGAGGTACCGGTTTTATTGTTATTCTGTCTTCCAGGTTTTATTGTT
ATTCTGTCTTCCAGGTTTTATTGTTATTCTGTCTTCCAGGTTTTAT 
Forward #2 
TGTTATTCTGTCTTCCAGGTTTTATTGTTATTCTGTCTTCCAGGTTTTATTGTTA
TTCTGTCTTCCAGGAGCGGCCGCCCTGCAGGCATGCAAGCT 
Reverse #1 
AGCTTGCATGCCTGCAGGGCGGCCGCTCCTGGAAGACAGAATAACAATAAAA
CCTGGAAGACAGAATAACAATAAAACCTGGAAGACAGAATAACAATAA 
Reverse #2 
AACCTGGAAGACAGAATAACAATAAAACCTGGAAGACAGAATAACAATAAAAC
CTGGAAGACAGAATAACAATAAAACCGGTACCTCTAGACTCGA 
 
11 miR-7 Sites 
 
Forward #1 
TCGAGTCTAGAGGTACCGGTTTTATTGTTATTCTGTCTTCCAGGTTTTATTGTT
ATTCTGTCTTCCAGGTTTTATTGTTATTCTGTC 
Forward #2 
TTCCAGGTTTTATTGTTATTCTGTCTTCCAGGTTTTATTGTTATTCTGTCTTCCA
GGTTTTATTGTTATTCTGTCTTCCA 
Forward #3 
GGTTTTATTGTTATTCTGTCTTCCAGGTTTTATTGTTATTCTGTCTTCCAGGTTT
TATTGTTATTCTGTCTTCCAGGTTT 
Forward #4 
TATTGTTATTCTGTCTTCCAGGTTTTATTGTTATTCTGTCTTCCAGGAGCGGCC
GCCCTGCAGGCATGCAAGCT 
Reverse #1 
AGCTTGCATGCCTGCAGGGCGGCCGCTCCTGGAAGACAGAATAACAATAAAA
CCTGGAAGACAGAATAACAATAAAACCTGGAAGAC 
Reverse #2 
AGAATAACAATAAAACCTGGAAGACAGAATAACAATAAAACCTGGAAGACAGA
ATAACAATAAAACCTGGAAGACAGAAT 
Reverse #3 
AACAATAAAACCTGGAAGACAGAATAACAATAAAACCTGGAAGACAGAATAAC
AATAAAACCTGGAAGACAGAATAACAA 
Reverse #4 
TAAAACCTGGAAGACAGAATAACAATAAAACCTGGAAGACAGAATAACAATAA
AACCGGTACCTCTAGACTCGA 
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1 miR-7 siRNA Site  
Forward 
TCGAGTCTAGAGGTACCGGACAACAAAATCACTAGTCTTCCAGGAGCGGCCGCCCTGCA
GGCATGCAAGCT 
Reverse 
AGCTTGCATGCCTGCAGGGCGGCCGCTCCTGGAAGACTAGTGATTTTGTTGTCCGGTAC
CTCTAGACTCG 
 
1 miR-7 7mer-1A 
 
Forward 
TCGAGTCTAGAGGTACCGGTTTTATTGTTATTCTTTCTTCCAGGAGCGGCCGCCCTGCA
GGCATGCAAGCT 
Reverse 
AGCTTGCATGCCTGCAGGGCGGCCGCTCCTGGAAGAAAGAATAACAATAAA
ACCGGTACCTCTAGACTCGA 
 
4 miR-7 7mer-1A  
Forward #1 
TCGAGTCTAGAGGTACCGGTTTTATTGTTATTCTTTCTTCCAGGTTTTATTGTTATTCTTT
CTTCCAGGTTTTAT 
Forward #2 
TGTTATTCTTTCTTCCAGGTTTTATTGTTATTCTTTCTTCCAGGAGCGGCCGCCCTGCAG
GCATGCAAGCT 
Reverse #1 
AACCTGGAAGAAAGAATAACAATAAAACCTGGAAGAAAGAATAACAATAAAACCGGT
ACCTCTAGACTCGA 
Reverse #2 
AGCTTGCATGCCTGCAGGGCGGCCGCTCCTGGAAGAAAGAATAACAATAAAACCTGG
AAGAAAGAATAACAATAA 
 
1 miR-7 7mer-8m  
Forward 
TCGAGTCTAGAGGTACCGGTTTTATTGTTATTCTGTCTTCCCGGAGCGGCCGCCCTGCA
GGCATGCAAGCT 
Reverse 
AGCTTGCATGCCTGCAGGGCGGCCGCTCCGGGAAGACAGAATAACAATAAA
ACCGGTACCTCTAGACTCGA 
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4 miR-7 7mer-8m  
Forward #1 
TCGAGTCTAGAGGTACCGGTTTTATTGTTATTCTGTCTTCCCGGTTTTATTGTTATTCTGT
CTTCCCGGTTTTAT 
Forward #2 
TGTTATTCTGTCTTCCCGGTTTTATTGTTATTCTGTCTTCCCGGAGCGGCCGCCCTGCAG
GCATGCAAGCT 
Reverse #1 
AACCGGGAAGACAGAATAACAATAAAACCGGGAAGACAGAATAACAATAAAACCGGT
ACCTCTAGACTCGA 
Reverse #2 
AGCTTGCATGCCTGCAGGGCGGCCGCTCCGGGAAGACAGAATAACAATAAAACCGGG
AAGACAGAATAACAATAA 
 
1 miR-7 6mer  
Forward 
TCGAGTCTAGAGGTACCGGTTTTATTGTTATTCTTTCTTCCCGGAGCGGCCGCCCTGCA
GGCATGCAAGCT 
Reverse 
AGCTTGCATGCCTGCAGGGCGGCCGCTCCGGGAAGAAAGAATAACAATAA
AACCGGTACCTCTAGACTCGA 
 
4 miR-7 6mer  
Forward #1 
TCGAGTCTAGAGGTACCGGTTTTATTGTTATTCTTTCTTCCCGGTTTTATTGTTATTCTT
TCTTCCCGGTTTTAT 
Forward #2 
TGTTATTCTTTCTTCCCGGTTTTATTGTTATTCTTTCTTCCCGGAGCGGCCGCCCTGCAG
GCATGCAAGCT 
Reverse #1 
AACCGGGAAGAAAGAATAACAATAAAACCGGGAAGAAAGAATAACAATAAAACCGG
TACCTCTAGACTCGA 
Reverse #2 
AGCTTGCATGCCTGCAGGGCGGCCGCTCCGGGAAGAAAGAATAACAATAAAACCGG
GAAGAAAGAATAACAATAA 
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Table 3.2: Primer list for cloning pmiR-Glo and pcDNA3.1 (-) miR-21 3’UTR containing constructs. 
 
miR-21 Primer List 
1 miR-21 Site  
Forward CTAGAGGTACCCCAAGTGGAATATTCTAATAAGCTACCAGC 
Reverse GCTGGTAGCTTATTAGAATATTCCACTTGGGGTACCTCTAG 
 
2 miR-21 Sites  
Forward #1 TCGAGTCTAGAGGTACCCCA 
Forward #2 AGTGGAACTAATAAGCTACCAAGTGGAATA 
Forward #3 TTCTAATAAGCTACCAGCGGCCGCCTGCAGGCATGCA 
Reverse #1 TAGTTCCACTTGGGGTACCTCTAGACTCGA 
Reverse #2  CTTATTAGAATATTCCACTTGGTAGCTTAT 
Reverse #3 TGCATGCCTGCAGGCGGCCGCTGGTAG 
 
3 miR-21 Site  
Forward #1 TCGAGTCTAGAGGTACCCCA 
Forward #2 AGTGGAACTAATAAGCTACCAAGTGGAATA 
Forward #3 TTCTAATAAGCTACCAAGTGGAATATTCTA 
Forward #4 ATAAGCTACCAGCGGCCGCCTGCAGGCATGCA 
Reverse #1 TAGTTCCACTTGGGGTACCTCTAGACTCGA 
Reverse #2  CTTATTAGAATATTCCACTTGGTAGCTTAT 
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Reverse #3 GGTAGCTTATTAGAATATTCCACTTGGTAG 
Reverse #4 TGCATGCCTGCAGGCGGCCGCT 
4 miR-21 Sites  
Forward #1 
CTAGAGGTACCCCAAGTGGAATATTCTAATAAGCTACCAAGTGGAATATTCTAAT 
Forward #2 
AAGCTACCAAGTGGAATATTCTAATAAGCTACCAAGTGGAATATTCTAATAAGCTACCA
GC 
Reverse #1 
GCTGGTAGCTTATTAGAATATTCCACTTGGTAGCTTATTAGAATATTCCACTTGGT 
Reverse #2 
AGCTTATTAGAATATTCCACTTGGTAGCTTATTAGAATATTCCACTTGGGGTACCTCTAG 
 
5 miR-21 Sites  
Forward #1 
CTAGAGGTACCCCAAGTGGAATATTCTAATAAGCTACCAAGTGGAATATTCTAATAAGC
TACCAAGTG 
Forward #2 
GAATATTCTAATAAGCTACCAAGTGGAATATTCTAATAAGCTACCAAGTGGAATATTCT
AATAAGCTACCAGC 
Reverse #1 
GCTGGTAGCTTATTAGAATATTCCACTTGGTAGCTTATTAGAATATTCCACTTGGTAGCT
TATTAGA 
Reverse #2 
ATATTCCACTTGGTAGCTTATTAGAATATTCCACTTGGTAGCTTATTAGAATATTCCACTT
GGGGTACCTCTAG 
 
6 miR-21 Sites  
Forward #1 
CTAGAGGTACCCCAAGTGGAATATTCTAATAAGCTACCAAGTGGAATATTCTAATAAGC
TACCAAGTGGAATATTCTAATAAGCTAC 
Forward #2 
CAAGTGGAATATTCTAATAAGCTACCAAGTGGAATATTCTAATAAGCTACCAAGTGGA
ATATTCTAATAAGCTACCAGC 
Reverse #1 
GCTGGTAGCTTATTAGAATATTCCACTTGGTAGCTTATTAGAATATTCCACTTGGTAGCT
TATTAGAATATTCCACTTGGTAGCTTA 
Reverse #2 
TTAGAATATTCCACTTGGTAGCTTATTAGAATATTCCACTTGGTAGCTTATTAGAATATT
CCACTTGGGGTACCTCTAG 
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11 miR-21 Sites 
Forward #1 
CTAGAGGTACCCCAAGTGGAATATTCTAATAAGCTACCAAGTGGAATATTCTAATAAGCTACC
AAGTGGAATATTCTAAT 
Forward #2 
AAGCTACCAAGTGGAATATTCTAATAAGCTACCAAGTGGAATATTCTAATAAGCTACCAAGTG
GAATATTCTAATAAGCT 
Forward #3 
ACCAAGTGGAATATTCTAATAAGCTACCAAGTGGAATATTCTAATAAGCTACCAAGTGGA 
Forward #4 
ATATTCTAATAAGCTACCAAGTGGAATATTCTAATAAGCTACCAAGTGGAATATTCTAATAAGC
TACCAGC 
Reverse #1 
GCTGGTAGCTTATTAGAATATTCCACTTGGTAGCTTATTAGAATATTCCACTTGGTAGCTTATTA
GAATATTCCACTTGGTA 
Reverse #2 
GCTTATTAGAATATTCCACTTGGTAGCTTATTAGAATATTCCACTTGGTAGCTTATTAGAATATT
CCACTTGGTAGCTTATT 
Reverse #3 
AGAATATTCCACTTGGTAGCTTATTAGAATATTCCACTTGGTAGCTTATTAGAATATTCCACTT 
Reverse #4 
GGTAGCTTATTAGAATATTCCACTTGGTAGCTTATTAGAATATTCCACTTGGGGTACCTCTAG 
 
1 miR-21 siRNA Site  
Forward 
TCGAGTCTAGAGGTACCCCATCAACATCAGTCTGATAAGCTAGGAGCGGCCGCCCTGCAGGC
ATGCAAGCT 
Reverse 
AGCTTGCATGCCTGCAGGGCGGCCGCTCCTAGCTTATCAGACTGATGTTGATGGGGTACCTCT
AGACTCGA 
1 miR-21 7mer-1A  
Forward  
TCGAGTCTAGAGGTACCCCAAGTGGAATATTCTACTAAGCTAGGAGCGGCCGCCCTGCAGGC
ATGCAAGCT 
Reverse 
AGCTTGCATGCCTGCAGGGCGGCCGCTCCTAGCTTAGTAGAATATTCCACTTGGGGTACCTCT
AGACTCGA 
 
4 miR-21 7mer-1A 
Forward #1 
TCGAGTCTAGAGGTACCCCAAGTGGAATATTCTACTAAGCTACCAAGTGGAATATTCTACTAA
GCTACCAAGTGG 
Forward #2 
AATATTCTACTAAGCTACCAAGTGGAATATTCTACTAAGCTAGGAGCGGCCGCCCTGCAGGC
ATGCAAGCT 
Reverse #1 
TTGGTAGCTTAGTAGAATATTCCACTTGGTAGCTTAGTAGAATATTCCACTTGGGGTACCTCT
AGACTCGA 
Reverse #2 
AGCTTGCATGCCTGCAGGGCGGCCGCTCCTAGCTTAGTAGAATATTCCACTTGGTAGCTTAGT
AGAATATTCCAC 
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1 miR-21 7mer-8m  
Forward 
TCGAGTCTAGAGGTACCCCAAGTGGAATATTCTAATAAGCTGGGAGCGGCCGCCCTGCAGGC
ATGCAAGCT 
Reverse 
AGCTTGCATGCCTGCAGGGCGGCCGCTCCCAGCTTATTAGAATATTCCACTTGGGGTACCTCT
AGACTCGA 
 
4 miR-21 7mer-8m  
Forward #1 
TCGAGTCTAGAGGTACCCCAAGTGGAATATTCTAATAAGCTGCCAAGTGGAATATTCTAATA
AGCTGCCAAGTGG 
Forward #2 
AATATTCTAATAAGCTGCCAAGTGGAATATTCTAATAAGCTGGGAGCGGCCGCCCTGCAGGC
ATGCAAGCT 
Reverse #1 
TTGGCAGCTTATTAGAATATTCCACTTGGCAGCTTATTAGAATATTCCACTTGGGGTACCTCT
AGACTCGA 
Reverse #2 
AGCTTGCATGCCTGCAGGGCGGCCGCTCCCAGCTTATTAGAATATTCCACTTGGCAGCTTATT
AGAATATTCCAC 
 
1 miR-21 6mer  
Forward 
TCGAGTCTAGAGGTACCCCAAGTGGAATATTCTACTAAGCTGGGAGCGGCCGCCCTGCAG
GCATGCAAGCT 
Reverse 
AGCTTGCATGCCTGCAGGGCGGCCGCTCCCAGCTTAGTAGAATATTCCACTTGGGGTACCT
CTAGACTCGA 
 
4 miR-21 6mer  
Forward #1 
TCGAGTCTAGAGGTACCCCAAGTGGAATATTCTACTAAGCTGCCAAGTGGAATATTCTACTAA
GCTGCCAAGTGG 
Forward #2 
AATATTCTACTAAGCTGCCAAGTGGAATATTCTACTAAGCTGGGAGCGGCCGCCCTGCAGGCA
TGCAAGCT 
Reverse #1 
TTGGCAGCTTAGTAGAATATTCCACTTGGCAGCTTAGTAGAATATTCCACTTGGGGTACCTCTA
GACTCGA 
Reverse #2 
AGCTTGCATGCCTGCAGGGCGGCCGCTCCCAGCTTAGTAGAATATTCCACTTGGCAGCTTAGT
AGAATATTCCAC 
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3.3  RESULTS 
3.3.1  Design of functional plasmid reporter genes for transcription 
An RNA can be broadly divided into four functional regions: 5’ untranslated region (UTR), 
coding region, 3’ UTR, and the poly(A) tail.  The coupling of fluorescent labels onto the 
RNA requires that each of these four regions remain largely intact.  Firefly luciferase is a 
gene whose protein output can be robustly detected by luminescence output, a feature 
ideal for testing the impact of the probe on coding function.  The insertion of microRNA 
(miRNA or miR) recognition elements (MRE) into the 3’ UTR represent a unique strategy 
to test the functional consequence of fluorophores on select regulatory processes in this 
region of the molecule.  Thus a series of plasmid constructs were designed, from which 
RNA are transcribed from, that bear the FLuc gene sequence and a varying number of 
MRE into the 3’ UTR of the template.   
 Cloned into the 3’ UTR of the dual luciferase plasmid (pmiR-Glo), bearing a 
firefly luciferase gene and the transfection control normalizing gene (Renilla Luciferase), 
were complementary sequences to select miRNA varying both in number (Figure 3.1A) 
and binding affinity (Figure 3.1B & C).  MREs were designed from validated miR-21 
(PDCD4) and miR-7 (UBXN2B) target sites, which had complete complementary 
throughout all 8 nucleotides (nt) of the seed sequence (8mer).  From these sites, I cloned 
mutant forms intended to weaken its affinity towards its intended miRNA, specifically at 
positions 1 (7mer-m8), 8 (7mer-1A), or both (6mer).  Each of these MREs were cloned 
into the 3’ untranslated region (UTR) of the Firefly luciferase (FLuc) gene within the dual 
luciferase plasmid constructs (Figure 3.1A – C).  For transcriptional purposes, we required 
the FLuc gene be directly downstream of a T7 promoter containing sequence.  To do this,  
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Figure 3.1:  Design of dual luciferase reporter and T7 promoter containing pcDNA3 (-) 
plasmid systems.  (A) Cartoon representation of the location and spacing of the inserted 
miR-21 and miR-7 MRE.  Each MRE is separated by a 17nt spacer and is cloned into the 
3’ UTR of the FLuc gene which is found before the poly(A) tail and after the coding 
sequence.  Black circle on the FLuc 5’UTR represents the cap structure.  (B) MRE 
sequence alignment of (B) miR-7 or (C) miR-21 and its perfectly complementary target 
site (siRNA), UBXN2B (miR-7) or PDCD4 (miR-21) miRNA site and related mutants, as 
predicted by TargetScan (557).  The extent of complementarity between the microRNA 
seed sequence (blue) and its MRE are demarked by the red font. (D) Cartoon 
representation of the FLuc coding gene and its artificial pseudogene.  Pseudogene was 
created by excising the first 27nt (X) from the gene and inserting two artificial stop-codons 
( ) downstream of the transcriptional start site (    ). 
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we restriction cut the pmiR-Glo plasmid with PmeI and Xba1 restriction enzymes and then 
ligated into the precut pcDNA 3 (-) plasmid backbone.  Also, for future experimentation, 
an artificial Firefly luciferase pseudogene (non-coding FLuc) was engineered (Figure 
3.1D) whereby the FLuc gene was cut from the parent plasmid, leaving behind the 
transcriptional start site, using PspOMI, in place of the PmeI restriction enzyme (Figure 
3.1D, red X).  For transcriptional purposes, the FLuc gene was cloned 28 nucleotides (nt) 
directly downstream of a T7 promoter containing sequence.  To ensure the FLuc 
pseudogene was rendered non-coding, the gene was further modified by mutating two-
potential down-stream transcriptional start sites (positions 243 and 774 from the Psp OMI 
cut site) into stop-codons through site directed mutagenesis (Figure 3.1D, red bars).  
Next, the 3’ UTR from the pmiR-Glo constructs were restriction cut and ligated into the 
multiple cloning regions of both the coding and pseudogene pcDNA3 (-) plasmid systems.   
To assess the function of the cloned plasmids, each were transfected into iSHiRLoC 
relevant cell lines and assayed for luminescence output according to their MRE number 
(Figure 3.2 & 3.3).  Since microRNA serve to repress protein translation initiation, then 
transfecting the plasmids in the presence of the targeting miRNA should produce a 
diminished luminescence signal.  As expected, HeLa cells transfected with plasmids 
bearing miR-7 MRE in their 3’ UTR had noticeably repressed luminescence output by 
comparison to those with no MRE, although only when co-transfected with exogenous 
miR-7 (Figure 3.2A); this is especially significant considering that miR-7 is not 
endogenously expressed in HeLa cells (558).  Also, translation repression increases with 
increasing numbers of MRE within the FLuc 3’ UTR, a phenotype that has been observed 
elsewhere (559).  Surprisingly, however, repeating the same experiment in miR-7 
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expressing U2OS cells resulted in little repression relative to a no-site control (Figure 
3.2B).  Furthermore, no trend was observed between extent of repression and MRE 
number within the 3’ UTR FLuc gene.  Considering that the FLuc gene is controlled 
through the medium-expression human phosphoglycerate kinase promoter, we ruled out 
the possibility of the plasmid system saturating the available pool of miR-7.  Rather, we 
suspect that the miR-7 pool was already saturated by an overwhelming endogenous 
targetome pool as the expected phenotype was observed by co-transfection of additional, 
but exogenous, duplexed miR-7 miRNA (Figure 3.2).  Dissimilarly, miR-21 MRE 
containing constructs demonstrated an MRE number dependent decrease luciferase 
signal in the cells that endogenously express miR-21 (Figure 3.3A) (558).  Collectively, 
this suggests that the pool of miR-21 is in excess by comparison the targetome pool, and 
thus is readily available to bind and repress newly transcribed RNA.  Alternatively, mouse 
primary mesangial cells (PMC), knocked out (KO or (-,-)) for miR-21 expression, only 
demonstrated repression in the presence of exogenously transfected miR-21 (Figure 
3.3B).  Collectively, these data demonstrate that the plasmids constructs make functional 
protein that are properly regulated by their corresponding microRNA.   
Eventually fluorescently labeled miRNA targets will be probed for their interaction 
kinetics with their corresponding microRNA.  Thus targets with varying MRE affinities for 
their miRNA must be cloned as well.  Optimally, MRE that are perfectly complimentary 
with nucleotides 1 – 8 (8mer) in the targeting microRNA sequence (seed sequence) bind 
with the highest affinity and thus elicit the most robust response.  Mutations within this 
sequence of the MRE will severely impair miRNA binding, and thus repression.  Mutations 
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Figure 3.2:  Luciferase repression assays of dual luciferase plasmid constructs containing 
0 – 6 & 11 miR-7 MRE, with various affinities to miR-7, on the FLuc gene.  All data is 
normalized to the 0 MRE control.  (A) HeLa cells or (B) DCP1a stably transfected U2OS 
cells, transfected with the reporter plasmid containing various numbers of 8mer MREs for 
miR-7 and either 100 nM duplexed miR-7 or control miRNA.  (C) HeLa cells transfected 
with dual plasmid reporters containing 0, 1 or 4 MRE with varying affinities (8mer, 7mer-
m8 or 6mer) and either miR-7 duplexed RNA or control miRNA.  Error bars in all cases 
represent standard deviations from triplicate samples.   
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Figure 3.3:  Luciferase repression assays of dual luciferase plasmid constructs containing 
0 – 6 & 11 miR-21 MRE, with various affinities to miR-21, on the FLuc gene.  All data is 
normalized to the 0 MRE control.  (A) Cells containing endogenous miR-21 (HeLa, 
DCP1a-EGFP stably transfected U2OS, and wild-type mouse primary mesangial cells 
(PMC WT) or (B) miR-21 double knock-out mouse primary mesangial cells (PMC KO), 
transfected with the dual luciferase reporter plasmid containing various numbers of 8mer 
MREs for miR-21 with either 100 nM duplexed miR-21 or control miRNA.  (C) PMC KO 
cells transfected with dual plasmid reporters containing 0, 1 or 4 MRE with varying 
affinities (8mer, 7mer-m8, 7mer-A1 or 6mer) and either miR-21 duplexed RNA or control 
miRNA.  Error bars in all cases represent standard deviations from triplicate samples.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
162 
 
are best tolerated at positions 1 and 8 (560).  Thus 1 or 4 of these mutant MRE (mMRE) 
were cloned into both FLuc coding and pseudogene constructs (Figure 3.1B & C).  To 
ensure they were properly cloned, both miR-7 (Figure 3.2C) and miR-21 (Figure 3.3C) 
containing mMRE reporter plasmids were transfected into HeLa or PMC KO cells.  In both 
cases, repression was only observed upon co-transfecting the associated microRNA, and 
the extent of repression correlated nicely with the predicted binding affinity (560).  As a 
note, in addition to the affinity of the binding site, the magnitude of the extent of repression 
is also dictated by the concentration ratio of microRNA to the targetome pool.  Thus 7m8 
site appears less repressed in the case of miR-21 vs miR-7 MRE.   
 Lastly, the function of the artificial FLuc pseudogene is tested for the loss of protein 
coding function.  First, to ensure that neither full length, truncated or frame shifted proteins 
were created, the plasmid was incubated in a rabbit reticulocyte translation assay and 
proteins of all sizes were detected using a BODIPY® labeled lysine charged tRNA 
(Fluorotect).  Both the FLuc coding RNA plasmid and the kit control both positively 
incorporate the fluorescent lysine residue into the peptide chain as indicated by the 
fluorescent protein band on the gel (Figure 3.4A).  However, no detectable fluorescent 
protein band of any size was detectable over background for the FLuc pseudogene 
plasmid, suggesting that transcribed RNA is incapable of being translated into protein.  
As an orthogonal approach, the FLuc pseudogene plasmid was transfected into HeLa 
and PMC WT cells and tested them for relative luciferase response.  Cells transfected 
with the FLuc coding gene luminesced 1 x 104 times more than those transfected with the 
pseudogene (Figure 3.4B).  Furthermore, cells transfected with the pseudogene plasmid 
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also only luminesced 2x over untreated cells.  Thus, demonstrating that pseudogene 
plasmids are indeed non-coding for protein.   
 
3.3.2  T7 Polymerase Body Labeling and Yeast Poly(A) Polymerase Labeling of 
Firefly and Renilla Luciferase RNA 
Two types of chemically modified nucleoside triphosphates (CNTP) were integrated into 
the RNA chain using enzymatic labeling methods:  co-transcriptional incorporation of 
Cyanine 5-Aminoallyluridine-5'-Triphosphate (Cy5-UTP, Figure 3.5A) using T7 RNA 
Polymerase and 2'-Azido-2'-deoxyadenosine-5'-Triphosphate (azido-ATP, Figure 3.5B), 
post-transcriptionally, using Yeast Poly(A) Polymerase.  From these, three labeling 
strategies (Figure 3.5C – E) were developed to either randomly incorporate the Cy5-UTP 
throughout the body of the RNA (5’ UTR, coding sequence and 3’ UTR, Figure 3.5C), add 
consecutive azido-ATP between the body and poly(A) tail (Figure 3.5D), or randomly 
incorporate azido-ATP throughout the poly(A) tail (Figure 3.5E).  Each of these strategies 
offer the unique capacity to place the fluorophore distally from a region of interest.  As an 
example, body or BBT labeling strategies may best suited for studying deadenylation, as 
the modifications are integrated away from the tail, whereas tail modification places the 
fluorophore furthest from the body of the RNA.   
It is known that T7 RNA polymerase will tolerate pyrimidine based CNTPs if they 
are altered at the 5 – position (556, 561-563).  Thus, supplementing a transcription 
reaction with Cy5-UTP will permit the co-transcriptional body labeling of a Firefly 
Luciferase gene (FLuc, Figure 3.5C).  To test the extent of tolerability and control of the 
labeling process, we substituted increasing proportions of the UTP pool with Cy5-UTP (0 
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Figure 3.4:  Artificial FLuc pseudogene do not code for protein.  (A) In Vitro rabbit 
reticulocyte translation assay system incubated with either no DNA (Lane 2), FLuc coding 
plasmid (lane 3), FLuc pseudogene (lane 4), or the kit provided Firefly luciferase positive 
control (lane 5).  To detect the protein, each incubation was supplemented with BODIPY-
FL labeled lysine-charged tRNA.  Incubated samples were analyzed on a 4-20% SDS- 
PAGE gel and assessed for fluorescent protein (green).  Lane 1 is an Amersham ECL 
Plex fluorescent rainbow marker (red) to detect fragment sizes.  (B) HeLa and PMC WT 
cells were transfected with either the pcDNA3 (-) FLuc inserted pseudogene or coding 
gene containing plasmids.  Relative FLuc luciferase is detected to indicate the extent of 
expression within each cell line.   
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– 10% of total UTP), incubated each reaction using standard conditions, and tested for 
the extent of incorporation.  In agreement with literature (556, 561, 562), the CNTP is a 
well-tolerated substrate as indicated by the consistency in RNA yield (Table 3.3) nor an 
increasing presence in aborted products beyond the 0% Cy5-UTP control (Figure 3.6a).  
Furthermore, gel electrophoresis of the purified RNA revealed a positive correlation 
between fluorescent RNA & percent input of Cy5-UTP (Figure 3.6A).  Plotting the molar 
ratio of Cy5 to mRNA concentrations (Table 3.3) and the percent Cy5-UTP input revealed 
a linear relationship within the range tested (Figure 3.6B).  This suggests that predicting 
and controlling the extent of labeling is easily achieved by adjusting the starting 
concentrations of Cy5-UTP in the transcription mixture, although the placement of the 
fluorophores may impact translational processes.   
Labeling an RNA between the body and tail (BBT, Figure 3.5B) is a unique 
approach that ensures the CNTP is incorporated outside a biologically relevant sequence 
within the polymer chain.  For this strategy, the RNA is first transcribed, capped, then 
modified with a successive chain of azido-ATP by yeast poly(A) polymerase (yPAP).  The 
extent of labeling is controlled kinetically by incubating the RLuc RNA for either 0, 5, 10, 
20, 30, and 60 minutes.  Following purification, the RNA was fluorescently labeled using 
the Click-IT® Alexa Fluor® 647DIBO Alkyne (Alexa647) reagent.  We chose to label the 
RNA using a strained-promoted alkyne-azide cycloaddition (SPAAC) click approach 
because the reagent is commercially available, uses gentle reaction conditions, and are 
high yielding.  Copper-based click approaches were attempted, however, they resulted in 
excessive RNA degradation (Figure 3.7A) and thus no protein translation (Figure 3.7B).  
BBT modification and SPAAC labeling of the RNA was extensive and rapid (Table 3.3), 
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as 2.2 Alexa647 molecules per RNA were incorporated in as few as 5 minutes.  
Considering these data, the extent of labeling may be challenging to control.  This 
suggests that gel analysis of the purified RNA demonstrate an increase in Alexa647 band 
intensity with incubation time (Figure 3.6C).  Plotting the molar ratio of Alexa674 to RNA 
demonstrates a positive linear correlation with incubation time (Figure 3.6D).  
Finally, the last strategy involves the random incorporation of azide-ATP during the 
poly(A) tailing process (Figure 3.5E).  This strategy is designed to save time and steps, 
something that is especially important when RNA yields are low.  To test the extent and 
controllability of RNA labeling, the transcribed and capped RLuc gene is yPAP tailed with 
varying concentrations of azido–ATP (0, 0.1, 0.5, 1.0, 5.0, & 10% of total ATP).  
Subsequently, the purified tail-modified RNA is Alexa647 labeled and gel analyzed 
(Figure 3.6E).  Here, the Alexa647 band intensity, corresponding to the RLuc RNA, 
negligibly changed with increasing azido – ATP concentrations.  However, calculating the 
molar ratio of the Alexa647 to RNA and plotting it against varying azido – ATP 
concentration revealed a positive and linear correlation (Figure 3.6F).  While a modest 
4.7 labels per RNA are observed for 10% azido-ATP condition, this strategy is best in 
instances where the extent of labeling needs to be tightly controlled. 
Aside from the m7G cap (541), functional eukaryotic mRNA requires a poly(A) tail 
(564).  A poly(A) tail comprises a successive string of 100 – 250 adenosines, and plays 
an intricate role in mRNA stability and translation.  While the tail modifying strategy 
simultaneously incorporates this feature, body and BBT strategies require an additional 
step following transcription.  To assess the impact of incorporated CNTPs on the extent 
of tailing, Body and BBT modified RNA were tailed using yPAP and assessed by 
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Figure 3.5:  Labeling schemes of the mRNA.  Modified CNTPs (A & B) are enzymatically 
incorporated into the RNA chain either co-transcriptionally (C) or by yPAP (D & E).  First, the body 
(black) of the RNA is transcribed with (C) or without Cyanine 5-Aminoallyluridine-5'-Triphosphate 
(A, red) using T7 RNA polymerase and m7G capped (blue).  In scheme (D), the RNA is modified 
with a series of consecutive 2'-Azido-2'-deoxyadenosine-5'-Triphosphate (B, az) and 
subsequently tailed (grey), both using yeast poly(A) polymerase.  In scheme (E), the capped RNA 
is simultaneously, and randomly, modified with 2'-Azido-2'-deoxyadenosine-5'-Triphosphate (az) 
during the poly(A) tailing procedure using yeast poly(A) polymerase.  In both schemes (D) and 
(E), the 2'-Azido-2'-deoxyadenosine-5'-Triphosphate (az) modifications are coupled with either 
DIBO Alexa Fluor® 647 or Alkyne Alexa Fluor® 647 (both red) via click reactions. 
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Figure 3.6:  Extent of labeling and post-transcriptional RNA modification for all three labeling 
strategies.  (A, C, & E) Gel images of a denaturing (1M urea) 1.2% agarose gel stained for total 
RNA (left pane, green), Cy5 or Alexa647 labeled RNA (middle pane, red), and overlaid to 
indicate the extent of RNA labeling (right pane).  Graphs of the Cy5 or Alexa647 dye to RNA 
ratio, using Beer’s Law, and plotting it against yPAP incubation time or CNTP % input, 
demonstrates a strong positive – linear correlation for body (B), BBT (D), and tail modified (F) 
labeling strategies.  (A) Co-transcriptional body labeling of FLuc RNA demonstrates a clear 
trend of increasing Cy5 intensity with percent Cy5-UTP (0, 0.1, 0.5, 1.0, 5.0, & 10%) input.  (C) 
Increasing the yPAP incubation time (0, 5, 10, 20, 30, & 60 min) of capped RLuc RNA in the 
presence of azide – ATP increased the extent of BBT labeling by comparison to untailed and 
tailed – ATP only – controls.  (E) Fluorescence increases modestly with increasing percent 
azide-ATP input (0, 0.1, 0.5, 1.0, 5.0, & 10%) in the tail modification strategy.  (G) Body labeled 
RNA can be subsequently polyadenylated with yPAP regardless of the extent of labeling.  Top 
pane is SYBR Gold stained FLuc RNA, middle pane is Cy5 fluorescence, and bottom pane is 
the overlaid image.  (H) Denaturing 1.2% agarose gel analysis of heavily BBT modified RNA 
either untreated (lane 1) and yPAP tailed (lane 2). 
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electrophoretic mobility shifts in a denaturing 1.2% Agarose gel (Figure 3.6G & H).  
Regardless of the extent of labeling, the body labeled approach had little difficulty tailing 
the RNA, as indicated by the change in molecular weight following yPAP treatment 
(Figure 3.6G).  Similarly, the azido-ATP modifications in BBT labeling strategy did not 
impede yPAP from further modifying the RNA with a functional poly(A) tail (Figure 3.6H). 
 
3.3.3  BBT & Tail Modification Strategies Permit Protein Coding Functions 
Next, we aimed to address concerns regarding the impact of each labeling strategy on 
the proper protein coding function of the mRNA.  Furthermore, we wanted to ensure that 
the presence of the fluorescent labels did not lead to aborted translation products.  To 
test this, Firefly luciferase RNA was heavily labeled, using one of the three approaches, 
and incubated in translation-active rabbit reticulocyte extract.  To detect all protein 
products, including aborted transcripts, each reaction was supplemented with BIODIPY® 
labeled, lysine-charged tRNA (FluoroTect™).  Each reaction was quenched and analyzed 
for fluorescently labeled protein on a 4 – 20% Tris – Glycine SDS gel.  In all instances, a 
protein product was observed at the proper molecular weight expected from the unlabeled 
and kit control mRNAs (Figure 3.8A & B).  As expected, the body labeled mRNA produced 
60% less FLuc protein relative to control (Figure 3.8A), suggesting that the body labeling 
strategy impedes coding functionality.  However, both BBT and Tail modified strategies 
produced protein bands with intensities + 10% of control (Figure 3.8B).  In all instances, 
there were no appearances of aborted products beyond what is observed in the unlabeled 
control (Figure 3.8A & B).  Considering these data, the body labeling strategy was not 
assessed further for coding functionality. 
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Figure 3.7:  Copper based click chemistry approach degrades BBT modified RNA.  (A) 4% 
denaturing PAGE analysis of each step of the BBT labeling process using copper based click 
chemistry.  FLuc mRNA, m7G capped (Lane 5), BBT modified (Lane 4), yPAP polyadenylated 
(Lane 3), and alkyne Alexa647 labeled using Cu based approach (Lane 2).  Capped and tailed 
FLuc RNA control is shown for reference (Lane 1).  RNA size is confirmed by the RNA ladder in 
lane 6.  SYBR Gold stained FLuc RNA (left pane, green), Alexa647 labeled RNA (middle pane, 
red), and the overlay image (right pane).  Excessive smearing – RNA degradation – follows from 
fluorescent labeling using copper based click coupling.  (B) SDS-PAGE analysis of a rabbit 
reticulocyte in vitro translation assay of unlabeled FLuc mRNA (lane 1), unlabeled BBT (lane 3) 
and copper click labeled BBT modified RNA (lane 2). 
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RNA Labeling Scheme 
  
Body Labeled BBT Modified Tail Modified 
5 Labels / RNA 0.79% Cy5-UTP 13.2 minutes 
10.9 % Azide-
ATP 
Normalized Yields 107% 100% 87% 
Normalized in vitro translation 
output 
28% 112% 97% 
 
Table 3.3:  Calculated parameters for each labeling strategy.  Adjusting only CNTP input or 
incubation time, the estimated quantities or times required to achieve 5 labels per RNA using 
standard incubation conditions.  Normalized yields are calculated based on final concentrations 
of each RNA following CNTP modification and purification, relative to unmodified control.  In vitro 
translation output is calculated as the FLuc protein band intensity for the labeled, from rabbit 
reticulocyte extract, normalized to unlabeled control.  
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Next, to assess in cellulo protein coding capabilities, BBT and Tail modified 
mRNAs were transfected into HeLa cells and measured for their relative luciferase 
responses (Figure 3.8C).  To our surprise, we saw approximately a ~2x increase in FLuc 
expression for labeled RNA versus unlabeled.  We attribute this finding to either the 
stabilizing features of the fluorophores to deadenylase activity and/or the elongation of 
the poly(A) tail as a consequence of the labeling procedure.  As a further proof of principle, 
we microinjected labeled and unlabeled RNA into both U2OS (Figure 3.9A) and HeLa 
(Figure 3.9B) cells and performed immunofluorescence for the FLuc protein.  A 10 kDa 
Cascade Blue® Dextran injection marker was co-injected to identify cells that were 
treated.  Similar to the unlabeled version, labeled BBT & tail modified RNA produced large 
quantities of FLuc protein, by comparison to non-injected cells and RNase-treated labeled 
tail modified RNA.  Collectively, the data suggest both of these strategies are viable 
options for labeling the RNA and maintaining the coding functionality of the RNA 
molecule.   
3.3.4  BBT and Tail Modification strategies have accessible 3’ UTRs 
Since miRNAs serve to inhibit translation initiation, RISC regulated RNA targets 
should have a repressed protein expression signature relative to their no-site containing 
counterpart.  As indicated earlier, transfecting dual luciferase reporter plasmids (RLuc 
and FLuc), containing an FLuc gene engineered with 0 – 6 or 11 miR-7 MRE sites (Figure 
3.1A & B) revealed an increase in miRNA dependent gene repression with increasing 
MRE number in both HeLa and DCP1a-EGFP stably transfected U2OS cells (Figure 3A 
& B).  This observation is strictly dependent on the co-transfection of miR-7, as both HeLa 
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Figure 3.8:  BBT & Tail Modified mRNA produce translate protein.  (A) SDS-PAGE gel analysis 
of translated FluoroTect® labeled FLuc protein from either 1ug of body labeled (lane 1) or 
unlabeled (lane 2) mRNA incubated in rabbit reticulocyte extracts.  (B) SDS-PAGE gel analysis 
of translated FluoroTect® labeled FLuc protein from either 1ug of unlabeled (lane 1) & labeled 
(lane 2) BBT modified RNA and unlabeled (lane 4) & labeled (lane 3) Tail modified FLuc mRNA, 
incubated in rabbit reticulocyte extract.  (C) Relative luciferase response of transfected labeled 
BBT and Tail modified FLuc mRNA, normalized with RLuc mRNA, in HeLa cells.   
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Figure 3.9:  Microinjected labeled BBT and Tail Modified mRNA selectively express FLuc 
protein.  U2OS cells (A) and HeLa (B) cells were microinjected with either 10 nM unmodified, 
labeled BBT or Tail modified mRNA in 1x PBS & 0.025% 10 kDa Cascade Blue® Dextran.  12hr 
post-injection, cells were fixed in 4% formaldehyde solution, ethanol permeabilized, stained with 
primary and secondary antibodies labeled with either Cy3 (A) and DyLight 650 (B) fluorophores.  
(A) Microinjected U2OS cells selectively express protein that colocalize exclusively with the 
Cascade Blue® injection marker for both fluorescent Tail modified and unlabeled FLuc mRNA.  
Microinjected RNase A – treated fluorescent tail modified FLuc mRNA did not express protein.  
(B) Microinjected fluorescent BBT modified FLuc RNA into HeLa cells selectively expressed 
protein that colocalize with the cell injection marker, unlike in non-injected cells.   
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and U2OS cells contain negligible quantities of endogenous miR-7 (558).  Similarly, 
transfecting labeled and unlabeled FLuc BBT and Tail Modified RNA bearing 0, 1, 3, 6, 
or 11 miR-7 MRE into HeLa cells demonstrated a similar repression signature as their 
unlabeled and unmodified control (Figure 3.10A).  Thus, the strategic placement of these 
fluorophores does not appear to impact the miRNA dependent translation initiation 
inhibition of RISC.   
Another component of miRNA regulation of an RNA target is RNA destabilization 
(565).  RNA destabilization involves the recruitment of deadenylase complexes (CCR4-
Not1 & PAN 2/3), for the shortening of the poly(A) tail (566), DCP1/2 decapping complex 
(567) and XRN1 dependent 5’ to 3’ RNA digestion (568).  These destabilization processes 
are thought to partially occur within large cytoplasmic aggregates, termed processing 
bodies (P-bodies) (569).  Thus, the recruitment of a target RNA to a P-body granule is an 
indication of RNA destabilization.  To assess if our labeled RNAs are capable of miRNA 
dependent destabilization, we created a stably transfected U2OS cell line that express 
DCP1a protein, chimerically linked to EGFP, as described elsewhere (500), and 
measured the extent of their colocalization with the P-Body markers in cellulo. 
Microinjected labeled mRNAs were assessed for the extent of colocalization with 
P-Body marker EGFP-DCP1a, 2 h post-injection (Figure 3.10B).  Injection solutions 
comprised of 1 nM Alexa647 labeled BBT or Tail modified RNA, containing 11 miR-7 
MRE, with or without 1 M duplexed mature miR-7 and 0.025% Cascade Blue® 10 kDa 
Dextran – for locating injected cells – in 1x PBS solution.  After 2 h, live cells were 
immersed in imaging solution and analyzed for Alexa647 foci (> 100 a.u. intensity) within 
a 4-pixel radius of the P-Body centroid, which persisted for > 9 frames.  At this threshold, 
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50% of P Bodies were found colocalized with Alexa647 labeled RNA, in the presence of 
miR-7, regardless of labeling strategy (Figure 3.10B & C).  In the absence of miR-7, 
however, on average < 10% of the P-Bodies colocalized with the RNA.  Even in the 
instance that fluorescent labeling impairs coding function of the RNA – as in the body 
labeled RNA –miRNA dependent colocalization of the RNA with P-Body foci was not 
precluded (Figure 3.11).  Taken together, these data suggest that the 3’ UTR was 
accessible after all three labeling strategies.     
 
3.4  DISCUSSION 
Herein, we systematically tested and validated two enzymatic methods to strategically 
incorporate chemically modified nucleoside triphosphates (CNTP) in vitro into three select 
regions of the RNA molecule:  the body, between the body and tail (BBT) and throughout 
the tail (Figure 3.2).  Each strategy has the unique capacity to place the fluorophores into 
distinct regions of the RNA molecule depending on the experimental need.  To achieve 
this, we employed two enzymes: T7 RNA polymerase and yeast poly(A) polymerase 
(yPAP).  For body labeling, T7 RNA polymerase will incorporate 5-position modified 
pyrimidines, like Cy5-labeled UTP (Figure 3.2A).  For BBT and Tail modified approaches, 
the yPAP enzyme can efficiently incorporate small modifications at the 2’ position of ATP, 
such as azido-ATP (Figure 3.2B).  Fluorophore labeling of the azido-moiety is rapidly and 
gently accomplished by incubating the modified RNA with a strained-promoted alkyne-
azide cycloaddition (SPAAC) fluorescent click reagent, which avoids background 
degradation when using the more common Cu2+-mediated click chemistry. 
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Figure 3.10:  Fluorescent BBT and Tail Modified FLuc RNA are repressed and degraded by miRNA.  (A) Renilla Luciferase 
normalized luminescence from transfected unlabeled and fluorescent BBT or Tail modified FLuc RNA, containing either 0, 1, 3, 6, or 
11 miR-7 MRE, in HeLa cells.  Live cell imaging of DCP1a – EGFP stably transfected U2OS cells, microinjected with either 
fluorescent BBT (B) or Tail modified (C) FLuc mRNA with or without miR-7, analyzed 2 hr post-injection.  Yellow arrows indicate 
colocalized fluorescent mRNA with cytoplasmic p-body granules.  (D) Quantification of extent of P-Body colocalization with 
fluorescent mRNA in DCP1a – U2OS cells.  Fluorescent p-body granules posessing Alexa647 fluorescence exceeding a threshold of 
100 a. u., within a 4 pixel radius of P-Body centroid and persisting for over 9 frames, is counted as a colocalization event.   
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Figure 3.11:  Cy5-body labeled mRNA colocalize with P-Body marker DCP1a-EGFP.  Fixed cell analysis of microinjected Cy5-body 
labeled FLuc RNA, containing 11 miR-7 MRE, 2 h post injection in DCP1a-EGFP cells.  Yellow circles indicate sites of colocalization 
between DCP1a-EGFP (green) and RNA (red) coinjected with (top panes) or without miR-7 duplex.  Cascade Blue 10 kDa Dextran is 
used as cell injection marker.  
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Co-transcriptional body (5’ through 3’ UTR) labeling of an RNA molecule using T7 
RNA polymerase is a well-established and efficient method (556, 561-563).  Herein we 
demonstrate that this method, while efficient and high yielding (Table 3.3), can be 
deleterious to important mRNA functions depending on where the label is incorporated 
(Figure 3.8A).  Thus, the more extensively the RNA is labeled, the more functions it can 
potentially hinder.  For the proper translation of a viable protein, the highly processive 
components of the translation machinery must traverse the coding sequence without 
obstruction (570, 571).  The fact that the average mammalian coding sequence is ~1,200 
nt, while the 3’ UTR is ~1,000 nt (572) and the 5’ UTR is ~150 nt (573), suggests that 
there is a high probability a fluorophore will be randomly incorporated into this region.  
Thus, this strategy is impractical for labeling intracellularly functional mRNAs. 
As discussed earlier, >80% of the transcribed genome is predicted to be non-
protein coding RNA (ncRNA) (1).  Long noncoding RNA (lncRNA) are a particular class 
of ncRNA, > 200 nucleotides (nt) in length, that might be less perturbed by a body labeling 
approach, since they are devoid of a coding region.  Considering we have demonstrated 
that the extent of labeling can be easily controlled through the concentration of CNTP in 
the transcription reaction mixture, theoretically, one can still employ this method with 
lncRNA.  By keeping the fluorophore to RNA-length ratio as low as possible, one can 
minimize the impact of these insertions on RNA function, the extent to which needs to be 
assessed prior to its use.  As an example, herein we demonstrate that while body labeling 
render a FLuc gene essentially non-coding, it’s 3’ UTR was still largely accessible for 
miRNA regulation (Figure 3.11).  Taken together, our data suggest that body-labeled RNA 
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are largely capable of demonstrating miRNA mediated repression, although we still need 
to determine what fraction were impacted.   
The other two strategies, BBT and tail modification, were both efficient and high-
yielding (Table 3.3).  Due to the nature of the labeling strategy and the relative ease to 
which yeast poly(A) polymerase (yPAP) inserts the azido-ATP (546, 554), the BBT 
strategy accrues extensive labeling at short time intervals.  Thus, BBT modification is best 
suited in instances where numerous fluorophores are less of a concern/ ideal for the 
experimentalist, while sequestering the modifications between, but never within, 
functional regions of the molecule.  Oppositely, the tail-modification strategy importantly 
dilutes the azido-ATP with unmodified ATP, thereby more easily controlling the extent of 
incorporation into the RNA molecule.  However, this strategy randomly incorporates the 
CNTP within a functional region of the RNA molecule.  
While coding functionality was severely hindered for the body labeling strategy, 
BBT and tail modified RNA proved unhindered.  As detected through in vitro rabbit 
reticulocyte translation (Figure 3.8B), in vivo luciferase assays (Figure 3.8C) and 
immunofluorescence (Figure 3.9), both BBT and tail modified mRNA transcribed 
luciferase protein comparably to an unmodified control.  This suggests that the placement 
of the CNTP largely do not impede protein coding functionality.  Furthermore, yPAP 
labeling FLuc mRNAs containing 0, 1, 3, 6, or 11 miR-7 MREs in their 3’ UTR 
demonstrated an MRE dependent decrease in luciferase expression similar to that of 
control (Figure 3.10A).  Thus, not only do both yPAP approaches result in unobstructed 
coding functions of the mRNA, but also make the RNA accessible to miRNA mediated 
repression.  Further exemplifying this finding, not only is protein translation initiation 
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inhibited, but the miR-7 MRE containing fluorescent FLuc mRNA colocalized with 
cytoplasmic p-bodies in DCP1a-EGFP stable U2OS cells in a miRNA dependent fashion 
(Figure 3.10B & C).  This result suggests that both aspects of the miRNA regulation 
pathway, translation initiation inhibition and RNA destabilization, remain active after yPAP 
labeling.  Taken together, both yPAP approaches yield functional coding functions and 
accessible 3’UTR following labeling. 
The MS2 RNA labeling system is the most widely used for studying RNA in a cell 
and in real time.  By genetically encoding the RNA with a ~21 nt MS2 coat protein (MCP) 
binding sequence (MBS, Figure 1.5A) (209, 325), expressed fluorescent protein tagged 
MCP will tightly bind and thus label the RNA molecule.  To visualize the RNA molecule 
over the diffuse background of unbound fluorescent MCP, 24 MBS are genetically 
encoded into the RNA between the body and poly(A) tail of the molecule.  This system 
presents advantages over other labeling techniques in that the RNA are transcribed and 
labeled within the cell and it has been well validated.  However, the large background 
noise contributed by the overexpression of fluorescent MCP necessitates image 
processing to sufficiently visualize and study the RNA of interest.  Furthermore, the 
expression levels of both the MCP and RNA are controlled by DNA promoters, thus 
making it challenging for the scientist to precisely control the number of molecules being 
visualized.  Lastly, 24 MBS require the insertion of 504 nt of unnatural sequence into the 
RNA, which are bound by, on average, 26x MCP, each with a mass of ~13.7 kDa MCP.  
The addition of mass and sequence presents opportunities to impede biological function 
or introduce off-target effects.  Our method does not require the incorporation of unnatural 
RNA sequence, only small chemical modifications to endogenous nucleotides within the 
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polymer chain.  Furthermore, unlike the MS2 coat system, which requires long cloning 
experiments and/or stable cell-line production, the number of labels per RNA are easily 
controlled.  Lastly, at a molecular weight of ~ 1500 g/mol, organic fluorophores are ~ 13x 
less massive than an MCP, rendering the molecule more like an endogenous version of 
the RNA molecule in both sequence and in mass.   
This study sought to probe the merits of three labeling strategies to best guide the 
user on which technique is most appropriate for their experimental needs.  Using in 
particular yPAP-based BBT and tail labeling, we can now begin to probe and understand 
the functions and mechanisms of mRNAs and potentially ncRNAs as well. 
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Chapter IV 
Intracellular Behaviors of Fluorescent mRNA and Pseudogenes 
 
4.1  INTRODUCTION 
MicroRNAs (miRNAs) are small (~ 22 nucleotides), ubiquitously expressed, and highly 
conserved non-coding RNA molecules that a cell utilizes to post-transcriptionally regulate 
targeted genes (138).  In their mature state, miRNAs are loaded into Argonaute (Ago) 
proteins and serve as recognition motifs for RNA targets that bear partially 
complementary sequences.  Base pairing between the Ago-loaded miRNA seed 
sequence (nucleotides 2-8) and its target is important for target recognition.  The extent 
of binding is dictated by the accessibility of the target’s miRNA recognition element (MRE) 
and the seed to MRE binding affinity.  This binding affinity is primarily dictated by the 
extent of base pairing between the seed sequence and the MRE (574).  Mismatches 
found within this region will curtail or, in most cases, abolish their interactions; although 
in select cases, non-canonical binding sites between the miRNA 3’ end and target can 
overcome the loss in free energy due to seed mismatches (574).  Once bound, Ago 
serves as a platform to recruit the remaining components of the RNA Induced Silencing 
Complex (RISC) to inhibit translation initiation and ultimately destabilize the target RNA 
through shortening of its poly(A)tail, removal of the 7-methylguanylate cap, and 5’ to 3’ 
degradation (565). 
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 With over 1,800 different human miRNA sequences discovered, over half of the 
human genome, both protein coding and non-coding RNA, are regulated by miRNA.  A 
single miRNA family can regulate hundreds of different genes and a single gene 
possesses, on average, 7 MRE for one or more miRNA sequence (444).  Cellular 
amounts of miRNA and their targets span a very large range (10 – 200,000 counts per 
cell) depending on the cell type and their environment; however, typically only the most 
abundant 20 miRNA within a cell are observed to have significant regulatory impact.  As 
a result, situations must exist where the ratio of miRNA to target quantities are saturating 
(for either target or miRNA) or near stoichiometric.  Therefore, target RNAs must compete 
with one another for the miRISC pool, creating significant crosstalk between the miRNA 
channels and their targets. This is termed the competitive endogenous RNA hypothesis 
(560, 575, 576).    
 miRISC dependent gene regulation is a relatively inefficient process (low 
turnover).  Pulse-chase experiments have demonstrated that inhibition of translation 
initiation occurs hours following induction of target gene transcription, with the subsequent 
RNA destabilization occurring hours after that (441, 565, 577).  Despite these findings, 
miRNA-loaded Ago often tightly binds its seed matched target (Kd ~ 26 pM) (574).  In 
vitro, the off-rate for seed matched mouse miRISC is approximately koff = 5.1 x 10-4 s-1 (t½ 
= 23 min) (574).  Thus, from the equilibrium constant the kon rate constant was calculated 
to be close to the rate of macromolecular diffusion at 2.1 x 108 M-1 s-1 (574).  This suggests 
that miRNA-target interactions form rapidly and reach steady-state well before their 
regulatory effects are observed.  Within this timeframe, it is assumed that a single target 
with multiple MREs can be bound by more than one microRNA-loaded Ago complex.  
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Therefore, in theory, each accessible MRE is a potential target and can compete for the 
miRNA pool.   
 Recent experiments (559, 560, 577, 578) have demonstrated that miRNA 
mediated translation inhibition and RNA stability can become derepressed in a threshold 
dependent manner based on the MRE:miRNA ratio and the sequence dependent affinity 
of each interacting site (560).  At the threshold, small changes in MRE or miRNA quantity 
result in large changes of free miRNA, target site occupancy and, consequently, in gene 
expression.  These experimental and computational analyses have also demonstrated 
that miRNAs preferentially bind high-affinity targets first so that only in circumstances 
where miRNA concentrations are higher than their targets low affinity targets are 
susceptible to regulation (559, 560, 577, 578).  Assuming that each site is accessible and 
can be bound simultaneously and non-cooperatively, and coding and non-coding RNA 
targets are indistinguishable to miRISC, then a simple stead-state equilibrium equation 
should suffice in describing the thresholds of a particular miRNAs buffering capacity on 
all gene regulation (Figure 4.1) (560):  
 
 
 
 
  
Unbound miRNA
(Unbound miRNA + Kd)
* i = MRE of a similar Kd
MRE Occupancy  = 
 = Unbound miRNA Total miRNA - S i [MRE]i*(MRE Occupancy)i
Kd
(Ki + Kd)
Kd + S i [MRE]i*Shifted Threshold For Specific MRE  = 
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Using the above mathematical model to fit experimental data or predict competitive 
effects in vivo demonstrates that most MRE:miRNA ratios are in regions of saturation, 
where either the MREs or miRNAs are in significant excess over the other (559, 560, 577, 
578).  Thus, in most cases, the extent of miRISC repression should be refractory to 
changes in MRE number (559, 560, 577, 578). There are select instances in vivo, 
however, where the MRE:miRNA ratios are low and mRNAs become susceptible to 
derepression upon the introduction of modest numbers of high-affinity competitive 
endogenous RNAs (ceRNA) (578).   
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Figure 4.1:  Quantitative modelling of competition effects for miR-20a binding.  (A) Free miR-20a 
concentration – computed for different models of a monocyte (solid lines) – is plotted as a function 
of total miR-20a concentration on a logarithmic scale.  Sequestration of microRNA (miRNA) is 
substantial (dashed line indicates where free miR-20a concentration is the same as total miR-20a 
concentration).  Regulation requires free miRNA concentration around the dissociation constant 
(Kd) of binding sites (shaded region).  Saturation requires unphysiological levels of miRNA 
(>100,000 copies per cell).  (B) Predicted occupancies of 7-nucleotide (nt; position 2-8) seed 
matches are shown.  The presence of many sites increase the 50% occupancy ( = 50%) 
thresholds (solid lines) relative to the in vitro measured Kd (dashed line).  Blue dashed lines 
indicate total concentrations at which  = 75% for an 8-nt site.  Red triangles indicate the 
approximate miR-20a concentration (~5,600 copies per cell), assuming that ~150,000 Argonaute 
proteins are expressed per cell(579) and that miR-20a abundance is proportional to its read count 
(580).  (C) Scenarios for increasing binding site concentrations are shown.  In the top panel, a 
single mRNA with two miRNA binding sites is strongly upregulated (+500 sites).  In the middle 
panel, the collective transcriptome changes by cellular differentiation (+5,000 sites). In the bottom 
panel, an artificial ‘sponge’ RNA (+20,000 sites) roughly doubles the total binding site 
concentration.  (D) Scenarios from part C are evaluated computationally.  Predicted occupancies 
of miRNA binding sites at the miR-20a concentration indicate in part b are plotted for 8-nt, 7-nt 
and 6-nt seed matches (the approximate Kd values of which are 61pM, 67pM and 118pM, 
respectively, at 37 oC).  Reprinted by permission from Macmillan Publishers Ltd: Nat. Rev. Genet. 
(560), copyright 2015. 
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These pivotal studies have indicated that, while ceRNAs are relevant in selective 
contexts (low MRE:miRNA ratio and concentrations), they are not commonplace (559, 
560, 577, 578).    Yet despite these findings, there are a substantial number of publications 
focused on the discovery of functional ceRNAs, where their expression relieves miRNA 
mediated repression of other select genes.  These RNA molecules fall into various 
classes of non-coding RNAs:  pseudogenes (183, 581-585), lncRNAs (183, 586-593), 
and circular RNAs (circRNA) (160, 161).  Not only are these ceRNAs all non-coding, but 
the surprising number of discovered ceRNAs suggests that this may be a more common 
phenomenon than originally perceived.  Therefore, perhaps there are salient, but 
anomalous, features that define a ceRNA and are not described by the above model.  
Some of these may include: non-coding and coding genes are kinetically dissimilar 
miRISC targets; miRNAs bind some targets cooperatively; multiple MREs on a single 
target are not equivalent to multiple targets with a single MRE; and/or the system is not 
at steady-state.   
Herein, I describe my approaches to testing the ceRNA hypothesis and the 
underlying assumptions used to thermodynamically model the extent of miRNA binding 
to predicted targets.  To determine the rate of miRNA dependent decay we employ fixed-
cell particle counting to measure the changes in fluorescent RNA particle number, with 
and without miRNA binding sites, and to determine if pseudogenes are preferential 
targets to their coding counterparts.  Secondly, we employ two-color single particle 
tracking of fluorescent FLuc RNA with either fluorescent miRNA or DCP1a-GFP 
(processing body marker) to measure their interaction kinetics over time.  While select 
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assay-related caveats had slowed progress in measuring these biological phenomena, 
two-colored approaches have poised us for future success.  
 
4.2  MATERIALS & METHODS 
4.2.1  Optimizing injectate concentration 
Cy5 body-labeled FLuc Pseudogene was capped and tailed, as described elsewhere, 
and 2x serial diluted from 1 nM to 16 nM into a solution of 0.5 mg/mL of Cascade Blue 
labeled 10 kDa dextran into 1x phosphate buffered solution (PBS).  Injectate solutions 
were spin filtered (0.22 m pore size) and held on ice until injection.  Just before 
microinjection, U2OS cells were washed twice and immersed in HEPES Buffering 
Solution (HBS).  Following injection, cells were washed twice with pre-warmed PBS and 
fixed in a 4% paraformaldehyde solution in 1x PBS solution for 20 min.  Following fixation, 
the U2OS cells were washed thrice in 1x PBS.  Just before imaging, cells were immersed 
into an oxygen scavenger system (OSS), comprising 5 mM protocatechuic acid (PCA), 
50 nM protocatechuate-3,4-dioxygenase (PCD) and 2 mM Trolox.  Single framed images 
were acquired at an acquisition time of 100 ms.  Imaris spot detection algorithm is used 
to identify spots that span > 5 pixels in diameter (134 nm/ pixel) and exceed 500 a.u. of 
intensity.   
 
4.2.2  Fluorescent dextran injection calibration 
Injection solutions were made by serial diluting Cy5 body labeled FLuc Pseudogene from 
1 nM to 15.6 pM, or no RNA control, into 0.3 mg/mL cascade blue 10 kDa dextran and 1x 
PBS.  Using a 0.22 m pore sized spin filter tube, injection solutions are filtered and stored 
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on ice until injection.  HeLa cells washed twice and immersed in HBS solution were 
microinjected with the injection solutions.  Following microinjection, cells were washed 
thrice with 1x PBS, fixed with 4% paraformaldehyde PBS solution, washed 3x with PBS 
and immersed in OSS media.  Images were acquired at 100 ms acquisition time for 4 to 
8 cells per injection concentration.  Masks were generated using the injection marker 
images, where cell boundaries were outlined using the freehand tool, all pixels outside of 
the boundary were set to maximum value and zeroed inside the boundary.  Cy5 FLuc 
Pseudogene images background subtracted with a rolling ball radius function, in ImageJ, 
at a pixel radius of 5 and mask subtracted.  Dextran images were mask subtracted only.  
Integrated intensities of the mask subtracted dextran images were used to measure the 
cascade blue signal intensity.  Since the same concentration of cascade blue dextran was 
the same at all concentrations of RNA, the intensities of the injected cells were dose 
corrected and plotted against particle number, identified using the Imaris spot detection 
tool. 
 
4.2.3  FluoSphere® Injection Volume Calibration 
Stock concentration of FluoSpheres® carboxylate-modified microspheres, 0.04 mm, 
yellow-green fluorescent beads (Invitrogen, Cat# F-8795) was diluted to 1.661 nM 
(1000x) with milliQ H2O, vortexed and sonicated.  Diluted FluoSpheres were further 
diluted to 200 pM into a solution containing 0.5 mg/mL cascade blue 10kDa dextran, into 
400 pM Cy5 body labeled Pseudogene and 1x PBS.  Injection solutions were purified by 
spin column filtration (0.22 m pore size) and kept on ice till injection.  Microinjected cells 
washed and fixed in 4% paraformaldehyde solution for 20 min, immersed into OSS buffer 
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and imaged.  Z-stacks were taken at 0.2 m slices for 60 frames at 100 ms acquisition 
time per frame.  Using the spots detection algorithm in Imaris, FluoSphere and Cy5 RNA 
particles were identified and counted. 
 
4.2.4  Particle Counting of Degraded RNA 
Alexa 647 labeled, BBT modified FLuc RNA was treated with 100 pg/mL RNase A and 
incubated for 5 min at 37 oC, and purified using the MegaClear™ Kit (ThermoFisher 
Scientific, Cat#: AM1908).  RNA integrity was tested on a 1.2% denaturing (1 M Urea) 
agarose gel in 0.5 TBE buffer.  Purified degraded RNA was mixed to a concentration of 
~ 1 nM in 0.5 mg/mL Cascade Blue 10 kDa dextran, 200 nM FluoSpheres (0.04 m, 
green-yellow fluorescence) in 1x PBS.  Injection mixture was spin filtered and stored on 
ice.  U2OS cells were injected and fixed with 4% paraformaldehyde – PBS solution either 
0 or 2 h post-injection.  Fixed cells were washed and immersed in OSS media and z-stack 
imaged at an acquisition time of 100 ms for 60 frames of 200 nm slices for 3 cells/ time-
point.  Imaris spot detection algorithm identified Alexa 647 spots and beads per image. 
 
4.2.5 Fixed-cell photobleaching analysis of microinjected Cy5 – UTP 
Cy5 – UTP was diluted to a final concentration of 0.1 M with 0.5 mg/mL Cascade Blue 
10 kDa dextran in 1x PBS.  Spin filtered injection solution is microinjected into U2OS cells 
and 4% formaldehyde fixed at either 0 or 4 h post-injection.  Fixed cells are immersed in 
OSS media and then imaged, for a single-plane, at 100 ms acquisition time for 150 
frames.  Using our in-house photobleaching analysis software, identified particles in each 
cell (n = 3 or 5 cells) were assessed for the number of stepwise photobleaching events.  
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Particles were distributed into those that had a single photobleaching event (monomers) 
and those that had more than one (multimers) as described elsewhere (594). 
 
4.2.6  Particle disappearance of FLuc RNA bearing 0 or 6 miR-21 MRE 
Alexa 647 labeled, BBT modified FLuc mRNA bearing 0 or 6 miR-21 MRE are diluted to 
a final concentration of 0.4 nM into a mixture of 0.2 nM FluoSphere beads (0.04 m, 
yellow – green) and 0.5 mg/mL Cascade Blue 10 kDa dextran in 1x PBS.  Spin filtered 
samples were microinjected into wild-type mouse primary mesangial cells (PMC WT) and 
fixed at 0, 1, 2, 4, 8, and 12 h post-injection with 4% paraformaldehyde.  Z-stack images 
were acquired at 100 ms acquisition time and at 200 nm slices for 60 frames.  Both RNA 
and FluoSphere particles are counted using the Imaris spot-detection algorithm. 
 
4.2.7  miRNA & mRNA Pre-Assembly Gel Shift Assay 
Cy3-miR-7 guide strand was diluted to 10 M with and without 15 M miR-7 unlabeled 
passenger strand and heat-annealed in 1x PBS.  Duplexed Cy3-miR-7 were diluted to 0.1 
uM in PBS with 1 mg/mL Cascade Blue 10 kDa dextran, and either 0, 0.001, 0.01, or 0.1 
M Cy5 body labeled mRNA with 11 miR-7 MRE.  As a positive control, 0.1 M single-
stranded Cy3-miR-7 was mixed with dextran and 0.01 M Cy5 body labeled mRNA with 
11 miR-7 MRE in 1x PBS.  As negative controls, 0.1 M duplexed miR-7 was incubated 
with Dextran in 1x PBS and with Dextran, 0.1 M Cy5 body labeled mRNA with no miR-
7 MRE, in 1x PBS.  All samples were allowed to incubate for 2 h at 25 oC.  At the end of 
each incubation, 10 L of each sample was diluted with 10 L of 2x non-denaturing 
loading dye and loaded onto a non-denaturing 15% polyacrylamide gel at a constant 13W 
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for 2.5 h at 4 oC.  The gel was scanned for both Cy5 mRNA and Cy3 miRNA and analyzed 
for gel shifting of the Cy3 miRNA to slower migrating products.   
 
4.2.8  Live and Fixed Cell Imaging of RNA 
HeLa or DCP1a – EGFP stably transfected U2OS were seeded (1 – 1.5 x 105 cells) and 
allowed to adhere for 1 day.  Prior to microinjection, cells were immersed in 1x HBS (see 
above).  Microinjection solutions comprised of 1 nM mRNA, 1 mg/mL Cascade Blue ® 10 
kDa dextran, with and without 1 M unlabeled miR-7 duplex, or 100 nM Cy3 or Alexa 647 
labeled miR-7 duplexed with 5’ – Iowa Black® labeled passenger strand, and 1x PBS to 
a total volume of 30 L.  Injection solutions were spin filtered (0.22 m pore size) and 
stored on ice until injection.  Femtotip micropipette is filled with 2 – 4 L of injection 
solution and cells were injected using a Femtojet pump and Injectman NI2 
micromanipulator (Eppendorf) for 0.5 s at 100 hPa with 20 hPa compensation pressure.  
Once completed, microinjected cells were returned to complete medium and incubated 
at 37 oC and in an atmosphere with 5% CO2 and 95% relative humidity.  Cells were 
allowed to incubate for the delegated time (0.5, 1, or 2 h post-injection) where they were 
subsequently washed thrice in HBS media and live cells were either immediately imaged 
or 4% formaldehyde fixed (20 min) and subsequently imaged in Oxygen Scavenger 
System (5 mM protocatechuic acid (PCA), protocatechuate – 3,4 – dioxygenase (PCD), 
and 2 mM Trolox (6 – hydroxyl – 2,5,7,8 – tetramethylchroman – 2 – carboxylic acid)).   
 
4.2.9  Single-Molecule Imaging 
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Microscopy imaging was conducted, similar to before (504, 505), on a home-built IX-81 
Olympus microscope with a 60x, 1.49NA oil immersion objective (Olympus), 2x 
magnification wheel, P-545.3C7 capacitive piezoelectric x-y-z stage (Physik 
Instrumente), IXon 897 (Andor) EMCCD camera, and a Cell-TIRF module (Olympus).  
Cells were illuminated using solid-state lasers with wavelengths of 405 nm (0.8 mW at 
the objective) and 640 nm (8 mW at the objective).  Highly inclined laminar optical sheet 
(HILO) microscopy was used to achieve sufficient illumination depth while minimizing 
background.  A quadband dichroic (Chroma) 405/488/532/647 was used to detect miR-7 
fluorescent particles and cell boundaries.  Cells were maintained at 37 oC on the Delta T 
open dish system (Bioptechs).  All videos were acquired at 100 ms camera exposure time 
for 50 - 200 frames.   
 
4.2.10  Validating Fluorescent miRNA Functionality 
HeLa cells were split and seeded into a 96-well culture plate to a density of 15,000 
cells/well.  Cells were allowed to adhere for 24 h, after which half of their media was 
replaced with transfection mixture.  Transfection mixture, per well, contained 0.4 L of 
Lipofectamine 2000, 60 ng of the dual luciferase plasmid reporter containing the FLuc 
gene with 11 miR-7 MRE and 100 nM of duplexed miR-7 into a total of 10 L in Optimem 
media (Gibco, Cat# 31985070).  While the concentration of the duplexed pool of miR-7 
remained constant, proportions of total comprised a mixture of fluorescently labeled miR-
7 guide strand heat-annealed to either an unlabeled or a 5’-Iowa Black® labeled 
passenger strand.  After 6 h, cell media was replaced by fresh media and incubated by 
an additional 18 h.  Cells were then washed thrice with 1x PBS, lysed and analyzed for 
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total RLuc and FLuc luminescence per the instructions of the Dual-Luciferase Reporter 
Assay System (Promega, Cat# E1910) and analyzed on a luminometer (Lmax Molecular 
Devices Luminometer Reader, BERTHOLD Luminescence).    
 
4.2.11  Cell Culture and Transfection 
HeLa (CCL-2, ATCC), mouse primary mesangial cells (Wild-Type and miR-21 double 
knockout), U2OS and DCP1a-EGFP stably transfected U2OS cells were grown in an 
incubator, held at 37 oC and in an atmosphere with 5% CO2 and 95% relative humidity.  
HeLa cells were maintained in DMEM media (GIBCO, Cat# 11995) and U2OS cells in 
phenol red free McCoy’s 5A, with L-Glutamine, media (GE Health, Cat# SH30270.01).  
For both cell lines, the medium was additionally supplemented with 10% (v/v) fetal bovine 
serum (FBS) and 100 U/mL Penicillin-Streptomycin (ThermoFisher Scientific, Cat# 
15140122).   
 
4.2.12  Preparation of Fluorescent microRNA Duplexes 
All labeled and unlabeled microRNA guide and passenger strands ordered from 
Integrated DNA Technologies (IDT, Supplemental Figure 3.5B).  For all combinations of 
guide and unlabeled passenger strand, each RNA molecule was modified to contain a 5’ 
phosphate and, in the case of the labeled guide strand, a 3’ NHS-ester linked Alexa Fluor 
647 or Cy3 fluorophore.  However, the synthesis of a 5’ Iowa Black® RQ labeled 
passenger strand precluded a 5’ phosphate.  Guide and passenger strands were HPLC 
purified by IDT, and their size and purity verified by denaturing, 8M urea, 20% 
polyacrylamide gel electrophoresis.  For the Alexa Fluor 647 and Cy3 labeled guide 
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strands, > 90% of the RNA was found to be singly labeled as determined by quantifying 
the molar ratio of fluorophore to RNA through UV-Visible absorbance measurements.  
Duplex formation between guide and passenger strand were performed at a 1:1.5 ratio in 
1x Phosphate Buffered Solution (PBS, Gibco, Cat# 70011) to a final concentration of 10 
M.  Duplex formation was assessed by electrophoretic mobility shift assay on a non-
denaturing 20% polyacrylamide gel in 1x Tris/ Borate/ EDTA buffer.   
 
4.3  RESULTS 
4.3.1 Optimization of single-molecule conditions 
Counting fluorescent particle disappearance as a measure of RNA decay requires the 
optimization of key biological and single particle conditions; most notably, delivering 
biologically relevant fluorescent RNA amounts while ensuring sufficient particle resolution 
for accurate counting.  Fortunately, microinjecting biologically relevant amounts of 
fluorescent RNA – median copy number ~100 counts per cell (595) – is a small enough 
population of RNA that should be well resolved spatially such that particle counting should 
be a reasonably simple task (504).  Injecting 0.5 – 2 nM solutions of fluorescent RNA 
resulted in 50 – 1000 particles / cell, as discovered by injecting U2OS cells with a variety 
of RNA concentrations and performing fixed cell particle counting (data not shown). 
 Due to the extent of photobleaching using our imaging conditions, the 
fluorescent RNA within a single cell can only be imaged for ~ 10 seconds.  Thus a single-
cell will constitute only a single time-point for both live and fixed cell studies.  To measure 
the extent of RNA disappearance over time, an internal standard must be co-injected to 
elucidate the number of particles initially injected.  This calibrant must be stable, 
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quantifiable, biocompatible, and avoid excretion from the cell in order to become an 
accurate and reproducible measure of injected RNA quantities.  Considering that human 
mRNAs are known to have slow rates of decay (596-599), median half-life of ~10 h (599), 
calibrant selection is crucial to properly define shallow decay curves.  Fluorescent 10 kDa 
dextrans have been used as internal standards elsewhere (505), however, I found poor 
correlation between cell intensity and RNA particle number (Figure 4.2A & B).  Since the 
dextran was used to identify cells that were microinjected, the variability is likely due to 
photobleaching that occurs during the searching process.  Considering that functionalized 
Fluospheres have been used elsewhere as markers for cellular internalization (600, 601), 
and are resistant to photobleaching, I next chose them as a viable option for calibrating 
injection volume.  To test this, 0.4 nM fluorescent RNA and 0.2 nM FluSpheres were 
coinjected into U2OS, HeLa, PMC WT and PMC KO, fixed immediately, and each particle 
was counted (Figure 4.2C).  Scatter plots of counted bead and RNA particle numbers 
were well correlated (Figure 4.2D).  Despite these merits, one potential concern 
associated with using FluoSpheres is that they are actively taken-up into the cell (600, 
601).  Thus, due to the compensation pressure of the microinjector, a continuous flow of 
injection solution always occurs and uninjected beads can lay on the surface of non-
injected cells or the dish, where cells can migrate on top of, leading to false positives.  
Thus to circumvent this issue, injection solutions will also contain the fluorescent 10 kDa 
dextran as an injection marker to help elucidate which cells were actually injected.   
 
4.3.2  Single particle tracking of microinjected fluorescent BBT and Tail Modified 
mRNA 
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Figure 4.2: Calibrating amounts of RNA injected.  (A) Representative images of cascade blue 10 
kDa dextran injection calibrated samples (right pane) and the Cy5 pseudogene foci (left pane) for 
the 1 nM injectate RNA concentration solution.  (B) Scatter plot of the dose normalized cascade 
blue cell intensity (a.u.) relative to the countable Cy5 pseudogene foci varying at injection solution 
concentrations (0, 15.6, 31.25, 62.5, 125, 250, 500, and 1000 pM).  (C) Representative (single 
plane) z-stack images of HeLa cells injected with Cy5 body labeled pseudogene (red) and yellow-
green fluorescent FluoSphere® beads (green), used to calibrate injection volume, and Cascade 
Blue 10 kDa dextran (blue), to identify cell boundaries.  (D) Scatterplots, fitted with a linear 
trendline, of bead vs. Cy5 RNA particle number for PMC KO, U2OS, HeLa and PMC WT cells.  
RNA particle number correlated well with bead number. 
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Thus far, we have addressed these labeling strategies from a series of ensemble 
experimental approaches, where the bulk properties have been averaged into a singular 
value.  However, the power of a tool of this type is that they can be implemented to 
understand an mRNA’s biophysical and biochemical properties in cellulo.  Time-averaged 
mean square displacement (MSD) analysis of microinjected fluorescent mRNA is an 
example of this.  Complex formation between biomolecules in cellulo can be closely 
regulated and can rapidly form or disassemble with the proper stimulus.  Changes in the 
formation of large complexes – P-Bodies in the case of miRNA – can result in a large 
change in diffusion behavior for select biomolecules.  Thus, measuring and monitoring 
these changes can be paramount to elucidating the spatiotemporal regulation of select 
processes. 
Microinjecting 1 nM of each labeled FLuc mRNA, bearing 11 miR-7 MRE, in the 
presence and absence of miR-7 duplex, into DCP1a-cells, and monitoring their diffusion 
characteristics 30 min post injection, we observe a very large range of MSD-calculated 
diffusion coefficients of the mRNA population (Figure 4.3A) (504, 505).  Of note, non-
denaturing PAGE analysis of the injection solutions indicate that no pre-assembly 
between the duplexed miRNA and the mRNA occur prior to injection (Figure 4.4A).  The 
histogram of diffusion coefficients for all trajectories 30 min after microinjection (n = 4 to 
6 cells, > 1000 total trajectories) can be broadly fitted with two populations, slow (BBT = 
0.108 um2/s & Tail = 0.124 um2/s) and fast (BBT = 0.917 um2/s & Tail = 1.03 um2/s); the 
averages of these distributions closely resemble those observed for a FLuc gene in 
literature (602).  Comparing these values to the MSD-calculated diffusion coefficients of 
processing bodies (Figure 4.3B), it is evident that there is little overlap between the two 
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population’s movement behaviors.  Furthermore, comparing the diffusion coefficient 
histograms of each RNA in the presence and absence of miR-7 are largely 
indistinguishable, as both samples have slow and fast populations with similar centers of 
gravity and areas under the curve (Table 4.1).  Despite this finding, P-bodies colocalized 
with fluorescent FLuc mRNA only in the presence of miR-7, even after only 30 minutes 
(Figure 4.3C).  This is likely due to the aggregation of multiple RNAs into comparatively 
few intracellular P-Bodies association – by comparison to total mRNA number – and 
competition with endogenous targets for the miR-7 pool.  While the overall diffusion 
coefficients of the mRNA population appeared relatively unchanged, two-color 
approaches offer insights about the changes within a subpopulation.  For example, we 
observe that in the absence of miR-7, at best, we see fluorescent mRNA encroach upon 
a P-Body, but upon discovering a physical barrier, they rapidly diffuse away from the 
granule (Figure 4.3C).  However, in its presence, we see colocalized RNA persist at the 
P-Body core for greater than 9 frames (~0.9 s).  Furthermore, we can elucidate details 
about the interactions between the two punctae.  As an example, a fluorescent FLuc 
mRNA, sequestered by a P-Body for over 0.4 s, escapes its terminable fate and, in theory, 
returns to the translating pool (Figure 4.3E, top panes). 
Co-tracking of fluorescent mRNA with large, slow moving aggregates is 
comparatively easier than co-tracking with its faster and smaller miRNA interacting 
partner.  Thus, to further demonstrate the power of these labeling strategies, we co-
microinjected 1 nM Alexa555 labeled BBT or Tail modified mRNA with 100 nM 3’  
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Figure 4.3: Single – molecule analysis of fluorescent mRNA in cellulo.  (A) MSD calculated 
diffusion coefficients of Alexa647 labeled BBT (left panes) and Tail Modified (right panes) FLuc 
mRNA with (top panes) and without (bottom panes) coinjected miR-7, analyzed 0.5 h post-
injection in DCP1a – cells.  Distributions were fit with two Gaussian functions, representing two 
major movement behaviors.  Distributions were generated from > 1000 particle tracks in 5 cells.  
(B) MSD calculated diffusion coefficients of P-Bodies.  Distributions were generated from ~500 
particle tracks in 16 cells.  (C) Pseudo-colored images of Alexa647 labeled mRNA (red) and 
DCP1a-EGFP fluorescent P-Body marker (green), cotracked with and without coinjected miR-7.  
(D) Live cell analysis of Alexa 555 labeled BBT (top panes) and Tail modified (bottom panes) 
FLuc mRNA (green) co-injected with Alexa647 labeled miR-7 (red) HeLa cells.  Yellow circles 
represent instances of colocalization observed for periods exceeding 9 frames.  (E) 
Pseudocolored images of a dissociation event (top panes) between a P-Body (green) and 
fluorescent mRNA (red) and co-trackable, fast diffusing (bottom panes) of a fluorescent mRNA 
(green) and miRNA (red) from live-cell single particle tracking experiments.  Blue lines represent 
the tracks the particles traverse during the course of the analysis.   
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Alexa647 labeled miR-7 (Figure 4.4B).  Of note, while testing the functionality of 
our labeled miRNA, we observed de-repression of a dual luciferase reporter gene, 
containing 11 MRE, in a dose dependent manner (Figure 4.4C).  This phenomenon was 
readily reversed by modifying the 5’ end of the passenger strand with an Iowa Black® RQ 
label.  Since Ago preferentially loads the RNA strand with the weakest 5’ terminal 
thermodynamic interaction with its duplexed counterpart (603), we conclude that 3’ 
labeling of the miRNA weakened its thermodynamic interactions with the 5’ end of the 
passenger strand.  However, labeling the 5’ end of the passenger strand with the Iowa 
Black® RQ moiety likely sterically hinders Ago’s ability to load the passenger strand, 
placing its preference back on the 3’ labeled Alexa647 miR-7.  Following a 1 h incubation, 
we performed live cell single particle tracking of the injected cells and co-tracked the 
fluorescent miRNA with the mRNA.  While the majority of the observable interactions 
between the two particles were relatively stationary, and extensive (Figure 4.3D), we were 
able to capture highly mobile interacting particles (Figure 4.3E, bottom panes).  Injecting 
Cy5-body labeled FLuc with 11 miR-7 MRE with Cy3 labeled miR-7 also revealed 
extensive colocalization between the two fluorophore in fixed U2OS cells (Figure 4.5).  
Collectively, all three labeling strategies are adequate for in cellulo single-molecule 
fluorescent microscopy assays, with the caveat that the body labeled approach is viable 
only for noncoding RNA.  
 
4.3.3  Fluorescent RNA behaviors are largely indistinguishable from degradants 
and Cy5-UTP  
209 
 
Previous reports have demonstrated that some intracellular labeling techniques can 
inhibit RNA degradation, thereby misrepresenting the RNA behaviors under assessment 
(604).  To test if our fluorescent, BBT modified FLuc mRNA – no MRE – are 
distinguishable from degraded RNA, we RNase treated (Figure 4.6A), purified and 
microinjected degraded RNA into U2OS cells.  Cells were fixed 0 or 2 h post-injection and 
the remaining fluorescent foci were counted (Figure 4.6B).  To our surprise, the number 
of fluorescent foci stayed fairly consistent between the two time-points, suggesting that a 
degraded RNA has a long half-life (Figure 4.6C).  Since BBT modification inserts 
consecutive modified azido modified nucleosides into the RNA chain, it is possible that 
the cell has difficulty processing this region into individual monomers.  To understand if 
this is a phenomenon exclusive to labeled polymers we injected Cy5-UTP into U2OS cells 
and assessed the change in particle number at 0 and 4 h post-injection (Figure 4.6D & 
E).  Once again, a large number of foci were observed by comparison to control, with a 
half-life on the order of 4 h.  Using stepwise photobleaching analysis, it was clear that 
single (monomer) and multiple (multimer) (multimer) photobleaching steps were observed 
(Figure 4.6D), indicating that these units are sequestered or aggregated inside the cell.   
This suggests that we will be less likely to differentiate degraded from intact by intensity 
or aggregation status, alone.  To assess the decay rate of an intact fluorescent BBT 
modified RNA, we injected FLuc coding genes, with and without 6 miR-21 MRE, into wild-
type mouse primary mesangial cells (PMC WT) and measured the change in particle 
number over 0, 1, 2, 4, 8, and 12 h post-injection.  FLuc mRNA without miR-21 MRE, 
remain relatively unchanged over a 12 h period, while the miR-21 MRE containing gene 
decayed with a half-life close to 4 h (Figure 4.6F).  Considering the FLuc mRNA with 6  
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Figure 4.4:  3’ fluorescently labeled miRNA will repress a luciferase reporter in cellulo.  (A) Gel 
electrophoretic mobility shift assay of injection solutions containing 0.1 M single-stranded (ss) or 
duplexed (ds) Cy3-miR-7 with varying concentrations of Cy5-body labeled mRNA.  The 15% non-
denaturing PAGE gel is scanned for Cy5 (red, left pane) and Cy3 (green, middle pane) and 
overlaid to indicate instances of gel shift of the miRNA (green).  Cy5-body labeled mRNA was 
added to a concentration of 0.1 M (lane 2 and 5), 0.01 M (lane 1 and 3), 0.001 M (Lane 4), 
and 0 M (lane 6).  Smearing was only observed when miR-7 is not duplexed with its passenger 
strand (ss-miR-7).  (B) Labeling strategies and sequences of purchased miR-7 RNA.  (C) 
Luciferase response of dual luciferase reporter plasmid, with FLuc containing 11 miR-7 MRE, co-
transfected in with 100 nM of total duplexed miR-7.  Proportions of the 100 nM duplexed miR-7 
were replaced with 3’ fluorescently labeled miR-7 containing either unlabeled passenger strand 
(dark grey bars) or 5’ Iowa Black® RQ labeled passenger strand.  Dose dependent miR-7 
repression is observed for labeled miR-7 duplexed with dark passenger strand.  Duplexing the 
fluorescent miR-7 with 5’ Iowa Black® labeled passenger strand reverses this finding. 
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Figure 4.5: Fixed cell analysis of Microinjected Cy5-body labeled FLuc RNA, containing 11 miR-
7 MRE, and 3’ labeled Cy3-miR-7 guide strand duplexed with 5’ Iowa Black® RQ labeled 
passenger strand.  Colocalization between the mRNA (red) and miRNA (green) is indicated by 
yellow arrows.  Cascade Blue 10 kDa Dextran is used as a cell injection marker to identify treated 
cells.   
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RNA Labeling Scheme 
  
Body Labeled BBT Modified Tail Modified 
Fast Population Diffusion 
Coefficient 
NA 
0.917 m2/s 
(0.664 m2/s) 
1.03 m2/s  
(1.32 m2/s) 
Fast Population AUC NA 0.075 (0.078) 0.062 (0.038) 
Slow Population Diffusion 
Coefficient 
NA 
0.108 m2/s 
(0.0787 m2/s) 
0.124 m2/s 
(0.126 m2/s) 
Slow Population AUC NA 0.17 (0.17) 0.18 (0.21) 
 
Table 4.1:  Calculated diffusion parameters for each labeling strategy.  Adjusting only CNTP 
input or incubation time, the estimated quantities or times required to achieve 5 labels per RNA 
using standard incubation conditions.  Normalized yields are calculated based on final 
concentrations of each RNA following CNTP modification and purification, relative to unmodified 
control.  In vitro translation output is calculated as the FLuc protein band intensity for the 
labeled, from rabbit reticulocyte extract, normalized to unlabeled control.  Average MSD 
calculated diffusion coefficients for the slow and fast populations, and the areas under the curve 
for each distribution, with (brackets) or without co-injected miR-7.   
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Figure 4.6: Cy5-UTP and partially digested RNA half-lives are close to 4 h.  (A) 1.2% denaturing 
(1 M Urea) agarose gel of Alexa 647 BBT modified FLuc RNA before (lane 1) and after (lane 2) 
RNase A treatment (lane 2).  Promega RNA Markers ladder denotes the RNA fragment size is 
<281 nt, considering the approximate molecular weight cutoff in the MegaClear kit, suggests the 
fragment is greater than 200 nt (lane 3).  (B) Representative z-stack images of U2OS cells 
microinjected with the RNase treated Alexa 647 labeled, BBT modified FLuc RNA immediately – 
0 h – and 2 h post-injection.  (C) Bar graphs of the ratio of degraded RNA particle number to bead 
number at 0 h or 2 h post-injection in HeLa cells (n = 3 per timepoint).  (D) Representative images 
of Cy5-UTP, or no-NTP control, injected U2OS cells, fixed 0 or 4 h post-injection.  Graphs at the 
right represent representative traces of single (monomers) or multiple (multimers) photobleaching 
events of fluorescent particles for each of the representative images.  The x-axis represents the 
frame number of the image and the y-axis is intensity in arbitrary units.  Purple line is the 
background subtracted intensity trace of the particle of interest.  The black line is a Chung-
Kennedy filter to help guide the eye to see photobleaching events.  (E) Bar graph of the number 
of single step (monomer) or multistep (multimer) photobleaching events for identified Cy5 – 
identified particles in Cy5 – UTP, or no-NTP control, microinjected UTP cells, as described 
elsewhere (594).  (F) PMC WT cells microinjected with Alexa 647 labeled, BBT modified FLuc 
RNA with or without 6 miR-21 MRE.  Cells were fixed at either 0, 1, 2, 4, 8, or 12 h post-injection 
and z-stack imaged to identify both FLuc particles and FluoSphere beads (internal standard).  
Ratios of Particle to bead number are plotted against time. 
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Figure 4.7:  Degraded RNA diffusion coefficients are indistinguishable from FLuc pseudogene 
and coding genes.  (A) Representative images of U2OS cells co-injected with Alexa 647 labeled 
degraded RNA (middle pane) and Alexa 555 labeled pseudogene (bottom pane).  Injected cells 
and boundaries were detected by Cascade Blue labeled 10 kDa dextran (top pane).  (B) 
Histogram plots of diffusion coefficients from n = 6 cells, fitted (blue line) into two 
subpopulations: fast (green, pseudogene: 64%, degraded: 64%) and slow (red, pseudogene: 
46%, degraded: 46%).  (C) Histogram plots of diffusion coefficients of Alexa 647 labeled from n 
= 6 cells, fitted (blue line) into two subpopulations: fast (green, coding gene: 63%, pseudogene: 
59%) and slow (red, coding gene: 37%, pseudogene: 41%).   
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miR-21 sites decay at a similar rate to injected Cy5-UTP, it is unclear if the rate limiting 
step is RNA destabilization or fluorophore clearance from the cell.  Therefore, there are 
hurdles to overcome for the fixed cell particle counting of microinjected fluorescent RNA 
to be used to measure changes in rates of decay of mRNA. 
 Since degraded RNA can persist in the cell for over 2 h, we next tested if we can 
differentiate their movement behaviors from intact RNA in live cells to understand how to 
interpret the single-particle tracking component of our analysis.  To do this, I injected 
Alexa 555, BBT modified FLuc pseudogene, no MRE, and Alexa 647 degraded RNA co-
injected into U2OS cells and imaged their movement behaviors 5 h post-injection (Figure 
4.7A).  On average, there were 43% more trackable pseudogene (~ 800 particles per cell) 
than degradant particles.  The distributions of MSD calculated diffusion coefficients 
(Figure 4.7B) of trackable particles were broadly fit with two movement populations: slow 
(red) and fast (green).  Comparing the two datasets, there is little discernable difference 
in the average diffusion coefficients for either population (1.5 and 0.2 m2/ s) nor the areas 
under each curve (slow: 47% and fast: 63%).  Considering pseudogenes may be rapidly 
degraded due to their non-protein coding status, next we co-injected Alexa 555 labeled 
coding gene with Alexa 647 labeled pseudogene – both without MRE – into U2OS cells 
and compared their diffusion coefficients (Figure 4.7C).  Same as above, the diffusion 
coefficients of each of the RNA populations can be broadly fit to two subpopulations.  
While the coding gene diffused slightly slower for both populations (coding: 2.0 & 0.25 
m2/ s, pseudo: 1.61 & 0.16 m2/ s), the overall shape of the distribution and areas under 
each curve (coding: 37% (slow) & 59% (fast), pseudo: 41% (slow) & 59% (fast)) are 
largely similar.  This suggests that distinguishing between degraded and intact RNA from 
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the diffusion coefficients alone will be extraordinarily difficult.  Likely more work will need 
to be done to tease out the differences between the two.   
 
4.4  DISCUSSION 
 
Exploiting the functionally relevant yPAP labeling strategies from Chapter 3, BBT and tail 
fluorescently labeled FLuc mRNA were intracellularly introduced via microinjection with 
and assessed in real-time for their trackability in both a single- and dual-color iSHiRLoC 
approach.  Using fluorescent BBT and Tail modified FLuc mRNAs bearing 11 miR-7 
MREs, labeled with either 9 (BBT) or 5 (Tail) Alexa-647 dyes, we were able to collect an 
average of 200 trajectories for an average of 2 s (100 ms / frame).  This is significantly 
improved over singly-fluorescently labeled RNA molecules (504), where we used similar 
imaging conditions.  Furthermore, these labeling strategies, coupled with microinjection, 
show clear signs of improvement for single particle analysis over the popular MS2 labeling 
system (209).  Specifically, our method overcomes the need for large quantities of 
background contributed by the free-diffusing fluorescent MS2 coat protein, making our 
RNA more easily identifiable and trackable.   
From the MSD calculated diffusion coefficient histograms, we can identify two 
major diffusing populations (Figure 4.7A), slow and fast, the averages and areas of each 
distribution were largely similar between both labeling strategies (Table 4.1), and those 
observed previously (602).  Interestingly, despite observing a miR-7 dependent co-
tracking with DCP1a-EGFP labeled p-bodies, the presence of unlabeled miR-7 had little 
impact on the average diffusion coefficient for each population and their respective areas 
(Table 4.1).  This suggests that either miRNA engages its targets with low probability, or 
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that sequestration of multiple fluorescent mRNA into only a few p-bodies, by comparison 
to the large pool of diffusing RNA, renders the illusion that the diffusion coefficients of the 
RNA are relatively unchanged.  Although considering we found little differences between 
the diffusing behaviors of degraded and intact RNA (Figure 4.7), an alternative hypothesis 
is that the RNAs are largely degraded and the coalesced distributions render the 
biologically relevant features hidden.  This is especially likely as fluorescent degradants 
and CNTP demonstrated slow cellular excretion (t½ > 4 h) (Figure 4.6).  However, these 
issues are not unique to our system as other more established labeling methods have 
been associated with similar caveats (604). 
 Despite the difficulties with interpreting the diffusional characteristics of an entire 
population of injected fluorescence RNA, an alternative approach is to monitor only those 
that are co-tracked with relevant biomolecules.  Thus the power of these labeling 
strategies comes from the dynamic interactions of yPAP fluorescently labeled mRNA with 
fluorescent p-bodies and miR-7 in real-time.  In one instance, a microinjected FLuc mRNA 
bearing 11 miR-7 MRE was found colocalized with the P-Body marker for 0.4 sec (4 
frames) prior to escaping its terminable fate and diffusing, presumably, back into the 
translational pool (Figure 4.3E, top pane).  This observation was, to the best of our 
knowledge, only captured once before via ensemble fluorescence microscopy 
approaches, where U1A-GFP labeled PGK1 mRNAs escaped p-bodies, in mass, 5 min 
after the re-addition of glucose following starvation (605).  In addition, we were able to 
observe highly mobile mRNAs with 11 miR-7 MRE co-tracking with fluorescent miRNA in 
cellulo (Figure 4.7E, bottom panes), an observation that was not achieved before.  Taken 
together, both of these yPAP approaches can provide real-time, mechanistic insights 
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about the RISC pathway.  Data from these assays are expected to reveal the stochasticity 
of these interactions, how they change under various cellular conditions, and ultimately 
model these findings using systems biology approaches to predict gene regulatory 
outcomes.   
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Chapter V 
 
Gene-Actin Tethered Intracellular Co-tracking Assay (GATICA) 
 
5.1 Introduction 
As has been discussed in great detail earlier in this thesis (Chapter 1.2.2), Argonaute 
bound microRNA serves as a recognition motif to bind its complementary (partially and 
completely) RNA target to regulate gene expression post-transcriptionally (136, 149-151).  
Considering the thermodynamic properties of an 8 nucleotide (nt) miRNA: mRNA 
interaction alone – without Argonaute protein – the extent of interaction should be 
implicitly weak and hypothetically should only associate for a short period of time (606-
608).  Yet, a recent in vitro single-molecule fluorescence microscopy study demonstrated, 
that intrinsic properties of the Argonaute protein help to optimize the fundamental 
properties of canonical RNA: RNA binding to that of a typical protein: RNA interaction 
(609).  More specifically, they measured a microRNA loaded mouse Ago2 to be bound 
on its target for ~ 5 min.  Furthermore, they measured the seed matched target to bind 
the Ago2 loaded miRNA with a Kd ~ 19,000 times tighter and dissociate ~ 360 times 
slower than if the miRNA was without Argonaute (609).  This study was pivotal in shaping 
our understanding of the mechanism of RISC binding to the target RNA, however, it was 
performed outside the crowded intracellular environment and without competition from 
other endogenous interacting partners, all which may have a profound impact on the true 
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dissociation constant.  Thus a nice compliment to this story would be to conduct a similar 
experiment in cellulo. 
Within the last decade, a variety of single-molecule fluorescence microscopy 
techniques have been used to understand the mechanisms and measure the rates of 
protein folding (610), transcription (611), and, more recently, translation (509, 612) within 
a cellular context.  In most cases, the rate of the process under investigation occur at 
rates that are significantly slower that the rate of diffusion of the complex (509, 612).  
Thus, creative means were employed to study the comparatively slow kinetic processes.  
One notable example, the rate of translation was observed by encoding the RNA being 
investigated with an endoplasmic reticulum localization sequence, thereby rendering the 
molecule stationary within the viewing window for the duration of the analysis (509, 612).  
Thus, to study the intracellular binding kinetics of a target with RISC, we will also require 
the target molecule to be tethered within the cell as the diffusion coefficient of the RNA is 
substantially faster (see Chapter 4) than the in vitro measured association tine (~ 5 min) 
(609). 
Actin is a highly abundant cellular protein that will polymerize into 7 nm diameter 
filaments, which can extend up to several micrometers in length, concentrated at the 
periphery of the cell near the plasma membrane (613).  Through the association of 
spectrin and ankyrin, the actin polymer is anchored to the plasma membrane (613).  Thus 
the actin cytoskeletal network represents a platform from which RNA targets can be 
tethered for long-term analysis and at a distance where we can employ near-total internal 
reflection fluorescence (TIRF) microscopy; thus minimizing the noise from background 
particles and photobleaching the pool of Ago-bound fluorescent miRNA.  Phalloidins are 
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a class of molecule known to bind actin filaments tightly (KD ~ 2 x 10-8 M (614, 615)) and 
prevent their depolymerization.  Biotinylated phalloidin have been used elsewhere to 
visualize the actin network using fluorescent streptavidin protein (616), representing a 
unique system for tethering our target RNA.  Another potential strategy is to use 
biotinylated actin protein to sequester streptavidin bound biotinylated fluorescent RNA 
target.  Through the use of microinjection technology, these pre-assembled complexes 
can be co-injected into cells with their cognate fluorescent miRNA duplex to visualize the 
kinetics of their interactions in a cellular context (Figure 1A).   
Herein, I systematically optimize and test both tethering strategies for the long-
term visualization of streptavidin bound, biotinylated and fluorescently labeled RNA 
target.  We will observe that through the use of biotinylated actin, co-injected with 
fluorescent phalloidin is the best strategy for the long-term visualization of particle 
interactions in cellulo.   
 
5.2 MATERIALS & METHODS 
5.2.1 Biotinylation of pseudogene RNA target 
FLuc pseudogene, bearing no site or 1 perfectly complementary miR-21 MRE, was co-
transcriptionally labeled (body labeling described in Chapter 2) with Cy5-UTP and 
subsequently capped and poly(A)tailed as described elsewhere (Chapter 2).  Capped and 
tailed RNA was then 3’ biotinylated using the Pierce RNA 3’ End Biotinylation Kit (Pierce, 
Cat# 20160).  Ligation of the target RNA with biotinylated cytidine (bis)phosphate was 
performed per kit instructions.  The extent of biotinylation was determined by measuring 
the amount of RNA bound by Dynabeads® MyOne™ Streptavidin C1 beads (Invitrogen, 
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Cat# 65001).  To achieve this, 50 L of Dynabeads were incubated with 6.5 g of 
biotinylated and non-biotinylated RNA for 20 minutes.  RNA adhered beads were washed 
twice using 100 L of binding solution and eventually removed from the bead surface 
using 50 L of milliQ H2O.  RNA concentrations were assessed at each washing step and 
following elution from the beads.  From UV-Vis analysis, only 20% of the total RNA pool 
was calculated to be biotinylated.   
 
5.2.2  Injection solutions 
Biotinylated (ThermoFisher Scientific, Cat# B7474) and Alexa 488 Phalloidin 
(ThermoFisher Scientific, Cat# A12379) were dissolved in methanol to a final 
concentration of 20 M and stored at -20 oC until further use.  Streptavidin powder was 
dissolved to a final concentration of 1 mg/mL in ddHO and stored frozen until use.  In the 
instance that miR-21 was co-injected, both 15 M passenger and 10 M guide strands 
were heat annealed from 90 oC to room temperature in 1x PBS.  First, 1.5 L of 
biotinylated Phalloidin was diluted in the appropriate amount of water (up to 30 L), 1 uL 
of 10 mg/mL Cascade Blue Dextran – injection marker – and 3 uL of 10x PBS.  
Streptavidin – phalloidin mixture was allowed to sit for 10 minutes to ensure adequate 
binding of the Phalloidin probe to the streptavidin protein.  In some cases, 1.5 uL of 20 
M Alexa 488 phalloidin was added to the cocktail mixture followed by 1.5 uL of 10 M 
Cy3 miR-21.  Lastly, 3 uL of 10 nM biotinylated FLuc pseudogene, bearing no or 1 
perfectly complementary miR-21 MRE, was added to the mixture.  Complexed samples 
were next spin filtered (0.22 m pore size) to remove any aggregates that may clog the 
microinjector capillary.  The mixture then sat on ice until the time of microinjection. 
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 Biotinylated-actin tethered RNA injection solutions were assembled similarly, 
with exception that the biotinylated Phalloidin was replaced by 3 uL of 10 M biotin actin 
protein.  Stock biotinylated actin protein (Cytoskeleton Inc., Cat# AB07-A) was dissolved 
in 5 mM Tris-HCl pH 7.8 with 0.2 mM CaCl2, 0.2 mM ATP and 0.5 mM DDT (to prevent 
polymerization and aggregation) to a final concentration of 10 M.  Protein is aliquoted 
into 4 uL samples and snap frozen using liquid nitrogen. 
 
5.2.3 Microinjection and imaging 
Injection mixtures (described above) were microinjected onto Delta T plated U2OS or 
mouse primary mesangial cells, knocked out for miR-21 (PMC KO).  Prior to injection, 
cells were washed twice and immersed with HBS imaging media.  Injected cells were 
either imaged immediately following microinjection (~ 0 to 30 min) or 2 h post-injection.  
Cells were identified by their Cascade Blue 10 kDa dextran injection marker signature.  
Once identified, samples were imaged at 100 ms acquisition rate for 100 or 150 frames.  
Most particles photobleached rapidly within the first 10 frames.  Fluorophores were 
excited using HiLo microscopy, with penetration depths of approximately 100 nm.  All 
microscope, cell culture, microinjection and particle tracking parameters were described 
in previous chapters.   
 
5.3 RESULTS 
5.3.1   Phalloidin tethered biotinylated and fluorescent RNA 
To study the intracellular binding kinetics of RISC to its target RNA, we chose to tether 
the target molecule onto the actin network (Figure 5.1A).  Biotinylated phalloidin (Figure 
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5.1B) is predicted to bind the actin network with a Kd of ~ 2 x 10-8 M (614, 615), which 
assumes that a tethered complex will reside for ~ 20 min, or 4x the average residence 
time of a RISC bound RNA target.  Pre-complexing streptavidin with biotinylated 
phalloidin and biotinylated fluorescent RNA the phalloidin molecule can be used to anchor 
the streptavidin bound RNA onto the actin fibril, rendering it immobilized for imaging.  To 
identify those molecules that are tethered and those that are non-specifically bound, we 
will also co-inject a fluorescent phalloidin to illuminate the actin network.  Thus, our 
analysis should be limited to those molecules that colocalized with the Alexa 488 bound 
actin fibrils (Figure 5.1C).   
 To test if our RNA can be tethered to the actin surface, pre-complexed 
biotinylated and Cy5 body labeled RNA, biotinylated-phalloidin and streptavidin were 
mixed with Alexa 488-phalloidin, cascade blue 10 kDa dextran – cell injection marker -- 
in 1x PBS and microinjected into PMC KO.  Immediately following microinjection (~0 to 
30 min), PMC KO were imaged at a penetration depth of 100 nm using HiLo microscopy 
(Figure 5.2A).  Foci were found to be randomly localized throughout the cell (Figure 5.2A), 
regardless if streptavidin was added to the injection mixture.  In the presence of 
streptavidin, the RNA appear to colocalized with the actin network (Figure 5.2A, top 
panes) where as in its absence, the RNA were found more interspersed between the actin 
fibrils (Figure 5.2A, bottom panes).  Using single particle tracking, the diffusion 
coefficients for each trackable fluorescent particle within the cell were calculated and 
plotted as either a histogram (Figure 5.2B) or as a cumulative distribution plot (Figure 
5.2C).  Both plots reveal a shift towards slower diffusion, although not to the extent – 
number of particles and rate of diffusion – that we were anticipating.  
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Figure 5.1: Gene-Actin Tethered Intracellular Co-tracking Assay (GATICA) design. (A) cartoon 
diagram of GATICA assay design.  Adherent cells are microinjected with a solution comprising of 
biotinylated-phalloidin and biotinylated fluorescent RNA coupled streptavidin complex.  The 
phalloidin molecule is designed to anchor the streptavidin bound fluorescent RNA to permit long-
term viewing of the complex. (B) Chemical structure of the phalloidin molecule modified with a 
biotin linker.  (C) Representative image of Alexa 488 labeled phalloidin, microinjected into U2OS 
cells.  Long actin polymer strands are easily visualized for colocalization purposes.   
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Figure 5.2:  Fluorescent RNA are tethered in a streptavidin dependent manner.  (A) PMC KO cells injected 
with Alexa 488-phalloidin actin marker (green), biotinylated phalloidin, and Alexa-647 labeled RNA – 1 
perfectly complementary MRE for miR-21 (red) – in the presence (top panes) or absence (bottom panes) 
of streptavidin.  Yellow box is used to demark the location of the magnified region for additional clarity 
on colocalization.  Extensive colocaliztion between actin and RNA were observed only in the presence or 
absence of streptavidin.  (B) Histogram plot of the log of MSD calculated diffusion coefficients of all 
trackable particles in A with (blue) or without (red) streptavidin.  A shift towards slower diffusing particles 
is observed in the presence of streptavidin.  (C) Cumulative distribution plot of the data from B to more 
clearly demonstrate a global shift towards slower diffusion in the presence of streptaviding (blue) than 
without (red).   
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Next, I sought to discover if fluorescent miRNA would associate with tethered RNA 
targets in PMC cells.  Thus, rerepeating the same experiment as above, only including 
Cy3 labeled miR-21 in place of Alexa 488 phalloidin, we observed seldom co-tracking 
events between the miRNA and the target RNA (Figure 5.3A).  Not only were these 
particles seldom observed to co-track with its RNA target, but the miRNA also did not 
extensively colocalize with the actin network, visualized by Alexa 488 phalloidin, when 
biotinylated, non-fluorescent –dark – target RNA was complexed to the streptavidin bound 
phalloidin molecule (Figure 5.3B).  This suggests that while we do observe Cy5 body 
labeled target RNA associating with the actin filaments, it may be difficult to capture 
colocalization events for targets bearing only a single miR-21 siRNA binding site.  
Perhaps this is a function of the complex and the means in which it is tethered, thus we 
attempted a second strategy.   
 
5.3.2  Biotinylated-actin tethered target RNA 
To improve upon the particle behaviors as observed with the phalloidin tethering strategy 
– more slow diffusing particles, slower diffusion coefficients, better target engagement, 
distinguishing specific from non-specific binding events, etc. – we next attempted a 
slightly different strategy: tether to biotinylated actin.  This approach has the added 
advantage of avoiding the toxicity associated with phalloidin.  Samples were pre-
complexed in similar fashion as the phalloidin tethering system, although supplanting 
biotin-phalloidin with biotin-actin protein.  Microinjected complex spatially appeared very 
similar to that of the phalloidin complex.  Thus, at a glance, it is still challenging to identify 
RNA particles that were inserted into fibrils and those that were un-complexed (Figure 
5.3A, top panes).  Furthermore, histogram (Figure 5.3B) and cumulative distribution plots 
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(Figure 5.3C) of the diffusion coefficients, calculated from MSD plots of the trajectories of 
trackable particles, did diffuse slower that those particles in the absence of streptavidin.  
However, they were noticeably faster than those particles tethered with phalloidin.  
Considering that cellular concentrations of actin are > 50 M in mammalian cells, of which 
only 60 – 65% are found to be polymerized (617), suggests that possibly only a small 
fraction of our microinjected actin-complexed target RNA are incorporated into the actin 
fibrils. 
 To facilitate polymerization, we next attempted to co-inject our biotinylated-actin 
tethered RNA with Alexa 488 phalloidin (Figure 5.4A, bottom panes).  The purpose of this 
was two-fold: (a) to enhance polymerization of the actin fibrils thereby improving the 
extent of incorporation of the complex into the polymer and (b) to facilitate the analysis 
by fluorescently labeling the actin network to help identify only those particles that are 
colocalized with the Alexa 488 labeled actin network.  What was observed was a stark 
difference in the localization pattern of the complexed RNA particles.  Qualitatively, a 
large fraction of these fluorescent particles were observed at the leading edge of the cell 
(Figure 5.4A) suggesting that these particles are being transported to the + end of the 
fibril strand for their eventual incorporation into the fibril network.  This localization 
phenomenon makes discovering intact from disengaged particles significantly easier due 
to changes in their movement behaviors.  Those that are disengaged or degraded will no 
longer sequester to the leading edge of the cell, thus diffusing away from the analysis 
window.  Quantifying these phenomena can provide insights into the extent of the RNA 
bound versus unbound, adding additional value to the overall experiment. 
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5.4  DISCUSSION 
 
The data herein present a scenario where biotinylated and fluorescently labeled RNA can 
be microinjected and tethered to the actin network through one or two possible methods: 
biotinylated Phalloidin or biotinylated actin protein.  In either instance, the RNA was 
proven to be more slowly diffusing when the streptavidin was present to complex the 
tethering agent with the fluorescent and biotinylated target RNA.  The phalloidin tethering 
system appeared superior to the actin system for slowing the diffusion rate of the target 
RNA, although was met with challenges associated with the clearly distinguishing specific 
from non-specific tethering events or from degradant or autofluorescent cellular 
components.  Furthermore, the phalloidin system did not demonstrate many instances 
where tethered target RNA were clearly colocalized with fluorescent miRNA.  However, it 
was often a challenge to distinguish the Cy3-miR-21 from background particles.  
Furthermore, we did not juxtapose this data to an untethered – streptavidin free – 
instances.  So we cannot accurately conclude that the lack of miRNA engagement is 
clearly a result of the tethering system or some other anomaly.  We do know, however, 
that transfecting the plasmid containing the FLuc gene bearing 1 perfectly complementary 
miR-21 MRE – siRNA behavior – elicits a robust repression signature (Chapter 3).  Thus, 
these RNA should engage and repress the target RNA. 
 Despite the merits of the phalloidin system, biotinylated actin tethering system 
proved superior to the phalloidin in that tethered RNA were clearly identifiable through 
their movement characteristics and localization patterns.  G-actin – ATP bound and un-
polymerized – is known to be actively transport to the leading edge of a cell to help 
facilitate locomotion of the cell (618).  Thus, qualitatively, explaining the numerous  
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Figure 5.3:  Fluorescent miRNA seldomly are found associated with tethered RNA target.  (A) PMC KO cells 
injected with Alexa 647 & biotinylated target RNA (red) – 1 perfecty complementary miR-21 MRE – and 
Cy3-miR-21 (green).  Yellow box indicates the location of the magnified image (zoom).  While a 
cololcalization event was observed (yellow arrow), this is not a common occurance.  (B) PMC KO cells 
injected with unlabeld biotinylated RNA, biotinylated phalloidin and streptavidin complex in the presence 
of Cy3 miR-21 (green) and Alexa 488 phalloidin (blue, actin marker).  Yellow box represents the location 
of the magnified image (zoom).   
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Figure 5.4: Biotinylated-actin diffuse more rapidly than phalloidin tethered target RNA.  (A) 
Representative images of biotinylated-actin tethered, streptavidin bound fluorescent RNA microinjected 
into U2OS cells with and without Alexa 488 phalloidin.  Presence of phalloidin causes an increase of actin-
complexed RNA to concentrate at the leading edge of the cell (yellow arrows).  (B) Histogram plot of the 
MSD calculated diffusion coefficients of biotinylated-actin tethered RNA in the absence of Alexa 488 
phalloidin.  In the absence of phalloidin, biotinylated actin complexed target RNA (green) diffuse more 
rapidly than phalloidin tethered (blue) molecules, but more slowly than in the absence of streptavidin 
(red).  (C) Cumulative distribution plot of diffusion coefficients from B.  Phaloidin tethered RNA (blue) 
travel the slowest, followed by actin tethered (green) and, lastly, untethered RNA.   
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instances where directed motion of the RNA particles is observed.  This finding is further 
enhanced upon the addition of phalloidin.  This presents a clear advantage over the 
phalloidin system in that the RNA that are properly complexed with biotinylated actin have 
significantly altered movement behaviors and are sequestered furthest from the peri-
nuclear autofluorescent cellular components.  Most importantly, these particles are 
concentrated into regions of the cell that are the flattest, largely preventing them from 
diffusing out of focus – Z-axis – increasing their residence time within the analysis window.   
 While each of the above tethering systems have promising features, they are 
not without caveat.  Firstly, a significant and unknown source of background fluorescence 
is observed on the dish surface that are particularly apparent when illuminated with the 
532 nm laser.  It is unclear if these are dust, cellular debris or other anomalous particles 
or if these are fluorescent miR-21 particles emanating from the micropipettor tip, as a 
result of the compensation pressure, that non-specifically adhere to the surface of the 
plate.  Regardless of its source, a solution is required to better tease out relevant from 
the debris particles.  Next, I was only able to successfully biotinylated 20% of the Cy5 
body-labeled pseudogene.  This likely was a major contributing factor to the modest 
change in stationary particles observed in the above assays.  Lastly, the RNA 
photobleach quite rapidly (~ 2 s) thus imaging parameters need and extent of labeling 
need to be optimized in order to sufficiently detect the RNA-RNA association and 
dissociation kinetics for processes that take long periods of time.  However, while not 
trivial issues, once overcome can provide a wealth of information about cellular dynamics 
for virtually any process, particularly those slower than the rate of diffusion.  Furthermore, 
235 
 
this system is applicable to any biomolecule capable of being biotinylated and streptavidin 
bound in vitro/ ex vivo.     
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Chapter VI 
Summary and Future Outlook 
6.1  SUMMARY 
microRNAs (miRNA or miR) represent a unique subset of small RNA molecules that are 
wielded by the RNA induced silencing complex (RISC) as a guide to seek targets bearing 
complementary (complete and partial) sequences (131).  RISC recruitment to the RNA 
target will initiate post-transcriptional gene silencing through translation initiation inhibition 
and/ or RNA destabilization (136, 149-151).  Taking into consideration that highly 
conserved miRNA has been shown to have hundreds conserved targets (444, 619), and 
a single target molecule can possess, on average, 7 microRNA response elements 
(MRE), for one or more miRNA, it is clear that miRNA mediated repression is a highly 
complex, cross-talking regulatory network (560, 575, 576).  Interestingly, there exist select 
transcripts, that when expressed in significant quantities can sequester particular miRNA 
away from its targetome pool, causing wide-spread derepression of select genes.  These 
RNA molecules fall into various classes of non-coding RNAs:  pseudogenes (183, 581-
585), lncRNAs (183, 586-593), and circular RNAs (circRNA) (160, 161).  Not only are 
these ceRNAs all non-coding, but the surprising number of discovered ceRNAs suggests 
that this may be a more common phenomenon than originally perceived.  Ultimately, the 
untimely change in expression in these ceRNAs have been implicated in the cause or 
persistence of select disease states (183, 587, 620, 621).   
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  In healthy liver tissue, my predecessor discovered reduced miR-21 target 
engagement and target destabilization relative to HeLa cells (496).  One potential 
hypothesis was that low molecular weight complexes, like non-coding RNA sponges, 
were serving as decoy targets and sequestering the miRNA away from relevant biological 
targets.  To test this hypothesis, we implemented and tested the functionality of 
fluorescently labeled target RNA and their corresponding miRNA, and tested their 
localization and spatiotemporal differences in primary and immortalized cancer cell lines 
using our in-house assay: intracellular single-molecule high-resolution localization and 
counting (iSHiRLoC) (136, 594).  While successful in our efforts to label functional RNA, 
we unveiled fluorophore dependent caveats that convoluted our data.  Yet throughout this 
document we observe clear signs of functionality that suggest select proportions of these 
molecules must function normally.  Thus, conducting two-colored fluorescence 
microscopy experiments and focusing only on those particles that interact, we can begin 
to tease out relevant populations from which key biological insights can be gathered.     
 Chapter 2 explores the movement behaviors of a fluorescent miR-21 molecule 
primary from cancer cell lines using our iSHiRLoC assay.  With the objective to test the 
hypothesis that miR-21 is primarily found on low-molecular weight complexes in primary 
versus cancer cell lines, microinjected miR-21 was expected to diffuse measurably slower 
in primary cells.  Yet, we discovered that the diffusion coefficients in both primary and 
cancer cell lines were comparatively similar.  Using ensemble luciferase repression 
assays, we discovered that FLuc reporter genes, bearing one or more MRE, were 
comparatively repressed in primary as cancer cells (Figure 2.8).  Thus, likely miR-21 poor 
target engagement is mouse liver specific and not a general property of primary cells.  In 
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addition, having discovered that less than 10% of the total miRNA population were found 
colocalized with p-bodies, we sought to characterize the remaining slowest moving 
population.  We discovered that a large fraction of the slowest microinjected miR-21 
particles colocalized with LAMP1-GFP – a lysosomal marker – foci in a RISC independent 
manner (Figure 2.7).  Microinjecting fluorescent dye into cells rendered the same pattern.  
Therefore, it is highly likely that these fluorescent miRNAs are degraded and the 
fluorophore is sequestered into the lysosomal compartment.  Thus degradant products 
likely convolute/ add noise, and thus influence the accuracy of the overall analysis. 
 Chapter 3 discusses the merits of two enzymatic methods used to strategically 
place fluorescent probes into one of three regions within a longRNA molecule (> 200 
nucleotides (nt)).  Here, yeast poly(A) polymerase incorporated (yPAP) 2’-Azido-2’-
deoxyadenosine-5’-triphosphate, and fluorescent DIBO alkyne clicked, were incorporated 
either between the body – includes the 5’ UTR, coding region, and 3’ UTR of the molecule 
– and the poly(A) tail (BBT) or throughout the poly(A) tail (Tail).  A second strategy 
employs a T7 RNA polymerase to incorporate Cyanine5-aminoallyluridine-5’-triphosphate 
throughout the body of the RNA molecule (Figure 3.5).  In short, yPAP labeling of an RNA, 
both BBT and tail strategies, was the only method that left the RNA still functional for 
protein coding and miRNA mediated repression (Figure 3.8).  Also important, BBT and 
Tail strategies were demonstrated to be efficient and high yielding.  Thus, both BBT and 
Tail fluorescently labeled Firefly Luciferase (FLuc) mRNA and pseudogenes were poised 
for success in our iSHiRLoC assay.  
 Chapter 4 uses the BBT and Tail modified approaches in a single-molecule 
capacity.  Through the real-time imaging and particle tracking portion of the iSHiRLoC 
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assay, microinjected BBT and Tail fluorescent FLuc mRNA are easily trackable and 
diffuse characteristically similar to what was observed elsewhere.  Furthermore, I 
demonstrate that sites of miRNA dependent degradation (processing bodies) co-track 
with fluorescent processing body marker – sites of miRNA dependent target 
destabilization – DCP1a-EGPF, only in the presence of the targeting miRNA.  
Additionally, these fluorescent target RNA were observed to colocalized with their 
fluorescent miRNA complement.  From these data we were able to demonstrate for the 
first time, to the best of our knowledge, real-time intracellular interactions between a 
single fluorescent RNA particle and P-Body or miRNA (Figure 4.3E), where we observe 
a mRNA disassociate from a p-body or a miRNA & its target move in tandem.  However, 
analyzing the entire population of injected fluorescent RNA diffusion behaviors, and rates 
of disappearance from the cell, were largely indistinguishable by comparison to injected, 
pre-degraded fluorescent RNA and Cy5-UTP (Figures 4.6 and 4.7).  This suggests that 
the persistence of degraded RNA can convolute the perceived behaviors of intact RNA 
during our analysis.  Yet, microinjected BBT and Tail modified RNA are functional, 
suggesting that with better controls we can identify the relevant populations from which 
we can make more accurate measurements on.  Thus, we were unable, as of yet, to test 
if non-coding targets are preferential miRNA sponging targets over their coding 
counterparts.   
 The relatively rapid rate of diffusion of long RNA in a cell make it challenging to 
measure association and dissociation kinetics of its interacting partners in real-time.  This 
is especially true for measuring the interaction kinetics of a RISC loaded miRNA with its 
target RNA target, as in vitro experiments suggest that these interactions can persist for 
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up to 5 minutes at a time (609).  Thus, Chapter 5 discusses a new method to tether an 
RNA molecule to the actin network for the purpose of maintaining the molecule’s identity 
within the cell for the duration of the analysis, thereby making it possible to measure 
association and dissociation kinetics in real time and in a cellular context.  Tethering 
requires the use of biotinylated fluorescent RNA and either biotinylated phalloidin (F-Actin 
inhibitor) or actin protein coupled by a streptavidin protein.  Biotinylated actin protein 
tethered RNA proved the most successful for future measurements as they have 
distinguishing characteristics that make identifying properly complexed particles easily 
recognizable.  Namely, the RNA will exhibit directed motion, will concentrate at the 
leading edge of the cell, and, once incorporated into F-Actin, will become stationary, a 
phenotype that is enhanced upon co-injecting either unmodified or fluorescent phalloidin.  
While no biological measurements were yet made using this technique, it is poised for 
success in assessing the RNA interactome in a cellular context. 
 Taken together, this body of work establishes and validates a method to label 
and a novel method to make measurements on long RNA with its interactome in a cellular 
context.  While caveats were discovered along the way, implementing two-colored 
fluorescence microscopy approaches biologically relevant populations were easily 
identified, from which single-molecule measurements can be developed. 
 
6.2  FUTURE OUTLOOK 
The advantage of single-molecule analysis is that it distills out subpopulations that would 
otherwise be averaged using ensemble approaches.  Yet, this is only an advantage in 
instances where there is great certainty that each subpopulation is biologically relevant 
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and not an artifact of the analysis or the method used to study the system.  Implementing 
proper controls is key to instill confidence in the fidelity of the molecule, its structure and 
behaviors.  In the case of intracellular single-molecule microscopy, this is especially 
necessary, albeit not trivial, given the complex and stochastic nature of the cellular 
environment; not to mention the background from autofluorescent endogenous biological 
molecules which can be difficult to distinguish from the bulk population (622).  To 
complicate matters further, select intracellular methods for delivery of fluorescent 
biomolecules, including microinjection, deposit – en masse – unprotected molecules into 
select cellular compartments.  These approaches, whilst necessary, can expose the 
delivered molecules to any number of atypical or asynchronous interactions with cellular 
components (623, 624) that would have otherwise never occurred if the molecule was 
made endogenously; biomolecule degradation is an example of this.  For molecules 
delivered via microinjection, we discover abnormally fast rates of degradation for 
displaced molecules like protein (625), plasmid DNA (626), and miRNA (data not yet 
published).  Again, microRNA, largely known to be extremely stable within cells (t ½ = 
119 h) (627), microinjected into cells appeared to be largely depleted from the cytoplasm 
– 4% remaining – 2 h following microinjection in U2OS cells under the conditions used in 
this thesis, a discovery by a prior lab mate.  While the data herein corroborate these 
findings, there are disparities between the number of fluorescent particles persisting 
within a cell following injection from of fluorescent passenger strand – data from a prior 
lab member – and from the experiments with injected fluorescent labeled guide strand, 
uncoupled dye, or Cy5-UTP – from my data – by ~3x; although these differences can be 
largely attributed by the chemical makeup of the injected material.  Thus careful 
242 
 
consideration and proper controls need to be implemented to ensure that one can tease 
out the resulting byproducts of these delivery systems.    
 Herein, we discovered numerous instances where degraded byproducts of 
fluorescent RNA had indiscernible behaviors to those molecules that were perceived to 
be injected intact.  Yet, throughout the thesis we discovered glimpses of hope as 
functional features stood out.  Specifically, we observed the cotracking of rapidly moving 
miRNA-mRNA pairs, and we saw miRNA dependent colocalization of mRNA with 
processing bodies, thus proving to be a promising, but convoluted, system.  Changes to 
the analysis or implementing better tools to identify intact vs. degraded should can extract 
the relevant information from the bulk population.   
 In the live cell imaging portion of my work, we were concerned largely with 
particles associating with lysosomal compartments and degraded RNA being 
indistinguishable from the bulk population.  To circumvent this issue, we can implement 
select methodologies/ technologies to identify, characterize and thus exclude select 
populations from the overall analysis.  Thus, one can use fluorescent organelle markers 
to identify and characterize the colocalized fluorescent particle behaviors and exclude 
them from the analysis.  An example of this might be to transduce cells with the LAMP1-
GFP marker, deselect those that colocalized with them from the analysis, and track only 
the particles of interest.  In instances where we are largely concerned with degraded RNA 
convoluting our particle tracking data, we can conduct an orthogonal fixed cell experiment 
testing for changes in the bulk population integrity using fluorescence in situ hybridization 
(FISH) (291, 292).  Probing the integrity of microinjected RNA over time can provide 
insights into selecting incubation periods for particle tracking experiments where the RNA 
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is largely still intact when assessing its movement behaviors.  To prevent off-target 
effects, we can also use select inhibitors to minimize instances where the fluorescent 
RNA might traverse non-endogenous pathways, asynchronous events, or prevent an 
entire subpopulation from convoluting the findings for other relevant systems.  
Alternatively, the slow diffusion of the degraded RNA and the compartmentalization of the 
dye may both be fluorophore related anomalies.  Thus, using alternative fluorescent dyes 
circumvent these anomalous/ off-target localization and diffusion behaviors (628); for 
example, using TAMRA-DIBO click reagent instead.   
 Current methods of delivering genetic materials into cells are typically performed 
through a variety of physical or chemical processes (629).  Of these, microinjection is the 
best selection for the well-controlled, efficient, and low-invasive delivery of genetic 
materials.  Yet despite the merits of microinjection, there are several challenges that are 
associated with the method: its laborious, requires substantial user training and can be 
poorly reproducible between users (630).  As a result, manual microinjection is a difficult 
technology to implement to comprehensively study a system across numerous time-
points, replicates, and sample types.  However, several groups are currently working on 
techniques that will automate the microinjection process to overcome these issues (631-
637).  In one instance a software was designed to identify cells using threshold-based 
imaging with bright-field microscopy, from which well-defined injection points, based on 
the cellular contour, were selected for injection (637).  This platform identified 87% of the 
cells to be injected and of those, 67.5% were successfully injected.  In another example, 
the authors use a microfluidic chip to pattern the cells into an easy to inject and visualize 
array (636).  Here, the authors were able trap 97.5% of viable and adherent cells onto 
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their microfluidic device and 80% of which were efficiently injected.  Taken together, 
technologies are becoming available to make microinjection a more practical resource for 
delivering genetic material in a more high-throughput manner. 
 Even more exciting, additional technologies are becoming available to the 
single-molecule fluorescent microscopist to improve throughput and instrument 
availability (638-640).  Most notably is the miniaturization of the microscope (641), largely 
eliminating the need for scientists to set aside large rooms or build core facilities to house 
these technologies, thus making them a cost effective tool.  Aside from the cost benefits, 
there is also time-consumption benefits as there can be more microscopes per user.  This 
is especially beneficial for those of us who work with cells, as we the challenge of timing 
microscope availability with the cell confluency.  Thus, the advent of cheaper options will 
foster single-molecule science through ease of use and accessibility.   
 With over 80,000 distinct non-coding RNAs having been identified, most of 
whom have yet to be characterized structurally and functionally, there is a great need for 
intracellular tools to probe their structure activity relationships within the cellular arena.  
Implementing the suggested controls can provide a clearer interpretation of the actual 
behavioral events that our microinjected fluorescent RNA undergo.  Additionally, through 
the use of the aforementioned high-throughput methods to microinject and image the 
cellular samples, we can more rapidly and extensively understand the intracellular RNA 
landscape.  The biochemical and biophysical parameters of the acquired data will 
contribute to our ability to understand, predict, treat, cure and even prevent human 
disease.   
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